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QUILL ON SCALPEL
This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

In spite of the introduction and progres
sive refinement of chemotherapy over the
past 40 years, tuberculosis continues to
present a problem, particularly in large
American and Canadian cities. The
Center for Disease Control of the United
States Public Health Service predicts that
tuberculosis will not be eradicated before
the year 2100 and draws attention to the
large number of infected individuals,
identified only by a positive skin test,
who carry a lifelong risk of tuberculous
breakdown.1 Emigration of people from
countries of high prevalence is undoubt
edly partly responsible for persistence of
the disease, but another factor is the loss
of interest on the part of both government
and private health-care agencies.
The classic picture of tuberculosis with
fever, night sweats and wasting is now
less often seen, and the disease frequently
presents in an insidious fashion. The

skin test may be negative and the
sedimentation rate normal. Other features
of “ modern” tuberculosis are the occur
rence in older age groups of manifesta
tions usually seen in the young, such as
pleurisy and meningitis, and an increas
ing proportion of extrapulmonary forms.2
Because it may be confused with other
entities, patients with the disease are often
referred to the surgeon. In this issue of
the Journal, two unusual examples of
extrapulmonary tuberculosis involving
the liver are presented, by Mustard and
associates (pages 449 and 450) and Gallinger and associates (pages 451 and 452).
Hepatic granulomas are frequently
found, not only in miliary tuberculosis
but also in localized pulmonary and
extrapulmonary forms of the disease.3
Nevertheless, the liver does not appear to
provide a favourable environment for the
tubercle bacillus. Klatskin3 has shown
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that caseation is rare in these granulomas
and it is difficult to demonstrate the
bacilli. In general, liver involvement is
asymptomatic and unassociated with
functional abnormalities. Single or mul
tiple macronodular forms, with symp
toms suggestive of liver disease, such as
those described in this issue, are rare,4
but it is possible that more such lesions
might be demonstrated with the newer
imaging techniques.
Most cases of tuberculosis can be
managed with chemotherapy alone, and
the role of surgery has become limited.
Short-course regimens, using combina
tions of all the major agents at the same
time, are popular. The possibility that
drugs may fail to penetrate some tuber
culous foci, such as an abscess in the
spine, or a necrotic lesion in the lung, has
been discounted.5,6 However, the
experience of Mustard and associates, in
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which a tuberculous abscess in the liver
became a problem after months of
chemotherapy, suggests limited access of
drugs to some lesions. In other forms of
tuberculosis, including tuberculous lym
phadenitis and intracranial tuberculomas,
the development of new lesions or the
enlargement of previous foci have been
reported during chemotherapy.7,8 It has
been suggested that the progression of dis
ease in these instances is due simply to an
immune reaction to tuberculoprotein.9
However, the immune response occurs in
all tuberculous lesions, and such a delay
in healing is rarely seen in pulmonary
tuberculosis. It is possible that such fac
tors as the local vascular supply, extent
of fibrosis or the simple bulk of an
abscess10 are also involved in the
response to therapy. A satisfactory result
may eventually be obtained by persisting
with chemotherapy, and in such cases
short-course regimens seem inappropri
ate. If surgical drainage is required, the
percutaneous m ethod described by

Mustard and coworkers is an attractive
option for visceral lesions and for psoas
abscesses.
The bottom line is that tuberculosis has
not disappeared and is still seen in our
hospitals. There are sometimes frequent
delays in diagnosis, exposing the attend
ing staff to the risk of infection, and the
disease may, unfortunately, only be dis
covered at autopsy. It may be impracti
cal to carry out routine admission chest
roentgenography and to do routine spu
tum cultures for acid-fast bacilli in, for
example, productive patients in intensive
care units, but at the very least the possi
bility of the disease should still be kept
in mind.
L eo M . K a h a n a ,

m d , m s c , frc pc

Associate clinical professor o f medicine,
McMaster University,
Ste. 604,
25 Charlton Ave. E,
Hamilton, Ont.
L8N 1Y2
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A Vascular Surgeon’s Dilemma

The article by Gagnon and colleagues in
this issue of the Journal (pages 411 to 418)
is of considerable interest to vascular sur
geons. This group led by Dr. Guidoin at
Laval University are known for their
studies on vascular grafts and their
interest in both the mechanical properties
and the morphologic features of these
grafts. They have developed a number of
different techniques to assess the mechan
ical properties of a graft, and they use
vascular endoscopy, light microscopy,
scanning and transmission electron
microscopy to assess the morphologic fea
tures. They, and others, have introduced
a new set of criteria by which grafts
should be evaluated. They have also
introduced new terms into the vascular
surgical literature, some of which may be
poorly understood by vascular surgeons;
they include such terms as dynamic com
pliance, stress-strain tests and Young’s
modulus.
From an analysis of the data reported
in this study, a surgeon would have to be
venturesome to use an umbilical vein
graft. The authors demonstrated large
variations in linear density between differ
ent grafts and between different samples
of the same graft. They pointed out that
41% of the specimens presented irregular
ities of wall thickness. Furthermore, 16%
394

of the specimens had a “ very thin wall” .
The authors noted that the Dacron mesh
had been knitted in a very open construc
tion that easily stretched. Nearly all 37
specimens had two longitudinal folds on
the flow surface, running the full length
of the graft. In 22% of the cases the lon
gitudinal folds were deep. In 27% of cases
the intimal surface had multiple trans
verse folds and in some the intima looked
crumpled. Furthermore, the pathological
studies showed frequent ruptures of the
basement membrane and 19% of the
grafts showed intimal breakdown. Some
of the authors’ specimens had their flow
surfaces exposed to blood before harvest
ing and even after such a short exposure
thrombotic debris was detected on the
flow surface. Furthermore, in terms of
mechanical properties it appeared that the
graft did not perform well. These studies
were carried out on only short segments
left over after the main segment of graft
was implanted. Since there is such great
variability between different segments of
graft it would seem likely that every graft
had a multitude of unsatisfactory charac
teristics.
One must balance these findings with
the experience reported in the literature
using the human umbilical vein graft.
Hirsch and Jarrett,1 Cranley and Haf-

n er,2 Eickhoff and colleagues3 and
Dardick and associates4 have all demon
strated that many of these grafts function
well in patients for reasonable periods.
Hirsch and Jarrett1 reported a 73.5%
patency rate at 1 year and 54.5% at 5
years. Furthermore, there were only two
instances of aneurysm formation and two
cases of graft infection which occurred
after re-exploration for graft occlusion or
bleeding. Cranley and Hafner2 compared
saphenous vein, polytetrafluoroethylene
(PTFE) and human umbilical vein grafts
for revascularization of the femoropopliteal arteries and concluded that the
umbilical vein graft is acceptable when the
saphenous vein is not available. Only two
aneurysms were detected in 247 such
grafts and only one was large. Eickhoff
and associates,4 in a randomized clinical
trial, concluded that the umbilical vein
graft was better than the PTFE — the
1-year patency rate was 75% compared
with 40% in the PTFE group. Dardik and
colleagues5 reported seven aneurysms in
a series of 756 human umbilical vein
grafts, the average time of occurrence
being 5 years after implantation.
What, then, is the relevance of the
study reported by Gagnon and associates
to the practising vascular surgeon faced
with a threatened limb in a patient whose
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saphenous vein is not available for graft
ing? A lternative m aterials to the
saphenous vein are limited and it appears
that, under such conditions, the human
umbilical vein graft is a reasonable
choice. As Dardik and colleagues5
pointed out, although aneurysm forma
tion in human umbilical vein grafts has
a low incidence it is still a concern. They
recommended that periodic angiography,
particularly 3 to 4 years after implanta
tion, should be a routine part of the
follow-up. Furthermore, the manufac
turer of the Dardik Biograft (the biograft
used in Gagnon’s study) has made several
modifications, resulting in more uniform
wall thickness and a much stronger and
denser Dacron mesh.
Additional studies o f the type carried
out by Guidoin’s group are important in

the evaluation of graft materials, as are
carefully performed studies in animals
and careful analysis o f all human data.
The authors have established an informa
tion retrieval program to determine the
fate of their grafts, and they plan to relate
the clinical performance of the graft to
the pre-im plant m orphologic and
mechanical properties. This is essential.
It would be extremely helpful if the
manufacturer o f the graft maintained a
similar registry.
N.M . Sheiner, md, frcsc
Surgeon-in-chief,
Chief of cardiovascular and
thoracic surgery,
Sir Mortimer B. Davis-Jewish General Hospital,
3755 Cote Ste-Catherine,
Montreal, PQ
H3T 1E2
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BOOK REVIEWS
COMPLICATIONS IN VASCULAR SUR
GERY. 2nd ed. Victor M. Bernhard and
Jonathan B. Towne. 983 pp. Illust. Grune
& Stratton, Inc., Orlando, Fla., Academic
Press Canada, Don Mills, Ont., 1985. S130.
ISBN 0-8089-1747-1.

This second edition of Complications in Vas
cular Surgery is an extension of the first, which
was based on a symposium held under the
auspices of the Medical College of Wisconsin
in June 1980. The purpose of this edition is to
update the material, to keep pace with the
many basic and technical advances that have
occurred in the past 5 years, especially in the
areas of diagnostic imaging, manipulation of
the coagulation mechanism, refinements in
noninvasive diagnostic methodologies and
interventional radiology.
The book is divided into nine sections and
46 chapters that analyse the etiology and
management of complications associated with
most vascular surgical procedures. These sec
tions include aortoiliac and peripheral artery
reconstruction and late problems associated
with these procedures, renal revascularization,
postoperative problems especially after aortic
surgery, venous and coagulation problems,
amputations, infections, complications of graft
healing and cerebrovascular surgery.
There are many contributors, most of whom
are well-recognized experts in their fields. They
bring great personal experience and extensive
reviews of the literature to their presentations.
Because of the number of authors involved
there is some unevenness in quality and for
mat, but overall the information is well
presented and the complications are clearly dis
cussed. This is a complete review of the
problems with sufficient depth to satisfy sur
geons of varying experience, and it fills a
needed place in the vascular literature. It will
be a necessary addition to the library of all

practising vascular surgeons and especially to
vascular residents who are approaching their
examinations in vascular surgery.

T. Keith Scobie, md, frcsc
Professor and chairman,
Division of Vascular Surgery,
University of Ottawa,
Ottawa Civic Hospital,
CPC, Ste. 632,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
CURRENT CONCEPTS OF INFECTIONS
IN ORTHOPEDIC SURGERY. Edited by
Hans K. Uhthoff and Elvira Stahl. 300 pp.
Illust. Springer-Verlag, New York, 1985.
S48.00 (US). ISBN 0-387-13560-X.

Uhthoff is to be complimented, not only for
his initiative in organizing the applied basic
science course on “ Infection in Orthopedic
Surgery” at the University of Ottawa in 1984,
but also for his editing of the papers in this
book.
There is some repetition and overlap in the
49 presentations from Europe, the United
States and Canada. They concentrate on
hospital-infection control (particularly in the
operating room), early recognition of infection
and the prophylaxis of infection by the rou
tine use of antibiotics in joint replacement,
open management of fractures and other
orthopedic procedures in high-risk patients.
Increased risk of infection is noted in patients
with rheumatoid arthritis, diabetes, psoriasis,
obesity and those treated with steroids.
Proof is provided of the value of hand scrub
and skin preparation with chlorhexidine and
alcohol and delaying shaving until the time of
operation. Staphylococcus epidermidis is very

common on the skin and is best controlled by
the bactericidal effect of cephalin drugs. Pen
rose drains are shown to contribute to infec
tion more than suction drains. Limitation of
operating room traffic and talking is also
shown to be important in controlling infection.
Operative infection of clean wounds should
be less than 1%. Aminoglycosides in cement
are appropriate and produce no noted side
effects. Canadian surgeons will appreciate
Papineau’s paper on open sky excision and
bone grafting of infected bone. The importance
of Haemophilus influenzae as a cause of sep
tic joints in children is noteworthy. Experience
with gentamicin beads and fibrin-antibiotic
bone-graft complex is provided.
This volume is an excellent summary of the
knowledge acquired in the last 25 years in the
field and its contents make an excellent even
ing of reading for residents and qualified sur
geons practising orthopedic surgery.

J ohn W. H azlett, b sc <med), frcsc
Associate professor of surgery,
Division of Orthopedic Surgery,
Queen’s University,
Kingston, Ont.
DIAGNOSTIC IMAGING OF THE LOWER
GENITOURINARY TRACT. Matthew D.
Rifkin. 339 pp. Illust. Raven Press, New
Y ork, 1985. $49.50 (U S ). ISBN
0-88167-045-6.

The stated emphasis of this book is the male
urinary and genital system, in particular the
prostate and scrotal contents. Chapters on
embryology and normal anatomy, the urinary
bladder perivesical spaces, and the urethra and
penis are also included. The book focuses on

VOLUME 29, NO. 6, NOVEMBER 1986 / THE CANADIAN JOURNAL OF SURGERY

continued on page 398

395

Ho antagonist
nounced advantages.
C More potent on a weight basis
G No drug interactions with
drugs hepatically metabolized
(SNo known contraindications

S N o significant CNS effects
S'N o serious adverse effects
SUnsurpassed safety profile
S Competitively priced

#-

*

i
4..

INJECTION
(RANITIDINE HCl)
Pronounced advantages in the prophylaxis of stress ulceration, acid aspiration (Mendelson’s)
syndrome and in the treatment of GI hemorrhage.

Glaxo
Glaxo Laboraloties
A Glaxo Canada Limited Company
Toronto, Ontario
Montreal, Quebec

THE BETTER ^

ANTAGONIST

For prescribing information see page 407

SURGEONS’ UPDATE
in surgery is the subject of this column. The short items are designed to let readers know
doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

Revascularization and Reperfusion
Once billed as competing techniques —
surgical versus medical — treatments for
coronary artery disease have been refined
so much since the first bypass operations
that they now complement each other and
can be selected according to the extent
and location of the occlusion. So said
specialists at one of the scientific sessions
held during the annual meeting of the
Canadian Medical Association in Winni
peg in August.
B.N. Corbett, FRCPC, and S.K. Bhattacharya, FRCSC, both from the Univer
sity of Manitoba, reviewed the data col
lected and published over the years and,
based on the findings, outlined criteria for
selecting patients for percutaneous trans
luminal angioplasty and for surgical
bypass. Garry MacKenzie, FRCPC, of
the Royal Jubilee Hospital in Victoria,
BC, reviewed data on thrombolytic ther
apy for myocardial infarction.
According to the presentations, the
placement of mammary artery grafts to
bypass occlusions is the most effective
treatment for disease causing 50% or
more occlusion of the left main coronary
artery or for disease in three or more ves
sels accompanied by dysfunction of the
left ventricle. Angioplasty is preferred for
patients who have disabling angina and
proximal discrete, subtotal, noncalcified
occlusions.
Contraindications to angioplasty, said
Corbett, are stenosis greater than 95%,
multiple-vessel disease, calcification and
involvement of the left main vessel.
O f 157 lesions in 113 patients selected
for angioplasty at the two hospitals
affiliated with the U niversity of
Manitoba, 137 were successfully dilated

Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery, PO
Box 8650, Ottawa, Ont. K1G 0G8.

(lumen increased more than 35% accord
ing to angiographic evidence).
At the time, 61 patients held jobs: 14
missed 1 to 3 days of work, 14 missed 3
to 7 and another 29 missed 7 to 14 days’
work. The evidence, said Corbett, is that
the pressure from the balloon inserted in
the vessel compresses and cracks the
plaque rather than destroying it, so the
trauma to the vessels is probably less than
originally anticipated. He reported that
within 1.5 years just over 20% of occlu
sions recurred at the site of removal.
Thus, a major focus currently is to work
out how to predict who will have recur
rences.
Bhattacharya reviewed data in a
cooperative study of 15 centres (14 in the
United States and 1 in Canada), indicat
ing that the percentage of patients dying
during surgical revascularization varied
from 0.3 to 6.4, according to where they
were treated. Of the 766 patients who had
had bypass, with grafts of either mam
mary artery or saphenous vein, to correct
left main coronary artery disease, 82%
and 70% were still alive after 10 years and
graft patency was 90% and 80% respec
tively.
Re-establishing myocardial blood flow
and preserving the myocardium were the
benefits MacKenzie noted with strep
tokinase administered intravenously
within 3 hours of the onset of symptoms.
Of 169 patients who had occlusions in
either the left anterior descending or right
coronary vessels, 70% experienced reper
fusion when administered streptokinase.
The in-hospital death rate was 6.2% for
the group who experienced reperfusion
and 12% for those who did not.
Although citing some controversy
about whether thrombolysis actually
minimizes damage to the myocardium,
MacKenzie summarized four studies
using measurements of the ejection frac
tion as indicators of damage. He con

cluded from them that the time of treat
ment is critical, with streptokinase
administered early minimizing the size of
the infarct. The best results reported were
in a small group of patients receiving
streptokinase within 1.5 hours of the
onset of symptoms.

Heart of the Matter
Research at the University of Ottawa
Heart Institute provides partial answers
to what mechanisms are at work after per
cutaneous transluminal coronary artery
balloon angioplasty and during infusions
of streptokinase.
Reporting at the annual meeting of the
Royal College of Physicians and Surgeons
in September, V.M. Walley, FRCPC, and
Gerald C. Taichman, Ph D, outlined their
respective groups’ studies.
A pathologist, Walley presented find
ings from autopsies of six patients who
had died during or after angioplasty
between 1982 and 1985 out of 594 who
had undergone the procedure; 1 other
patient died but had not been subjected
to autopsy. In three of the patients, the
balloons had been inflated in the left main
artery as a last resort because, said Wal
ley, “ the infarcts in these patients were
so well established that the surgeons could
not go in and perform a bypass” . The
others had the balloon inserted in either
isolated marginal or left anterior descend
ing arteries. Serial sections of the arter
ies revealed fracturing not only o f the
atherosclerotic plaque but also of the ves
sel walls. Two of the patients had survived
longer than 24 hours — one for 1 month
and the other for 9 months — and had
died from causes unrelated to the
angioplasty. Their arteries showed heal
ing of tears that had extended through the
vessel walls to the adventitia.
Said Walley to CJS, “ We confirmed
what has been alluded to in experimental
settings: the balloon in the coronary
artery does produce a considerable
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amount o f physical and mechanical
trauma. But what is interesting is that the
vessel seems to tolerate the severe histo
logical disruption without major func
tional impairment.”
Taichman presented information from
recent work to determine whether strep
tokinase has any pharmacologic effects
besides its action as a thrombolytic agent.
He and his colleagues used seven mongrel
dogs, anesthetized them and then moni
tored the effects o f the drug on the left
anterior descending artery. In an inter
view with CJS, Taichman said, “ The
overall result is that, given a whole series
o f measurements to quantitate coronary
vasomotor activity, we found no differ
ence in animals with and without an
intracoronary infusion of half a million
units o f streptokinase in 1 hour. There
fore, the conclusion we reached was that
streptokinase probably does not act
directly on the coronary artery but
relieves the thrombus, or gets rid of the
thrombus, and thus causes reperfusion
which increases the perfusion o f the
m uscle.”

Using Lasers to Remove
Atherosclerotic Plaque
Within a few months, the University of
Ottawa Heart Institute will use Excimer
lasers
on patients to
rem ove
atherosclerotic plaque from coronary
arteries, says a researcher who has been
working on the technique for the last 24
months.

BOOKS REVIEWS
continued from page 395
the analysis and comparison of the newer imag
ing techniques, namely ultrasonography, com
puterized tomography, magnetic resonance
imaging and nuclear techniques. Lower urinary
tract disease, which can be evaluated by the
newer imaging techniques, receives special
emphasis.
There are six chapters. A short history of the
development and progress, to the present, of
ultrasonography, computerized tomography
and magnetic resonance imaging begins the
book. Chapter 2 describes the embryology and
normal anatomy of the lower urinary tract. The
use of the newer modalities in imaging and the
normal and abnormal bladder and perivesical
spaces are detailed in chapter 3. The next chap
ter is devoted to imaging of the prostate and
seminal vesicles and provides a detailed des
cription of the various ultrasonographic
approaches. Normal cross-sectional anatomy
and evaluation of prostate and seminal vesi
cle size are described followed by imaging in
benign and malignant disease of the prostate.
Prostatic biopsy techniques, including the
ultrasonographic guidance of the biopsy nee
dle in nonpalpable prostatic carcinoma, and
imaging seminal vesicle disease are also
described. Chapter 5 includes imaging tech-
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Edward Farrell, MD, elaborating on
studies reported at the Royal College
meeting in Toronto, said to CJS: “We are
directing our studies toward integrating
a laser into our cardiac operating theatres
as a tool to do coronary endarterectomies
as opposed to the conventional technique
that has been popularized around the
world by Dr. Wilbert Keon and others.
“ The Excimer laser has the ability to
remove the atherosclerotic tissue and to
leave the normal tissue intact. This is in
sharp contrast with its counterparts — for
instance, carbon-dioxide and argon
lasers.
“ What we are trying to do is generate
an instrument that, in our hands, can be
used to remove the blockages of coronary
arteries in patients for whom standard
bypass techniques are not applicable.
Currently, about 25% of the patients in
our institution undergo coronary endar
terectomy because they have diffuse dis
ease that is beyond the reach of conven
tional bypass techniques designed for the
treatment o f discrete disease.
“ We exposed normal and athero
sclerotic arteries to treatment by the laser;
then we assessed healing responses and
tissue effects o f the laser in atherosclerotic
laboratory animals. We think we will be
able to take this technology into clinical
work within the next few months, when
we are convinced that the laser can be
used reliably without complications.”
A m y C h o u in a rd

niques in neuromuscular disorders, spinal cord
injuries, bladder outlet obstruction, urethral
strictures and diverticula, Peyronie’s disease,
impotence, penile trauma and tumours. The
final chapter outlines imaging modalities in the
assessment of pathologic conditions of the
scrotum and its contents. Emphasized are the
two most important modalities — nuclear iso
tope studies, and ultrasonography for the
assessment of normal testes and epididymis,
congenital testicular anomalies, testicular and
extratesticular benign lesions. Malignant tes
ticular lesions, testicular torsion and testicu
lar trauma are also detailed.
Each of the chapters ends with a short sum
mary indicating the value of each modality and
the one of choice in the area of interest.
This book fulfils its stated objectives, focus
ing on the newer imaging techniques and
emphasizing the use of ultrasonography, par
ticularly in the assessment of the prostate and
scrotal contents. Some of the urethral
ultrasonographic prints are dark but are
accompanied by a diagrammatic explanation
that will be helpful to readers uninitiated in the
art of transrectal ultrasonography. If any criti
cism can be levelled, it is that there is a lack
of knowledge of the literature on urethrogra
phy, and there are at least two misstatements
continued on page 418

BOOKS RECEIVED
This list is an acknowledgement of
books received. It does not preclude
review at a later date.
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Actualites chirurgicales. Association fran?aise
de chirurgie. 87e congres fran?ais de chirurgie. 1. Chirurgie generate. Chirurgie diges
tive. Textes publies par la Commission des
publications sous la direction de M.
Malafosse. 367 pp. Masson, Paris, 1986.
Prix non mentionne, broche. ISBN
2-225-80908-9.
Actualites chirurgicales. Association frangaise
de chirurgie. 87e congres francais de chirur
gie. 2. Endocrinologie chirurgicale. Chirur
gie vasculaire. Chirurgie thoracique.
Orthopedie. Urologie. Textes publie par la
Commission des publications sous la direc
tion de M. Malafosse. 284 pp. Illust. Mas
son, Paris, 1986. Prix non mentionne,
broche. ISBN 2-225-80909-7.
Anatomy of the Temporal Bone With Surgi
cal Implications. Harold F. Schuknecht and
A. Julianna Gulya. 350 pp. Illust. Lea &
Febiger, Philadelphia, 1986. $125.00 (US).
ISBN 0-8121-1011.
Atlas of Endourology. Kurtz Amplatz and
Paul H. Lange..344 pp. Illust. Year Book
Medical Publishers, Inc., Chicago, 1986.
Price not stated. ISBN 0-8151-0160-0.
Basic Surgery. 2nd ed. Edited by John A,
McCredie and Gerard P. Burns. Illustrated
by Carol Donner. 656 pp. Illust. Collier
Macmillan Canada Inc., Toronto, 1986.
$44.95. ISBN 0-02-378750-3.
Drug Interactions in Anesthesia. 2nd ed. N. Ty
Smith and Aldo N. Corbascio. 482 pp.
Illust. Lea & Febiger, Philadelphia, 1986.
$47.50 (US). ISBN 0-8121-0998-8.
Inflammatory Bowel Diseases 1986. Proceed
ings of the Second International Sympo
sium on Inflammatory Bowel Diseases,
Jerusalem, Sept. 8-11, 1985. Edited by
Daniel Rachilewitz. 330 pp. Martinus Nijhoff Publishers, Dordrecht, The Nether
lands; Kluwer Academic Publishers, Hingham, Mass., 1986. $82.50 (US). ISBN
0-89838-796-5.
Introduction to Vascular Ultrasonography. 2nd
ed. Edited by William J. Zweibel. 503 pp.
Illust. Grune & Stratton, Inc., Orlando,
Fla.; Academic Press Canada, Don Mills,
Ont., 1986. $82.75. ISBN 0-8089-1781-1.
Organ Procurement II. Proceedings of the
Second International Congress on Organ
Procurement October 3-5, 1985, Detroit,
Michigan. Edited by Luis H. ToledoPereyra. 239 pp. Illust. Grune & Stratton,
Inc., Orlando, Fla.; Academic Press
Canada, Don Mills, Ont., 1986. $79.50.
ISBN 0-8089-1822-2.
Pathology of the Testis and Its Adnexa. Edited
by Aleksander Talerman and Lawrence M.
Roth. 263 pp. Illust. Churchill Livingstone,
Edinburgh; Academic Press Canada, Don
M ills, O n t. 1986. $79.95. ISBN
0-443-08351-7.
Pediatric Surgical Oncology. (The Principles
and Practice of the Pediatric Surgical
Specialties). Edited by D.M. Hays. 292 pp.
Illust. Grune & Stratton, Inc., Orlando,
Fla.; Academic Press Canada, Don Mills,
Ont., 1986. $86.50. ISBN 0-8089-1782-X.
Principles of Behavioral Neurology. (Contem
porary Neurology Series: 26). M-Marsel
Mesulam. 405 pp. Illust. F.A. Davis Co.,
P hilad ep h ia, 1985. $55.00. ISBN
0-8036-6151-7.
continued on page 404
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Action Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by
causing a reduction in the rate of synthesis of nucleic acids.

Cllnlcil and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate
(clindamycin phosphate) were followed w ith clinical laboratory tests, including complete hematology,
urinalysis and liver and kidney function tests. Some of these tests were abnormal initially and returned
to normal during therapy w ith Dalacin C Phosphate, while others were normal initially and became
abnormal during therapy. Overall evaluation of clinical laboratory values in these patients does not
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal
systems. Transient elevations of serum transaminases have occurred in some patients, but other liver
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and
there have not been clinical signs of drug-induced hepatic toxicity.

Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections
where the oral route is not indicated or feasible.
,X A.

Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium
species and microaerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) when
the patient is intolerant of, or the organism resistant to other appropriate antibiotics.

-

>

Symptoms ind Troitmont ol Owrdosaga: No cases of overdosage have been reported. No specific antidote
is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days have been
given without adverse effects.
DOSAGE AND ADMINISTRATION

Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or
clindamycin palmitate. Although cross-sensitization w ith Lincocin® (lincomycin hydrochloride) has
not been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have
demonstrated lincomycin sensitivity.

Adults
Intramuscular Injection: 600 m g/day in 2 equal doses.

Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn
(infants below 30 days of age), or in pregnant women.

Moderately severe infections: 600 to 1200 m g/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 m g/day in 2, 3 or 4 equal doses. Intramuscular injections of more than
600 mg into a single site are not recommended

Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy with
Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been
performed, some of these cases have shown pseudomembrane formation.

Intrsvimjus Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted p rio rto I V.
administration to a dilution of 300 mg in 50 ml of diluent (6 m g/ml) or more, and infused in not less
than 10 minutes. Administration of more than 1200 mg in a single 1 hour infusion is not recommended.
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.

If significant diarrhea occurs during therapy, this drug should be discontinued or, if necessary,
continued only w ith close observation. Significant diarrhea occurring up to several weeks post-therapy
should be managed as if antibiotic-associated.
' -
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If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes may
respond to simple drug discontinuance. Moderate to severe cases, including those showing ulceration
or pseudomembrane formation, should be managed w ith fluid, electrolyte, and protein supplementa
tion as indicated. Corticoid retention enemas and systemic corticoids may be of help in persistent
cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes of colitis
should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco
mycin were administered orally four times a day for 5 -1 0 or more days, there was a rapid observed
disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.

Moderately severe infections: 900 to 1800 m g/day by continuous drip or in 2 or 3 equal doses, each
infused over 20 minutes or longer.
Severe infections: 1800 to 2700 m g/day by continuous drip or in 3 or 4 equal doses, each infused over
20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 m g/day by continuous drip
or in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and Infusion rates:
Dose
300 mg
600 mg
900 mg
1200 mg
Alternatively, drug may be administered
by continuous I V, infusion as follows:
To maintain serum
clindamycin levels
Above 4 mcg/ml
10
Above 5 mcg/ml
15
Above 6 mcg/ml
20
Children: (Over one month of age)

Is should be noted that serious relapses have occurred up to one month after apparently successful
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with
caution in atopic individuals.
Dalacin C Phosphate must be diluted for intravenous administration. (See Dosage and Administration)

A

The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly
yeasts. Should superinfections occur, appropriate measures should be taken as indicated by the
clinical situation.

r

Adverse Reactions: Local.

•-A

(a) Intramuscular Injections: Of 404 patients treated w ith Dalacin C Phosphate (clindamycin phos
phate) intramuscularly (w ith a solution containing 150 mg/mL), six (1.5%) demonstrated local
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at the
injection site and two developed sterile abscesses.
(b) Intravenous Infusions: Of 192 patients treated w ith Dalacin C Phosphate by intravenous infusion,
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and
one patient developed both superficial and deep thrombophlebitis. The m ajority of these cases
developed in conjunction w ith the use of indwelling I V. catheters and it is difficult to know how much
the drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as
follows:

I

I

Number o f Patients
R ash................................................................................................................................................................. 7
U rtica ria .......................................................................................................................................................... 1
Pruritus............................................................................................................................................................ 1
Fever, Leucocytosis .................................................................................................................................. 1
Nausea, with or without v o m itin g .............................................................................................................. 1
Diarrhea (See also under "Warnings") ..................................................................................................... 4
Hypotension ................................................................................................................................................... 1
Hypertension................................................................................................................................................... 1
Shortness of Breath .................................................................................................................................. 1
Superinfection*.............................................................................................................................................. 4
Cardiac arrest** ............................................................................................................................................ 1
Bad and bitter taste inm o u th ................................................................................................................... 5
* Superinfection is a complication of antibiotic therapy in general and is not necessarily a true
side effect of clindamycin phosphate.
'* Due to underlying myocarditis in this patient.

in the form of a single rapid infusion of the first dose followed
Rapid
infusion rate
m g/min. for 30 min.
m g/min. for 30 min.
m g/min. for 30 min.

Maintenance
infusion rate
0.75 mg/min.
1.00 mg/min.
1.25 mg/min.

Moderately severe infections: 15 to 20 m g/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 m g/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 m g/kg/day by continuous drip or in 3 or 4 equal doses, each
infused over 20 minutes or longer. In severe infections, it is recommended that children be given no less
than 300 mg/day regardless of body weight. (Dilute Dalacin C Phosphate Sterile Solution in the same
manner as for adults.)

Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic
liver function tests should be performed during prolonged therapy. Blood counts should also be
monitored during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in
patients with impaired hepatic function is greater than that found in normal patients, the dose of
Dalacin C Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysis are not
effective means of removing the compound from the blood. Periodic serum levels should be determined
in patients with severe hepatic and renal insufficiency.

Time
10 min.
20 min.
30 min.
45 min.

Intramuscular injection: 10 to 15 m g/kg/day in 2, 3 or 4 equal doses.

As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.

r

Diluent
50 ml
100 ml
150 ml
200 ml

Dilution and Compatibility:
4 ml (600 mg) Dalacin C Phosphate when diluted w ith 1000 ml of the following commonly used in
fusion solutions was found to be physically compatible and demonstrated no significant change in pH
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection
Dextrose 5% in water
Dextrose 5% in saline
Dextrose 5% in Ringer’s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride
Dextrose 2V;>% in Lactated Ringer’s Solution (Hartmann's Solution)
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is
not recommended that Dalacin C Phosphate be mixed w ith any infusion solution containing B vitamins.
Supplied:
Dalacin C Phosphate contains the following per m l of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg
Benzyl alcohol 5 mg
Disodium edetate 0.5 mg
Water for injection q.s.
When necessary the pH is adjusted w ith sodium hydroxide and/or hydrochloric acid to maintain a pH
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 ml and 4 ml ampoules.
NOTE: Do not store below 15°C.
Product Monograph available upon request. CE 1377.1C
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HOST DEFENSE
Recent in-vitro research has shown that clindamycin concentrates within
the PMN in amounts greater than are found outside of the PMN.1 The
rates of chemotaxis, phagocytosis and killing of bacteria by PMNs are also
enhanced by the presence of this antibiotic.2^3 These characteristics may
help explain clindamycin’s outstanding record of clinical efficacy in both
anaerobic and gram-positive aerobic infections.
Since host defense factors may be crucial in determining the outcome of
an infection, selection of antibiotics based on host defense parameters
may become a trend in infectious disease therapy.
1) Klempner MS, et al (Nov 1981) J Infect Dis 144( 5)
2) Johnson JD, et al (March 1980) J Lab Clin Med 95(3)
3) Gemmell C, et al (1980) Current Chemotherapy and Infectious Disease
(eds. J Nelson, C Grassi) Am Soc Microbiol Vol 2
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Oral Acetylsalicylic Acid Improves Patency Rates
in Small-Vessel Anastomoses
Because p la te le t aggregation is the c riti
cal step in vascular th ro m b o sis, th is
stu d y in v e s tig a te d th e p o ssib ility th a t
a c e ty ls a lic y lic acid given orally w o u ld
im p ro ve pa ten cy o f anastom oses in small
arteries. U nder clean c o n d itio ns, in male
S p ra g ue-D aw ley rats, th e superficial
fe m o ra l a rteries w ere divided and
rea n astom osed using the sleeve te c h 
nique w ith 10-0 nylo n suture. F ifty-one
rats rece ive d a fu ll laboratory diet and
a c e ty ls a lic y lic acid in their drinking w a te r
(1 .0 8 m g /m l), before and a fte r operation.
A c o n tro l group o f 5 4 rats w a s m atched
fo r w e ig h t, w ater intake and duration o f
vessel o cclu sio n . Vessel patency was
assessed on postoperative day 7, at
s a crifice , b y dye angiography.
In th e experim ental group 7 (1 3 .7 % )
a n a sto m o se s became occluded, co m 
pared w ith 2 0 (3 7 .0 % ) in the co n tro l
group (x2 = 5 .9 9 , d f = 1, p < 0 .0 2 5 ).
Serum th ro m b o xa n e B2 levels in fiv e rats
given a c e ty ls a lic y lic acid orally (33.1 ±
6.1 n g /m l) were s ig n ific a n tly (p <
0 .0 0 1 ) lo w e r than in five co n tro l rats
(8 6 .6 ± 4 9 .1 ng/m l).
The a u th o rs concluded th a t ace tylsa li
c y lic acid adm inistered in th e drinking
w a te r to Sprague-D aw ley rats im proved

From the Department o f Surgery, St.
Joseph’s Hospital, University o f Western
Ontario, London, Ont.
Presented at the 90th annual meeting o f the
Canadian Association o f Clinical Surgeons,
eastern division, Quebec, PQ, May 29,
1986 and at the 8th annual meeting o f the
Canadian Society fo r Vascular Surgery held
in conjunction with the 55th annual meet
ing o f the Royal College o f Physicians and
Surgeons o f Canada, Sept. 25, 1986
Accepted fo r publication July 2, 1986
Reprint requests to: Dr. S.E. Carroll,
Department of Surgery, St. Joseph’s
Hospital, 268 Grosvenor St., London, Ont.
N6A 4V2
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th e patency rate o f fem oral artery
anastom oses probably because o f a
reduction in pla te le t aggregation. O rally
adm inistered ace tylsa licylic acid m ay be
o f clinical b e n e fit to patients w h o
undergo sm all-vessel anastom oses.

Com m e I'ag re g a tion plaquettaire est un
fa c te u r critiq u e dans la fo rm a tio n des
throm boses vasculaires, cette etude a
vo u lu m esurer la p ossibility que I'acide
a ce tylsa licyliq u e adm inistre par voie orale
ameliore la perm eabilite des anastom oses
de petites arteres. Dans des co n d itio ns
de chirurgie propre, chez des rats m ales
S prague-D aw ley, les arteres fem orales
superficielles o n t et£ divisees, puis reanastom os6es avec du fil de nylon 1 0 -0
par la m ethode en m anchon. C inquantee t-un rats o n t recu de I'acide acetylsalicyliq u e dans leur eau (1.0 8 m g/m l)
a va n t et apres I'op e ra tio n, ainsi q u 'u n
regim e co m p le t de laboratoire. Un groupe
tem oin de 5 4 rats a ete apparie pour le
poids, la q u a n tity d'eau absorbee et la
durye d 'o cclu sio n des vaisseaux. La perm yability vasculaire a ete evaluee au
m om ent du sa crifice, 7 jours apres ('o p e 
ration, par angiographie sous colorant.
Dans le groups tra ite , 7 (1 3 .7 % ) anas
tom oses se so n t bouchees com parativem e n t a 20 (3 7 .0 % ) dans le groupe
te m o in (x2 = 5 .9 9 , 1 dl, p < 0 .0 2 5 ).
Les taux de th ro m b o xan e B2 seriques
chez cinq rats a qui on avait adm inistre
de I'acide a ce tylsa licyliq u e par voie orale
(33.1 ± 6 . 1 ng/m l) etaient sig n ifica tive m en t (p < 0 .0 0 1 ) inferieurs a ceux de
cin q rats te m o in s (8 6 .6 ± 4 9 .1 n g/m l).
Les auteurs co n clu e nt que I'acide
a ce tylsa licyliq u e adm inistre dans I'eau de
breuvage a des rats Sprague-D aw ley a
ameliore la perm Sabilite des anastom oses
d'arte re s fym ora le s, vraisem blablem ent
par une d im in utio n de I'ag re g a tion p la 
quettaire. L 'acide a ce tylsalicylique a d m i
n istre par voie orale pourrait beneficier
cliniquem ent aux patients qui subissent
une anastom ose de p e tits vaisseaux.

Platelet aggregation has been shown by
histologic and electron microscopic
studies to be the critical initial step in
anastom otic th ro m b o ses.1 In the
m ajority o f cases, th rom b osis o f
microvascular anastomoses is attributed
to technical error.2 In the hands o f an
experienced microvascular surgeon, tech
nical errors are minimized. The sleeve
technique3 is associated with a higher
rate o f thrombosis (16% ) than a standard
end-to-end anastomosis (4% to 6% ). We
chose to use the sleeve technique in this
study to demonstrate a difference in
patency rates with and without the oral
administration of acetylsalicylic acid
(ASA).
Although platelet inhibitors are fre
quently used to p ro tect vascu lar
anastomoses, there is little experimental
evidence to support this practice. We
believe that patency o f small-vessel
anastomoses can be improved by inhibit
ing platelet aggregation.
Material and Methods
Male Sprague-Dawley rats, weighing
between 268 and 567 g, were anesthetized
with xylazine (6.5 mg/kg) and ketamine
(100 mg/kg) intraperitoneally. The thigh
o f each was shaved and the skin prepared
with 7.5% povidone-iodine detergent.
Under clean conditions, a 4-cm longitu
dinal incision was made in the thigh. The
superficial femoral artery was isolated
and stripped o f its sheath for 1 cm, then
clamped with microclamps, divided shar
ply and reanastomosed using an operat
ing microscope (25 X magnification).
Before dividing the artery, 2% xylocaine
solution was applied to relieve vessel
spasm. After division, the vessel ends
were irrigated with a 1:200 solution of
heparinized saline. With the sleeve tech
nique of anastomosis two sutures o f 10-0
nylon were placed, one anteriorly and the
other posteriorly. When they are tied the
proximal end telescopes into the distal end
o f the artery (Fig. 1).
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To assess technical proficiency a stan
dard end-to-end anastomosis with inter
rupted sutures (Fig. 2) was performed on
the opposite leg in the first 76 animals.
The experimental group of 51 rats
selected randomly by coin toss, received
ASA in drinking water (Table I) 24 hours
preoperatively and for 7 days postoperatively, in addition to a full laboratory diet.
The control group of 54 rats was matched
for weight (Table II), water intake (Table
III) and duration of vessel occlusion
(Table IV).
Vessel patency was assessed by dye
angiography at sacrifice (carbon dioxide
chamber), on day 7. Through a transverse
lower abdominal incision, the distal aorta
was isolated and clamped below the renal
arteries before injecting 2 ml o f Wright’s
stain. Patency was indicated by the pas
sage of dye beyond the anastomosis.
Serum thromboxane B2 studies were
performed on a separate group of 10 rats
matched for weight and water intake
(Table V). Blood was obtained by cardiac
puncture in anesthetized rats. The sam
ples were withdrawn into heparinized
syringes, placed in tubes containing

ethylenediamine tetra-acetic acid (EDTA)
and frozen until assayed. Thromboxane
B2 was measured by radioimmunoassay
in a liquid scintillation counter.
The animals were handled according to
the guidelines of The Canadian Council
on Animal Care.4 The data were ana
lysed using the unpaired Student’s r-test
and x2 test.
Results
In the preliminary phases of the study,
a standard end-to-end anastomosis with
interrupted sutures (Fig. 2) was per
formed to monitor for technical errors.
Figure 3 shows the thrombosis rate versus
the number of rats operated upon over
time using the standard end-to-end tech
nique. Each point on the graph represents
the mean thrombosis rate per group of
five rats operated upon. The graph indi
cates that as operative experience
increases, there is a corresponding
decrease in thrombosis rate to a certain

level, after which the rate becomes sta
ble. In order to minimize the contribution
of technical error to the results, rats were
included only after the thrombosis rate in
both groups remained stable at less than
10%

.

With the sleeve technique (Table VI),
7 (13.7%) anastomoses in the experimen
tal group became occluded compared
with 20 (37%) anastomoses in the control
group (p < 0.025).
Serum thromboxane B2 levels (Table
V) in five rats given ASA orally (33.1 ±
6.1 ng/ml) were significantly (p < 0.001)
lower than in the five control rats (86.6
± 49.1 ng/ml).
Discussion
Platelet aggregation is the critical ini
tial step in anastomotic thromboses. Cer
tain metabolites of arachidonic acid play
a key role in platelet function. In partic
ular, thromboxane A2, the predominant
metabolite of arachidonic acid in the

Table II—Weight of Rats
Technique
End-to-end technique*
No.
Weight, g
Mean
Range
SO
Sleeve techniquet
No.
Weight, g
Mean
Range
SD

No ASA

ASA

46

30

368.7
257.2 - 485.8
51.6

396.9
291.2 - 458.8
47.0

54

51

422.3
266.5 - 568.2
59.1

413.5
291.2 - 510.7
51.1

*t - 2.38, p > 0.01.
ft = 0.80 p > 0.02.
FIG. 1—Placement of sutures in sleeve
anastomosis (top) and completed anastomosis
(bottom).

Table III--Daily Water Consumption (ml/rat)
Water consumption
Mean intake
Range
SD

No ASA
In - 10)

ASA
(n - 10)

52.2
41.0 - 67.0
7.5

52.2
40.0 - 70.0
8.8

t = 0.003, df - 18, p > 0.02.
Table IV-Period of Warm Ischemia
FIG. 2—Standard end-to-end anastomosis
with interrupted sutures.

Table 1-Daily Acetylsalicylic Acid (ASA) Intake
Mean water intake, ml/rat
Average weight of rats, kg
ASA solution* used
(325 mg ASA dissolved
in 300 ml water [25°C]I, mg/ml
Daily ASA ingestion
mg/d
mg/kg

52.17
0.42
1.08
56.52
135.25

*1 g dissolves completely in 300 ml of water
at 25°C.

Technique
End-to-end technique*
No.
Clamp time, min
Mean
Range
SD
Sleeve techniquet
No.
Clamp time, min
Mean
Range
SD

No ASA
46
37.8
10 - 100
19.4
54
13.7
8 -3 0
4.5

ASA
30
24.7
10 - 30
5.7
51
15.7
10 - 25
4.2

*t = 2.54, p > 0.01.
tt = 2.29, p > 0.05.
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platelet, is a potent vasoconstrictor and
stimulates platelet aggregation. Prostacy
clin, the principal metabolite of arachidonic acid form ed in vascular
endothelium, is also a potent vasodilator
but inhibits platelet aggregation. There
are three key enzymes in this pathway

FIG. 3—Thrombosis rate versus number o f
rats operated upon over time. N = 75. Each
point equals group of five rats.

Table VI—Rate of Thrombosis Using
Sleeve Technique
Status of
anastomosis
Thrombosed
Patent
% thrombosed
X2

No ASA
(n = 54)

ASA
(n - 51)

20
34
37.0

7
44
13.7

- 5.99, p < C1.025.

(Fig. 4): cyclo-oxygenase, thromboxane
synthetase and prostacyclin synthetase.
One of the explanations for ASA’s action
is that each of these enzymes has a differ
ent sensitivity to inhibition by ASA, such
that at any dose of ASA, thromboxane
synthetase is more sensitive to inhibition
by ASA than prostacyclin synthetase. The
net result of ASA therapy would be a net
production of prostacyclin over throm
boxane, resulting in net vasodilation and
inhibition of platelet aggregation.5
In this study, the experimental group
of rats received 56 mg of ASA daily
(Table I) or 135 mg/kg body weight. The
human equivalent of this dose appears
very large (9.45 g/d). Acetylsalicylic acid
is relatively unstable in water, so we could
not determine how much was actually
absorbed. The group receiving ASA in
their drinking water did have a signifi
cantly lower rate of thrombosis than the
control rats, demonstrating a definite
benefit of the ASA. There may also be
a large difference in reaction to ASA
among species.
Patency was determined on postoper
ative day 7 by angiography using a
supravital dye technique. With this tech
nique, we could show only those
anastomoses that were either completely
patent or totally occluded. Should one
wish to determine partial occlusions, such
techniques as radiographic angiography
or radiolabelled microsphere flow meas
urements could be used. Such determina
tions would likely increase the difference
between the two experimental groups.
From previous studies using the sleeve
technique we know that recanalization of
small arteries does not occur for 36 to
48 days.3 The patency in all our
anastomoses was studied at day 7 to
exclude recanalization.
Although thromboxane A2 is the
metabolite of arachidonic acid responsi
ble for platelet aggregation and vasocon
striction, thromboxane B2, the immedi
ate product of thromboxane A2, is
routinely measured. The reason for this
is that thromboxane A2 is extremely

unstable with a half-life of 30 seconds
compared with thromboxane B2 which is
much more stable, having a half-life of
20 minutes.6
Conclusions
We conclude from this study that in
male Sprague-Dawley rats, orally
administered ASA improves the patency
of small-vessel anastomoses — probably
through a reduction in platelet aggrega
tion. Thromboxane B2 levels were also
lowered. In our opinion it is also impor
tant to administer ASA preoperatively, so
that the inhibition of platelet aggregation
is maximal at the time of surgery, when
endothelial damage is also at its
maximum.
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Fine-Needle Aspiration Cytology
in Breast Lumps
The authors reviewed retrospectively
368 breast lumps subjected to fineneedle aspiration cytology alone or to open
biopsy as well.
Of those lumps for which the results
of both studies were available, there
were 39 true-positive results, 32 true
negative, 1 false-positive and 7 false
negative results when the definitive find
ings of fine-needle aspiration biopsy
were compared with the histologic fea
tures. Also, in the 40 patients in whom
the aspirate was suggestive of malig
nancy or the findings were atypical, 22
had malignant disease on open biopsy
and 18 had benign disease.
These results are consistent with
those reported in the literature and point
to the importance of a positive or sug
gestive report and the current unreliabil
ity of a negative report.
Les auteurs font une revue retrospective
de 368 tumeurs du sein qui ont ete soumises h une cytologie par aspiration a
I'aiguille fine, soit seule ou accompagnee
d'une biopsie ouverte.
Dans les cas de tumeurs pour lesquelles on possede les resultats des deux
examens, on observe 39 vrais positifs,
32 vrais negatifs, 1 faux positif et 7
faux negatifs quand on compare les
resultats definitifs de la biopsie par aspi
ration h I'aiguille fine aux caracteristiques
histologiques. De plus, chez 40 patientes
dont la biopsie a I'aiguille indiquait la
possibility d'un cancer ou dont les resul
tats etaient atypiques, 22 presentaient
un cancer a la biopsie ouverte et 18
avaient une maladie benigne.

From the Department o f Surgery, St.
Joseph’s Hospital and McMaster Univer
sity, Hamilton, Ont.
Presented at the 90th annual meeting o f the
Canadian Association o f Clinical Surgeons,
eastern division, Quebec, PQ, May 30,
1986

Ces resultats coincident avec ceux qui
ont ete signales dans la presse medicate
et indiquent I'importance d'un rapport
positif ou douteux, et le manque de fiabilite d'un rapport negatif.

Fine-needle aspiration biopsy is being
promoted as an important step in the
management of breast lumps. Its propo
nents list the advantages of the technique
as follows: it is a simple office procedure,
leaves no scar and is psychologically
acceptable to most patients; necessary
equipment is minimal, the technique is
easy to master and the result rapidly avail
able; if confidence exists about the results,
many open biopsies can be avoided,
resulting in substantial savings of money
and operating time. Dixon and asso
ciates1 have addressed the issue with the
following comment: “ If no technique
other than history, physical examination
and mammography were available in the
diagnosis of breast lumps, it would be
necessary to biopsy all solid lesions to
ensure that no malignant lesions are
missed; this approach is standard prac
tice in many centres.”
The current literature abounds with
reports of the high accuracy, sensitivity
and specificity of the technique; indeed,
more than 50 reports have appeared in the
past 4 years.2 The results have shown
considerable variation, with a general
trend toward greater accuracy with
increasing experience of both aspirator
(usually a surgeon) and cytopathologist.
With this background, we undertook
a review of the recent use of fine-needle
aspiration biopsy in our hospital to
address two questions; (a) can a positive
result from fine-needle aspiration biopsy
be grounds for a decision on the defini
tive management of a breast lesion? and
(b) can a negative result be sufficient to
rule out the possibility of carcinoma in
a breast mass?

of the free hand. Once the needle is in the
mass, suction is applied to the syringe. If
fluid is encountered, it is all removed. If
any mass remains, or if the lesion does
not contain fluid, several passes are made
through the mass, then suction is released
and the needle withdrawn. Early in the
series, the aspirate was expelled onto a
glass slide, smeared and immediately
fixed in 95% alcohol. More recently, to
improve cell yield, the aspirate has been
lavaged into a small amount of 50% alco
hol, then filtered preparations have been
made and stained using the Papincolaou
technique. The slides are screened by a
cytotechnologist and read by a pathol
ogist.
The reporting system uses four
categories:
• No reading — acellular or unsatis
factory samples.
• Benign — epithelial cells with nor
mal nuclear size and chromatin pattern.
• Malignant — a highly cellular
aspirate with cellular dissociation, marked

Technique and Material

Accepted fo r publication June 16, 1986
Reprint requests to: Dr. S.E. O ’Brien,
Department o f Surgery, St. Joseph's
Hospital, 50 Charlton Ave. E, Hamilton,
Ont. L8N 4A6

Fine-needle aspiration is carried out in
the surgeon’s office. A 22-gauge needle,
attached to a 10-ml syringe, is inserted
into the mass which is fixed by the fingers

FIG. 1—Positive cytologic finding from
fine-needle aspiration biopsy showing high cellularity, cellular dissociation, irregular nuclei
and mitosis (arrow) (Papanicolaou stain, origi
nal magnification x 250).
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variation in nuclear size and shape,
irregularity of the chromatin pattern and,
rarely, a mitosis (Fig. 1).
• Other — epithelial cells that are
atypical (variation in nuclear size but no
significant change in chromatin pattern)
or suggestive of malignancy (irregular
nuclei and coarse chromatin pattern). A
report in this category is usually accom
panied by a recommendation for open
biopsy.
The cytology records for the period
Jan. 1, 1983 to Dec. 31, 1985 were
screened and all aspirations of breast
lumps noted. These were then used to
screen the histology computer files to
identify those patients who had also
undergone open biopsy of the lesion con
cerned.
During the study period, 368 breast
masses were subjected to fine-needle aspi
ration biopsy. In 135 patients open biopsy
was subsequently performed. Of the other
233 masses, the majority were cysts that
disappeared after aspiration of the fluid.
Findings
This report concentrates on the 135
masses for which data on both fine-needle
aspiration and paraffin section were avail
able. O f these, 71 masses were proven to
be carcinoma on microscopic examina
tion o f the biopsy specimen and 64
benign. Thirty-nine of the malignant
lesions were considered malignant from
the findings of fine-needle aspiration
biopsy. A further 22 had been labelled
suggestive and open biopsy recom
mended. Seven biopsies were interpreted
as benign but carcinoma was present at
open biopsy and three patients with
cancer had aspirates that were unsatisfac
tory and categorized as “ no reading” on
the cytology report.
O f the 64 masses that were histologi
cally benign, 32 were also cytologically
benign, in 18 the cytologic findings were
atypical or suggestive of a malignant
lesion, 1 was categorized as malignant and
in 13 the aspiration specimens were
unsatisfactory (Table I).
Our one false-positive result occurred
in a 47-year-old woman who had aspira
tion of a left breast mass. Fluid was
obtained and there was no residual mass.
The aspirate was sent for cytologic exami
nation, and when it was categorized as
malignant the patient was recalled. Clin
ical examination revealed a small mass
that was subjected to open biopsy. Histo
logic exam ination showed marked
epitheliosis, which some pathologists may
have labelled atypical hyperplasia.
We initially had a second false-positive
result in a 70-year-old woman who under
went fine-needle aspiration of a solid
lesion in her left breast. The cytologic
findings were unequivocally in the malig
406

nant category; however, subsequent
biopsy showed only florid papillomato
sis. The patient was followed up for about
6 months, then underwent repeat open
biopsy because of local recurrence of the
mass. This biopsy confirmed a welldifferentiated cancer with vascular inva
sion, therefore we classified her result as
a true positive.
The sensitivity of the method was 55%
if only a positive label is considered a
marker of malignancy; however, this rate
increases to 86% if suggestive findings are
included, based on the consideration that
a suggestive finding will lead to an open
biopsy and the correct diagnosis.
The specificity is 78% if suggestive
findings are included with the negative
group, but it drops to 50% if the sugges
tive cytologic findings are included with
the positive group.
If we look only at cases in which a
definitive cytology report (malignant or
benign) is made on fine-needle aspiration
biopsy, then the sensitivity is 85% and the
specificity is 97%.
More important to the goals of our
study, the positive predictive value of the
method is 97.5%, the negative predictive
value is 82% and the accuracy 90% for
a definitive cytology report. The false
positive and false-negative rates were
2.5% and 18% respectively.
Discussion
The use of fine-needle aspiration cytol
ogy in the management of breast lesions
was first reported by Martin and Ellis in
1934.3 Little attention was paid to the
technique until the 1970s when Zajicek4
reported his use of the technique. Since
then, it has become quite popular in
Europe, with slower acceptance in Britain
and North America.5
A summary of the recent literature6
reported the following data on fine-needle
aspiration cytology in breast lesions:
accuracy in diagnosing malignant lesions
77% to 96%, false-positive rate 0.1% to
1.8%, false-negative rate 3.6% to 17%.
Much of the variation comes from the
method of reporting results; for example,
some authors1'7,8 include suggestive find
ings with the positive results, others8' 10
include them with the negative results and
others11 ignore them.
The positive predictive value is the key

to the question of whether a positive fineneedle aspiration cytology report can
form the basis for definitive therapy,
which will vary in form but does include
the possibility of mastectomy.
The gold standard against which cyto
logic results must be weighed is histologic
findings, which are assumed to be 100%
accurate. Frozen-section diagnosis com
pares favourably with this standard;5'12
thus, definitive therapy can be chosen on
the basis of a frozen-section report.
Several centres report a similar reliance
on a positive result from fine-needle aspi
ration biopsy. On the basis of our current
results — with a false-positive rate of
2.5% — we do not yet believe that we can
use the cytologic diagnosis to determine
definitive therapy. Also, because of the
current technique for measuring hormone
receptors, and their present prominence,
an open biopsy is still considered neces
sary. A number of studies are under way
on methods for measuring hormonal
receptors directly from histologic sections
and aspiration biopsy smears, that, if suc
cessful, will weaken this argument.
In spite of these facts, we do modify
our management of a breast lesion if the
cytologic findings indicate a malignant
lesion. We use the information inthe psy
chological preparation of the patient; we
attach some urgency to the timing of
biopsy and often perform it as an inpa
tient procedure in one stage, usually with
frozen section and definitive treatment.
If the patient is a candidate for lumpec
tomy and axillary dissection as definitive
treatment, we modify the biopsy to an
appropriate segmental resection, aiming
for tumour-free margins and the most
cosmetically pleasing result.
The negative predictive value is the key
to the question of whether a definitive
negative aspiration result is sufficiently
reliable to omit biopsy of a solid lesion.
There is considerable debate on this issue:
some authors2,9 rely on the aspiration
result and apparently do not miss breast
cancers.2 Just as many, however,
disagree6,7,9 because of the average false
negative rate of 10%. Those who support
the use of fine-needle aspiration biopsy
in this role cite a diagnostic accuracy for
the triad of physical examination, mam
mography and fine-needle aspiration
approaching 99%. But they do state that
whenever the clinical or mammographic

Table 1--Com parison of Cytologic and Histologic Findings
Fine-needle aspiration
cytology category

Histologic findings
M alig nant

Benign

No reading (unsatisfactory)
Benign
Suggestivefatypical
M alignant

3
7
22
39

13
32
18
1

16
39
40
40

Totals

71

64

135

T o tals
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findings do not agree with the cytology
report, a biopsy is indicated. Most
authors agree that the probable cause of
a false-negative result is sampling error.
Our own false-negative rate of 18% has
led us to side with those who demand that
all solid lesions be biopsied. However,
negative cytologic findings influence our
approach in ways similar to those
described for a positive aspiration result;
that is psychological preparation, urgency
for biopsy (which is usually done as an
outpatient procedure) and extent of the
biopsy.
Summary
This retrospective review of a small ser
ies does not allow us to commit ourselves
to total reliance on fine-needle aspiration
biopsy in the management of patients
with breast lumps. There currently are no
definitive studies in the literature,
although there is certainly a wealth of
data suggesting that, with increasing
experience, this goal may eventually be
achieved. Our hospital uses many aspira
tors and many pathologists instead of a
single aspirator and pathologist, as in
many of the reporting centres. That our
results are comparable to those in the cur
rent literature bodes well for the general
use of the technique. Since diagnosis from
paraffin sections is the current gold stan
dard, what is needed is a prospective
study of a large number of patients, com
paring fine-needle aspiration cytology to
paraffin section in a situation where car
cinoma cannot be excluded on clinical
grounds alone.
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Z A N T A C " IN JE CTIO N (ranitidine hydrochloride)
PH A R M A C O L O G IC A L C L A S S IF IC A TIO N
Histamine H2-receptor antagonist
IN D IC A TIO N S AN D C L IN IC A L USE
Zantac injection is indicated for the treatment of duodenal ulcer,
benign gastric ulcer, post-operative ulcer, reflux esophagitis,
Zollinger-Ellison syndrome and other conditions w here reduc
tion of gastric secretion and acid output is desirable. These
include the prophylaxis of gastrointestinal haemorrhage from
stress ulceration in seriously ill patients, the prophylaxis of
recurrent haemorrhage in patients with bleeding peptic ulcers
and before general anaesthesia in patients considered to be at
risk of acid aspiration (M endelson’s) syndrome, particularly
obstetric patients during labour.
For appropriate cases Zantac Tablets are also available.
C O N TR A IN D IC A TIO N S
There are no known contraindications to the use of Zantac
(Ranitidine).
W A R N IN G S
G astric u lc er-T re a tm e n t with a histamine H,-antagonist may
mask symptoms associated with carcinoma of the stomach and
therefore may delay diagnosis of the condition. Accordingly,
where gastric ulcer is suspected the possibility of malignancy
should be excluded before therapy with Zantac is instituted.
PR E C A U TIO N S
Use in p regn an cy and n u rsin g m o th e rs -T h e safety of
Zantac in the treatment of conditions w here a controlled
reduction o f gastric secretion is required during pregnancy has
not been established. Reproduction studies performed in rats
and rabbits have revealed no evidence o f impaired fertility or
harm to the fetus due to Zantac. If the administration o f Zantac
during pregnancy is considered to be necessary, its use requires
that the potential benefits be weighed against possible hazards
to the patient and to the fetus. H owever, therapeutic doses of
Zantac administered to obstetric patients in labour or undergo
ing caesarean section have been without adverse effect on
labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers
but the clinical significance of this has not been fully evaluated.
U se in im p aired ren a l fu n ction -R a n itid in e is excreted via
the kidney and in the presence of severe renal impairment,
plasma levels of ranitidine are increased and prolonged.
Accordingly, in the presence of severe renal impairment, clini
cians may wish to reduce the oral dose to half of the usual dose
taken twice daily, sim ilarly it is recommended that ranitidine
injection be administered in doses o f 25 m g to patients with
renal dysfunction.
C h ild ren -E xp erien ce with Zantac in children is lim ited and
such use has not been fully evaluated in clinical studies. It has
how ever been used successfully in children aged 8-18 years in
doses up to 150 m g orally twice daily without adverse effect.
AD VERSE R E ACTIO N S
No serious adverse effects have been reported to date in
patients treated with Zantac. There has been no clinically signi
ficant interference with endocrine, gonadal or liver function,
nor has the drug adversely affected the central nervous system
even in elderly patients.
The incidence o f adverse events among Zantac-treated
patients (8 .1 % ) was very little greater than that among
placebo-treated patients (7 .7 % ). Only fiv e adverse events,
namely, tiredness (0 .3 8 % ), headache (0.9 0% ), dizziness
(0 .3 2 % ), diarrhea (0 .5 2 % ) and skin rashes (0.52% ) had a
greater incidence in the ranitidine treated group than in the
control group.
A small proportion (1 .9 9 % ) o f patients treated with
ranitidine injection experienced itching or burning at the injec
tion site. This reaction was mild and usually subsided within
10-15 minutes.
Headache was experienced by 2.54% of patients receiving
ranitidine injection. Th e majority o f these cases w ere not
thought to be treatment-related. In som e instances the headache
was thought to be due to over-rapid injection of ranitidine, and
did not recur on rechallenge with slow intravenous injection.
Similarly, some patients experienced nausea after rapid injec
tion of the drug, but on subsequent occasions with slow-intra
venous injection, experienced no ill-effects.
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Zantac is very specific in action and accordingly no particular
problems are expected follow ing overdose with the drug.
Symptomatic and supportive therapy should be given as
appropriate. If need be, the drug m ay be rem oved from the
plasma by haemodialysis.
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In the prophylaxis o f haem orrhage from stress ulceration
in seriously ill patients or the prophylaxis o f recurrent haem or
rhage in patients bleeding from peptic ulceration, parenteral
administration may be continued until oral feeding commences.
Patients considered to be still at risk may then be treated with
Zantac tablets 150 mg twice daily.
In patients considered to be at risk of developing acid
aspiration syndrom e Zantac injection 50 m g may be given
intramuscularly or by slow intravenous injection (s e e * above)
45-60 minutes before induction o f general anaesthesia.
Experience with Zantac in children is lim ited and it has
not been fully evaluated in clinical stu d ies-see PRECAUTIONS.
A V A IL A B IL IT Y
Zantac Injection is available as 2 m L ampoules each containing
50 mg ranitidine (as the hydrochloride) in 2 mL solution for intra
venous or intramuscular administration. Packages of 10
ampoules.
Zantac Tablets are available as white film -coated tablets
engraved ZAN TAC 150 on one face and GLAXO on the other
containing 150 m g ranitidine (as the hydrochloride), in packs of
28 & 56 tablets.
Zantac tablets are also available as white, capsule shaped,
film -coated tablets engraved ZAN TAC 300 on one face and
GLAXO on the other, containing 300 m g ranitidine (as the
hydrochloride) packed in cartons containing 28 tablets.
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Clinical Experience With Biliopancreatic Bypass
and Gastrectomy or Selective Vagotomy
for Morbid Obesity
In 1980 Scopinaro described biliopan
creatic bypass for the treatment of
obesity. This procedure was aimed at
selective malabsorption. The authors
used Scopinaro's procedure in 33
patients, but in 17 they modified it by
doing selective vagotomy with closure of
the duodenum in continuity instead of a
subtotal gastrectomy.
Eighteen months after the operation,
88% of the patients had what the
authors considered was a good to excel
lent result, that is a loss of more than
25% of the patient's initial weight.
Morbidity of many kinds was encoun
tered but most was self-limiting or easily
corrected by medical means. From their
experience the authors conclude that
biliopancreatic bypass as a procedure for
the treatment of morbid obesity should
continue to be performed and evaluated.
L'exclusion bilio pancreatic est une nouvelle forme de traitement de I'obesite
morbide. La technique fut decrite par
Scopinaro en 1980. La physiologie sousentendant cette intervention est celle de
creer une mal-absorption selective et
I'absence d'anse exclue.
Les auteurs ont modifie la technique
originale en pratiquant une vagotomie
selective avec fermeture du duodenum
en continuity au lieu d'une gastrectomie
subtotale chez la moitie de leurs
patients.
Depuis janvier 1984, ils ont pratique
33 bypass bilio-pancr£atiques. Ils £valuent un resultat comme bon ou excel
lent lorsque le patient a perdu 25% ou
30% de son poids initial. Quatre-ving-
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huit pourcent des patients 6 18 mois
franchissent ce niveau qui se maintient a
24 mois.
Cette intervention produit une morbi
dity certaine. Celle-ci est souvent limitee
ou facilement corrigible par des moyens
medicaux. Chacune des complications
est dycrite. Les auteurs concluent que
ces interventions doivent continuer a
etre pratiquees et gvaluees.

Because the causes, and thus the ideal
treatment, of obesity remain obscure, sur
gical procedures were introduced more
than two decades ago to manage this con
dition. The surgical history of morbid
obesity is one of multiple surgical varia
tions on two themes: malabsorption —
procedures designed to prevent ingested
food being absorbed — and restriction —
those designed to minimize the amount
of food ingested.
As a malabsorptive procedure, jejuno
ileal bypass produced satisfactory weight
loss but was almost completely abando
ned because it was often followed by
serious, and sometimes fatal, complica
tions. Most of these complications can be
ascribed to two main defects of the clas
sic operation.1
The first is the indiscriminate malab
sorption caused by the short bowel and
the interruption of enterohepatic bile-salt
circulation. The second is the presence of
a long section of excluded intestinal tract,
which may play a substantial role in the
pathogenesis of liver damage.
Restrictive procedures have evolved
through a number of technical variations.
Despite their technical ease, they are asso
ciated with high failure rates.
In the search for a better procedure,
Scopinaro and colleagues1 reported their
technique of biliopancreatic bypass in
1980. In this operation they recognized
three separate parts of the intestinal tract:
the alimentary tract from the stomach to
the jejunoileostomy; the biliopancreatic
tract from the duodenal stump to the jeju
noileostomy; and the common tract from
the jejunoileostomy to the ileocecal valve.
Theoretically, biliopancreatic bypass has

the following advantages: it produces a
selective rather than indiscriminate
malabsorption; the enterohepatic bile-salt
circulation remains intact; and there is no
long, excluded intestinal loop. It was anti
cipated that this procedure would over
come the complications associated with
the classic operation of jejunoileal bypass.
As described, this procedure is similar
to the Mann-Williamson operation for
the experimental production of peptic
ulcer. To avoid this complication,
Scopinaro recommended the addition of
a 75% distal gastric resection. Since then
highly selective vagotomy has been widely
recognized as the treatment of choice for
peptic ulcer disease. Because of our
experience2 with highly selective vagot
omy, we feel that we can rely on a selec
tive vagotomy to protect the anastomo
sis from peptic ulcer formation. So, based
on Scopinaro’s clinical experience with
biliopancreatic bypass and on our clini
cal experience with highly selective vagot
omy, we decided, more than 2 years ago,
to offer two new options to morbidly
obese patients seeking help in our insti
tution.
Patients and Methods

From January 1984 to May 1986, 33
patients (27 women, 6 men, ranging in age
from 21 to 53 years [mean 36 years])
underwent a biliopancreatic bypass for
obesity in our hospital. Informed consent
for the procedure was obtained from all
of them. All were either twice their ideal
weight or had medical complications
related to their obesity. All had under
gone multiple medical treatments without
success and had suffered from obesity for
more than 5 years. An extensive medical
work-up preoperatively failed to show
any endocrine disorders. Five of the 33
patients had already undergone a gastric
partition procedure that had failed.
Sixteen patients (10 women and 6 men)
underwent biliopancreatic bypass with
gastrectomy and the other 17 women
underwent biliopancreatic bypass with
selective vagotomy.
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In four patients the biliopancreatic
bypass was Scopinaro’s type III (i.e., the

FIG. 1—Biliopancreatic bypass with gas
trectomy.

common tract is 50 cm long and the
biliopancreatic and alimentary tracts are
of equal length). In the other cases we
transected the small bowel 250 cm from
the ileocecal junction. The proximal loop
was then anastomosed end-to-side 50 cm
from the ileocecal junction. The small
bowel was measured along its mesenteric
border. The distal loop was anastomosed
to the stomach after subtotal gastrectomy
or selective vagotomy with closure of the
first part of the duodenum (Figs. 1 and 2).
Wedge biopsy of the liver was per
formed in 29 cases. When present, the
gallbladder was removed with one excep
tion. In two of the five patients with a
failed gastric partition procedure we
found it necessary to do a gastrogastrostomy to facilitate normal alimen
tation.
Most patients were instructed to take
a liquid diet from the time of discharge
until follow-up 3 weeks after operation.
Then, their diet was returned to normal
as tolerated. Follow-up visits were at 3
and 6 months after operation and every
6 months thereafter. Blood tests were per
formed routinely at 6 and 12 months.
At each visit, the dietician recorded the
patient’s food intake and gave advice.
Weight, bowel habits, level of activities
and any problems were recorded.
A few patients did not return at some
of the follow-up times, but we were able
to see them or reach them by phone to
question them about their degree of satis
faction, quality of life and bowel habits.
The results of operation were evaluated
using three measurements: weight in kilo
grams, body mass index (weight divided

by height in square metres) and percen
tage over the ideal weight.
R esu lts

Because bariatric surgery carries high
risk of morbidity we were concerned not
only with the amount of weight lost but
also the number and type of complica
tions, length of hospital stay, quality of
life and bowel habits.
Weight Loss
The mean initial weight was 123 kg (116
kg for women, 155 kg for men). It ranged
from 88 to 179 kg. The mean body mass
index was 46 (45 for women and 50 for
men) and ranged from 37 to 64. Mean
average percentage over the ideal weight
was 124 (120 for women and 135 for
men), ranging from 73 to 211.
Weight loss was quite rapid for the first
12 months and continued, though more
slowly, up to 24 months (Fig. 3). Weight
loss expressed as a percentage of the ini
tial weight reached 30% at 12 months and
almost 40% at 24 months (Table I). At
18 months the mean weight loss was the
same for both operations (Table II) and
was similar to Scopinaro’s results.1
Freeman3 recommended grouping the
results as “ excellent” (30% weight loss
or over), “ good” (25% to 29% weight
lost) and “ poor” (under 25% weight
lost). Using these criteria we had excel
lent results at 18 months in 64.7% of
patients, good results in 23.5% and a
poor result in the remaining 11% (Table
III).

Table 1-Percentage Weight Loss (Mean ± SD) After Operation

Weight loss, %
FIG. 2—Biliopancreatic bypass with closure
of duodenum and selective vagotomy.

Initial weight
Initial weight
over ideal

22.6 ± 6.9

Follow up, mo
12
18
(n = 19)
(n = 17)
30.0 ± 11.1
35.2 ± 12.7

24
(n - 7)
38.3 ± 15.0

43.3 ± 16.1

57.6 ± 18.9

66.1 ± 20.7

6
(n = 261

65.4 ± 19.0

Table II—Percentage Weight Loss (Mean ± SD) at
18 Months According to Type of Surgery
Biliopancreatic bypass with
Weight loss, %
Initial weight
Initial weight
over ideal

FIG. 3—Weight loss curves up to 24 months
for all patients (squares), group with gastrec
tomy (circles) and with vagotomy (triangles).

Result
Excellent > 30%)
Good (25% - 29%)
Poor ( < 25%)

Gastrectomy
(n - 9)
36.7 ± 17.0

Vagotomy
(n = 8)
33.6 ± 5.9

64.4 ± 24.5

66.5 ± 1 1 . 5

Table Ill-Grading of Results According to
Percentage Loss of Initial Weight Over 24 Months
Follow-up, mo
12
18
(n = 19)
(n - 17)
11
9
4
2
8
2
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(n - 7)
5
1
1
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Hospital Stay and Follow-up
The mean postoperative hospital stay
was 10 days overall (12 days for those
with gastrectomy, 8 days for those with
selective vagotomy). The mean follow-up
was 14 months (range from 1 to 28
months).
Complications
The overall early complication rate was
42% (14 of 33). One patient (3.03%) died
of necrotizing hepatitis.
There was one case of a blown duo
denal stump. On postoperative day 7,
laparotomy was performed to secure bet
ter drainage. One patient needed reintu
bation because of pulmonary insuffi
ciency. She was the only one who had to
be kept on a respirator for more than 2
hours after operation.
O ther postoperative complications
included ileus, which subsided rapidly
when a nasogastric tube was inserted,
fever from atelectasis, urinary tract infec
tion and a minor wound infection in two
patients.
Late complications were of many
kinds. Three patients had anastomotic
ulcers: in two (one in each operative

group) first symptoms appeared within 1
month of operation and eventually
required surgical revision of the gastroen
terostomy; the third patient experienced
epigastric pain 7 months after operation
(she was in the vagotomy group). She
responded well to cimetidine and is now
free of symptoms.
Six patients (18%) were found to have
an incisional hernia at follow-up. Three
(9%) had to be readmitted because of
malnutrition. The striking feature in these
cases was that they had almost stopped
eating to accelerate their weight loss. With
dietary counselling all were able to regain
a near-normal nutritional status without
operation. Two of these patients were in
the group of five with failure of a gastric
partition procedure.
One patient had continuous colicky
abdominal pain and multiple episodes of
small-bowel obstruction. We finally
decided to re-establish small-bowel con
tinuity. She was another of the five with
failure of a gastric partition procedure.
Bowel Habits
Nine patients complained of loose
stool. In two, all bowel movements were
loose and frequent (four to six a day). The

others had two to four formed stools fol
lowed by a loose one.
The change of bowel habits most often
mentioned was the early morning stool.
Many patients had to get up at around 5
or 6 in the morning to have a bowel
movement.
Comments
Biliopancreatic bypass is a major
procedure that may have a spectacular
effect on body weight. There are major
side effects but these can usually be
managed medically. Patient acceptance is
greater than professional acceptance.
It is our opinion that biliopancreatic
bypass with gastrectomy or vagotomy
should continue to be evaluated. Bariatric
surgery will continue to be performed
until we have the medical capability to
influence the basic metabolic problems.
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The Virgin, Modified, Human, Umbilical Vein Graft:
Morphologic Characteristics and Mechanical Properties
The a uthors used m acro p h o to g ra p hy,
endoscopy, roe n tg e n o gra p h y, lig h t m icro
scopy, and tran sm issio n and scanning
electron m icro sco p y to assess th e mor
phologic c h a ra c te ris tic s o f 37 virgin,
human, u m bilical vein g ra fts. The speci
mens sh ow ed deep lo n g itu d in a l folds
(22 % ) and m u ltip le transverse fo ld s of
the in tim a l surface (2 7 % ), irre g u la rity o f
w all th ickn ess (4 1 % ) and in tim a l break
do w n exposing th ro m b o ge n ic layers of
the vein w a ll to blood (19 % ).
The m echanical properties also studied
w ere dynam ic com pliance, Y o u n g 's
m odulus, breaking s tre n g th and breaking
strain. The mean d yn a m ic com pliance
was 6 .4 4 x 1 0 - 4 m m H g ~ 1 (SD =
2 .0 2 x 1 0 “ 4 m m H g ~ \ i.e ., 3 1 % ),
w h ich is in agreem ent w ith resu lts of
others. The specim ens sh ow ed great
va ria b ility in Y o u n g 's m odulus, breaking
stren g th and breaking strain.
The s tru c tu ra l deficiencies and variable
m echanical p roperties o f hum an umbilical
vein g ra fts require in ve stig a tio n to deter
mine th e ir e ffe c t on pa ten cy rates due to
increased th ro m b o g e n ic ity and th u s to
establish w h e th e r there are p o te n tia l haz
ards associated w ith th e ir use.
Les auteurs o n t a n a ly s t les caracteristiques m orphologiques e t les propri£t6s
mScaniques de 3 7 segm ents de prothfe-
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ses art6rielles D a rdik-B io g ra ft vierges.
Leur m orphologie a 6t6 pr6cis6e par
une s6rie d'exa m e n s: observation
m acroscopique, endoscopie, angiographie, m icro sco p ie o p tiqu e , m icroscopie
g le ctro n iq u e & balayage e t m icroscopie
d le ctro n iq u e a tran sm issio n. Les veines
p r6 se n te n t frS quem m ent des depressions
lon g itu d in a les (2 2 % ) e t de m ultiple plis
de la surface lum inale (2 7 % ). Les parois
s o n t d '6paisseurs variables (41% ) e t la
surface lum inale pr6sente des ruptures
qui e xp o sen t les couches internes de la
paroi au sang (1 9 % ).
Les p ropri6t£s m 6caniques S tu d ie s
o n t 6t6 la co m pliance dynam ique, le
m odule d 'Y o u n g , la co n tra in te de rup tu re
e t I'a llo n g e m e n t 6 la rup tu re . La c o m 
pliance d ynam ique s '6 ta b lit a 6 .4 4 x
1 0 ~ 4 m m H g " 1 (SD = 2 .0 2 x 1 0 ~ 4
m m H g - 1 , i.e ., 3 1 % ), ce qui corrobore
les rgsu lta ts ob ten u s par d'autres
auteurs. Le m odule d ’ Y oung, la co n 
tra in te de rup tu re e t I'allongem ent d la
ru p tu re so n t e xtrd m e m e n t variables.
Les consequences des faiblesses stru ctu ra le s e t des p ropri6t6s mecaniques
variables sur la perm a b ilite in-vivo des
proth6se art6rielles d o iv e n t etre etablies
en c o n fro n ta n t ces observations aux
resu lta ts cliniques. Les im perfections
c o n s titu te n t des sites privil£gi£s de
th ro m b o se bien que la surface lum inale
des veines om bilicales humaines traite e s
so it th ro m b o r£ sista n te.

Although the human umbilical vein
(HUV) graft has given satisfactory per
form ance in fem orop opliteal and
femorodistal arterial bypass,1'3 its dura
bility requires further assessment. Bio
degradation and aneurysm formation
have been reported,614 but the deficien
cies predisposing to these complications
have not been emphasized.15
Because o f their biologic origin, the
glutaraldehyde-stabilized HUV prostheses
would not be expected to demonstrate
homogeneous mechanical and morpho
logic characteristics. The purpose o f this
study was to analyse the variability o f
these characteristics in a group of virgin,

modified, HUV grafts processed by Meadox Medicals Inc. (Oakland, NJ) and sold
as the Dardik-Biograft.
The morphologic characteristics of
these grafts were assessed by macro
photography, endoscopy, roentgenogra
phy, light microscopy and scanning and
transmission electron microscopy. The
linear density (weight per unit length)
gave a gross index for comparing the
general structure. The mechanical proper
ties — compliance and stress-strain be
haviour — were also studied because of
the importance of the viscoelastic proper
ties o f an arterial substitute for success
ful grafting.16'20
Compliance (Cde) is defined as the
relative change in volume (AV) per unit
change in pressure as follows:

c

dc

=

VAP

= ?ad

DAP

where A D is the change in external
diameter for a change in pressure AP,
and D is the mean external diameter. As
we used external diameters, the dynamic
compliance is identified by Cde.

Material and Methods
Thirty-seven specimens o f HUV grafts
were obtained at the time o f surgery per
formed at three local hospitals (StFranyois d ’Assise, l’Enfant-Jesus and
PHotel-Dieu). The excess segments o f the
grafts were removed at the time of
implant and used for this study. Segments
traumatized by clamps were rejected.
Blood contact with the endothelial surface
had occurred in some specimens. The
specimens were preserved in 1.5%
buffered glutaraldehyde solution. They
were rinsed in distilled water twice and
then immersed in graded solutions o f
ethanol up to 40%.
M orphologic and Pathological Studies
The specimens were weighed and meas
ured to determine their linear density.
Seventeen specimens longer than 2.5
cm were investigated by endoscopy, using
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a 4-mm outer diameter endoscope with a
fibre light “ cold” light unit (Edward
Fletcher and Partners, Richmond, UK).
Twelve HUV prostheses longer than 8
cm were subjected to roentgenography
with Hypaque-M 30% (Winthrop Labor
atories, Aurora, Ont.), containing 30
mg/ml meglumine diatrizoate and 141
m g/m l bound iodine. Views were
obtained in two planes at right angles.
The specimens were then rinsed with
0.9% saline and stored overnight in
saline. They were rinsed again with 0.9%
saline and put back in 40% ethanol ready
for further investigation.
With a Tessovar macrophotography
optical system (Carl Zeiss, Oberkochen,
West Germany), the HUV grafts were
examined externally and short segments
were opened longitudinally for examina
tion of the luminal surface.
Each sample was then divided in three
parts for pathological investigation.
Light microscopy.— After postfixation
in formalin and routine processing, the
slides of all the samples were stained with
Weigert’s resorcin-fuchsin and Masson’s
trichrome to facilitate the observation of
collagen. Some samples were postfixed in
1% aqueous osmium tetroxide solution
with a phosphate buffer at pH 7.2 to 7.3,
dehydrated through graded ethanol solu
tions and then embedded in Epon 812
acrylic resin. Semi-thin sections were
made, stained with paraphenylenediamine
(PPD) or with toluidine blue and
observed in a light microscope with and
without phase contrast.
Scanning electron microscopy.—All
samples were postfixed in 1% thiocarbohydrazide and 1% osmium tetroxide,
rinsed twice in distilled water and
dehydrated in graded solutions of
ethanol. After critical point drying in a
Bomar SPC 1500 apparatus (Bomar Co.,
Tacoma, Wash.) using liquid carbon
dioxide as the transfer medium, the sam
ples were coated with gold under vacuum
using Humer V sputter equipment (Tech
nics Inc., Alexandria, Va). A Jeol JSM
35CF scanning electron microscope
(Soquelec Ltee, Montreal, PQ) was used
at a 15 to 25 kV accelerating voltage.
Transmission electron microscopy.—
These observations were limited to speci
mens prepared in semi-thin sections. Con
trasting of selected areas was achieved
with uranyl acetate and lead citrate stains
before observation in a Philips 300 trans
mission electron microscope (Philips Elec
tronics Ltd., Montreal, PQ).
Mechanical Tests

Morphologic Studies
Macroscopically, the surrounding
Dacron mesh appeared to separate from
and slide off the vein readily since the two
were not attached. Furthermore, the mesh
had been knitted in a very open construc
tion which easily stretched.
When examined by Tessovar macro
photography nearly all the 37 specimens
had two longitudinal folds on their flow
surface running the full length of the
graft. In many grafts these folds were
shallow, but in eight (22%) specimens
they were deep (Fig. 3A). In 10 cases
(27%) the intimal surface had multiple
transverse folds (Fig. 3B) that may cor
respond to the places where the cord had
been straightened during processing.
These specimens showed either numerous
individual folds or their intima looked
crumpled. Fifteen prostheses (41%)
showed irregular wall thickness around
their circumference (Fig. 3C). Of these,
six (16%) showed serious thinning of the
wall (Fig. 3D). In one case, we found a
gelatinous deposit inside the graft. It

Results
Linear Density
The linear density measured on 60 sam
ples from the 37 specimens (with their
polyester mesh) ranged from 0.21 g/cm
to 0.70 g/cm. The mean linear density
w as0.38±0.09g/cm (i.e., 23% standard
deviation). The values of linear density
for the 17 grafts in which more than one
sample was measured are shown in Fig.
1. The variability in linear density was
related to wall-thickness variations as
confirmed by angiography (Fig. 2).

FIG. 2—Angiography of grafts taken in two
planes at right angles. Wall thickness varies
along length of graft.

P ro s th e s is

Fifteen samples from 13 HUV grafts
more than 7 cm long were used to deter
mine the dynamic compliance of the vir
gin HUV prostheses. The specimens were
fixed on the test bench,21 elongated to an
412

additional 10% of their resting length and
subjected to a pulsatile flow of physio
logical saline at a mean pressure of
100 ± 6 mm Hg. The pulse amplitude was
approximately 40 + 6 mm Hg with a fre
quency of 1 Hz. The pressure inside the
specimen was measured with a Millar
Mikro-Tip catheter pressure transducer
PC-671 (M illar In strum ents In c.,
Houston, Tex.). The diameter was meas
ured with a cantilever transducer.21 The
specimens stabilized in a few minutes,
then the pressure variation, mean pressure
and diameter variation were recorded on
a Dynograph recorder R511A (Beckman
Instruments Inc., Schiller Park, 111.).
Stress-strain tests were carried out on
test samples from 26 longitudinally
opened prostheses. The samples were 32
x 5 mm with their long axes along the
longitudinal axes of the vein. The thick
ness of the specimens was measured with
a micrometer model CS-49-055 (Custom
Scientific Instruments Inc., Whippany,
NJ). Three measurements were taken for
each test sample. The tests were per
formed with a model 1130 tensiometer
(Instron Corp., Canton, Mass.) When
possible, several samples were taken from
the same graft. Stress-strain curves were
obtained for grafts with and without their
polyester mesh and for the mesh alone.

No

FIG. 1— Linear density o f 17 grafts measured on two or more samples from each graft.
Horizontal bars represent samples with maximum and minimum linear densities for each
prosthesis.
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FIG. 3—Tessovar observations. (A) Inside view of longitudinally opened graft with deep fold running full length of specimen. (B) Lon
gitudinally opened graft shows multiple transverse folds of inner surface. (C) Irregularity of wall thickness. (D) Thinning of graft wall which
becomes translucent.
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seemed poorly adherent to the intima and
reduced the inner diameter of the graft.
Pathological Studies
The basement membrane of the 37
specimens was relatively smooth, with fre
quent ruptures and occasionally some
remnants o f endothelial cells (Fig. 4). The
internal elastic lamina had been disrupted
in places as a result of mandrel insertion
(Fig. 5A). Seven (19%) o f our human
umbilical vein grafts showed intimal
breakdown. The underlying layers of the
vein wall were visible and accessible to
blood. Some of our specimens had their
flow surfaces exposed to blood before
being harvested. Even if this exposure to
blood flow was very short, the defects
noted above had time to induce acute
thrombotic debris in some instances (Fig.
5B).
Cross-sectional views of the wall again
showed an absence of endothelial cells.
The elastic lamina had a corrugated
appearance close to the luminal surface
indicating a certain degree of contraction.
The subintimal layer showed fascicles of
smooth-muscle cells, most with a longitu
dinal orientation. In some sections a
different orientation was evident and
large areas of W arton’s jelly continuous
with the external perimuscular layer were

observed separating the fascicles of
smooth-muscle cells (Fig. 6). Transmis
sion electron microscopy facilitated the
observation of amorphous areas of elastin
surrounded by microfibrils located
between the lumen and the subjacent
layers of collagen and smooth-muscle
cells (Fig. 7). The ultrastructure of these
cells showed some variability in the degree
of preservation. The cell nuclei were
indented and their perinuclear cisternae
dilated, indicating some cell contraction.
Some cytoplasm ic filam ents were
observed, together with rough endoplas
mic reticulum and some dense bodies. No
nerves or vasa vasorum were evident in
the stroma (Fig. 8).
Mechanical Properties
The dynamic compliance of the 15 sam
ples tested (13 specimens) ranged from
3.75 to 11.77 x 10"4 mm Hg'1. The aver
age value was 6.44 x 10'4 ± 2.02 x 10'4
mm Hg'1 (31% SD). Our results did not
show any dependence of compliance on
the diameter of the graft.
In the two grafts for which two sam
ples were tested, the compliance values
were 8.71 and 5.90 X 10'4 mm Hg'1 for
one graft and 7.31 and 5.53 x 10'4 mm
H g'1 for the other.
A typical stress-strain curve is shown

FIG. 4— (A) Luminal surface is relatively smooth. Endothelium
generally is no longer visible: basement membrane only remains with
some disruption (bar = 100 nm). (B) Exceptionally, small islands of
dead endothelial cells are still visible (bar = 10 nm).
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in Fig. 9. The Young’s modulus* was cal
culated in the quasilinear region before
vein rupture.21 For the HUV graft with
its polyester mesh, the breaking strength
and the breaking strain were determined
by the point of vein rupture (Fig. 9).
The Y oung’s modulus, breaking
strength and breaking strain for the HUV
grafts with and without their mesh and
for the mesh alone are presented in Table
I.

In some specimens, we made two
stress-strain measurements. Figure 10
shows the values obtained for each sam
ple from each specimen.
Discussion
Failures of the modified HUV graft
due to biodegradation and aneurysm for
mation, to intimal breakdown and sus
ceptibility to bacteremic colonization have
been reported.7,Ui13'14 The 41% of speci
mens demonstrating variable wall thick
ness in our morphologic studies and the
considerable variation of linear density
•Young’s modulus (E) is the ratio of stress (a)
present in the material (the applied force per
unit area) to the strain (e) resulting from it and
can be represented by the form ula

FIG. 5—Graft damaged during processing. Luminal surface has
deteriorated and internal elastic lamina is ruptured as result of man
drel insertion (A, bar = 100 nm). This traumatized area is more likely
to trap blood elements when exposed to blood (B, bar = 10 nm).
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FIG. 6—Phase contrast photomicrograph from Epon-embedded graft stained with paraphenylenediamine. No endothelial cells were observed
in this specimen. Note pleated and sharply outlined elastic lamina (EL), wide extracellular space (arrows) in subjacent muscular layers (M).
Perimuscular collagenous fibrous layer is to lower right (original magnification x 400).

A

FIG. 7—Transmission electron micrograph of stabilized graft. Partial view of subendothelial elements separating lumen from subjacent
muscle cells of media and collagen fibres. Elastic lamina (arrows) appears as electronlucent amorphous areas of eiastin surrounded bv microfibrils
(original magnification x 3000).
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between different specimens and between
samples from the same specimen under
line the irregularities in structure of this
biomaterial. Such irregularities are espe
cially important in the very thin wall
specimens (16%) which, when submitted
to blood pressure, will become even thin
ner,3’14 perhaps leading to graft break
down.
Intimal breakdown is a serious defect.
It was present in a substantial proportion
(19%) of our specimens and has been
associated with cases of early graft
failure.11'21 It may be caused by manipu
lation during processing of the graft or
during implantation.

Breakdown of the fragile intima will
expose the thrombogenic layer of the
graft.22 Other irregularities of the flow
surface may lead to turbulence and to
thrombus formation thus explaining
thrombosis even with a theoretically
thromboresistant intimal surface.23,24
Added to the increased thromboxane B2
production in the umbilical graft com
pared with host artery (indicating a low
resistance to platelet adhesion and aggre
gation),25 these phenomena, together
with poor run-off, may cause graft
thrombosis.
The serious implications of bacterial
penetration due to intimal tearing have
been discussed elsewhere.13 This may, in
part, account for the documented high
bacteremic entrapping o f the HUV
graft.26
There are many ways o f determining
and expressing the viscoelastic properties
o f conduits as arteries and arterial
prostheses.20’27-36 Despite some draw
backs, compliance has the advantage of
being an easily determined index of the

or

FIG. 8—Transmission electron micrograph
o f stabilized graft. Partial view of medial layer
which exhibits different degrees of ultrastructural preservation. Note indented nucleus (N),
w ell-preserved nucleolus (N u ), dilated
perinuclear cisterna (arrows). D ilated,
perinuclear, rough, endoplasmic reticulum
(RE) profiles are seen in fibrillar cytoplasmic
areas (original magnification x 4500).

FIG. 9—Typical stress-strain curve obtained
from graft with its polyester mesh demonstrat
ing point of rupture of vein and numerous rup
tures of polyester fibres of mesh, a = stress,
e = strain.

viscoelastic properties of the wall; it is
simply a relative volume change per unit
pressure change. Because we wanted to
work in the physiologic range, the need
to specify the mean operating pressure
was not bothersome. Likewise the use of
external diameters was not of major con
cern since we were merely comparing our
specimens and did not want absolute
values.
Many workers have used external
diameters in their calculations of compli
ance of arteries or prostheses. Our results
are compared with those of others in
Table II;17'20,34-36 the compliance of
human arteries and saphenous vein is also
given.
Compliance characterized the circum
ferential viscoelastic properties of the
HUV graft. The longitudinal properties
were characterized by Young’s modulus.
It is important to note the great variation
in mechanical properties from graft to
graft and between samples from the same
specimen. Rigid prostheses are prone to
occclusion. On the other hand, it is not
unreasonable to speculate that very plia
ble prostheses (great compliance or low
Young’s modulus) may have a tendency
towards dilatation and aneurysm forma
tion. This needs to be investigated, and
we have established an information
retrieval program that will permit such
clinical correlation between morphologic
and mechanical characteristics before
im plantation and the fate of the
implanted grafts.
Microscopic studies showed various
alterations of the structure of HUV grafts
and varying degrees of preservation of
cells. The importance of these findings
needs to be further explored.

Table 1—S tress-S train Characteristics of Human U m bilical Vein G ra fts (HUV)

M easu rem ent
No. of
m easurem ents
M ean
S ta n da rd deviation
%
M inim um
M axim um

HUV
+ mesh

30
11.26
3 .52
3 1.3
6 .96
19.48

Breaking strain

Breaking strength

Young's modulus
(E), M P a

K ) , MPa

HUV

M esh

12
15.07
1 7.60
1 16 .8
1.52

5
20.62
6.19
30.0
11.91

5 7 .5 5

2 8.5 2

HUV
+ mesh

23
1.96
0 .64
32.7
0.98
3.08

HUV

11
2 .76
2.43
8 8 .0
0 .59
7.05

(£„), M P a
M esh

HUV
+ mesh

5
8 .7 3

23
0 .34

2.51
2 8 .8
6 .1 8
12.41

3 5.3
0.17

0.12

0.60

HUV

Mesh

11
0 .48
0 .2 9
6 0.4

5
0.70
0.25
35.7

0 .18
1.21

0.25
0.85

Table II--C om pliance of the Human Um bilical Vein (HUV), Human Saphenous
Vein (HSV) and Human A rteries (HA) in 10~4 mm H g -1 *
A u th ors/year

HUV

S ch u ltz and associates, 1 96 7 36
Lye and associates, 19 7 5 3S
B aird and associates, 1 97 7 20
B o u ch ie rH a y e s, 1 9 7 8 34
W alden and associates, 19 8 0 17
Pre sen t study

_
-

4 .9
(6)
9.1 (22)
7.4 (16)
6 .4 4 (15)

HSV
6.8 (20)
-

—

—

8.8

HA
4 .3 8 t (10)

-

(5)

-

11.84

(8)

-

" R e s u lts have been adjusted to conform to our definition of compliance. The number of specim ens tested is in parentheses,
t R ight external iliac arteries free of atherom a but w ith plaques in aorta or common iliac arteries (autopsy specimens).
TFem oral arteries (autopsy specim ens).
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Conclusions

57.6

Alterations of the intimal surface of the
HUV grafts were frequent. These defi
ciencies may explain the low resistance of
the graft to platelet adhesion and aggre
gation, in spite of its theoretically thromboresistant flow surface. It could also
play a role in the graft’s susceptibility to
bacteremic colonization. In some speci
mens, a thin wall may result in aneurysm
formation.
There is considerable variation in the
mechanical properties from graft to graft
and between samples from the same graft.
The clinical implications of this heter
ogeneity have yet to be established.
6

469 510 621 622 519 535 541 543 621 543 621 Prosthesis
HUV+mesh

HUV

mesh

No

Fig. 10a
12.4
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R. Paynter, J.C. Forest, D. Boyer, G. Drouin,
G. Roy, S. Dube, C. Rouleau and J.F. Girard
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Correction
In the article by A.A. Luoma, C.H.
Scudamore and J.D. Longley entitled
“ Experience with fine-wire localiza
tion breast biopsies for nonpalpable
breast lesions detected mammographically” in the September 1986 issue,
pages 315 to 318, there are two errors.
On page 316, line 6 under the heading
“ Fine-wire localization technique”
should read “ into the suspicious area
through a no. 20” and in Table I on
page 317, in the right hand column,
the number 11 should be followed by
an asterisk indicating p < 0.005.
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BOOKS REVIEW S
continued from page 398
regarding anatomy and urethrography, (e.g.,
the parasympathetic, sympathetic and puden
dal nerves all innervate the periurethral striated
sphincter. In fact only the pudendal nerve
innervates the external striated sphincter [Invest
Urol 1982; 20: 415-416]). In addition, the
described anatomy of the urinary sphincters is
outdated, no mention being made of the intrin
sic sphincter and the value of dynamic retro
grade urethrography in the assessment of mem
branous urethral stricture (Radiol Clin North
A m 1979; 17: 227-243). Apart from these dis
crepancies, the book is well written and illus
trated, and is a comprehensive reference for
the state-of-the-art radiologist and urologist.
This book is recommended to every department
of diagnostic imaging.
R .W . M c C a l l u m , m b , f r c p c , fa cr
Professor of radiology,
St. Michael’s Hospital,
30 Bond St.,
Toronto, Ont.
M5B 1W8
ENDOCRINE ASPECTS OF ACUTE ILL
NESS. Edited by Glenn W . Geelhoed and
Bart Chernow. 350 pp. Illust. Churchill
Livingstone, Edinburgh; Academic Press
Canada, Don Mills, Ont., 1985. $52.75.
ISBN 0-443-08309-6.

With some success, this book attempts to
encompass the broad range o f metabolic and
hormonal difficulties producing and produced
by acute illness. The overall quality is excel
lent, but as usual in a text with many contri
butors, there is variation in style and depth of
coverage.
The two chapters on basic metabolism could
be shortened by the use of more metabolic
pathway drawings. There is much excellent
information, although a serious omission is a
review of lactate metabolism and the effect of
unfitness on recovery, a serious problem in the
elderly and chronically sick people.
The chapter on problems in younger patients
is an excellent review for an “ adult” internist,
but it does not provide sufficient detail for the
practising pediatrician. The chapter on thyroid
function is verbose and occasionally confus
ing, covering too wide a range and presenting
too little detail on the effects of the acute ill
ness on thyroid function. The review of adrenal
cortical function is clear and practical.
Prostaglandin metabolism is excellently
covered, but since it is divided into two chap
ters there is much overlap. The chapters on cal
cium, phosphate and magnesium metabolism
in the critically ill are excellent and a clear
reminder that these are common disturbances
in the seriously ill.
The chapters on management of hyperglyce
m ia, pheochrom ocytom a, diabetic and
hyperosmolar coma, and nutrition are all
useful.
Neuropeptides in shock and trauma is a
masterful overview of the present state of the
art, providing many insights into the possibil
ities of manipulation of this system in the
future.
Overall, the book could have been shortened
and clarified by more ruthless editing. Despite

this it remains an excellent text with provoca
tive ideas to promote further work. It would
be of most value in an intensive care unit, par
ticularly in a teaching hospital, not only for
reference to those often-forgotten causes of
hypocalcemia, but also as a stimulus for fur
ther reading and research.
G . J o n e s , m b , bs , fr c pc
Director,
Intensive Care Unit,
Ottawa General Hospital,
Ottawa, Ont.,
K1H 8L6
H E M A T O P O R P H Y R IN DERIVATIVE
PHOTORADIATION THERAPY OF
CANCER. Edited by Michael W. Berns.
133 pp. Illust. Alan R. Liss, Inc., New
Y ork, 1984. $29.50 (U S ). ISBN
0-8451-0237-0.

Although the idea behind this text originated
25 years ago, for most of us this is a new and
fascinating subject. The 14 contributions
include an excellent introduction to the sub
ject in the form of a preface by the editor. In
addition to therapeutic applications there is a
section describing the use of this modality in
diagnosis. Excluding the exposure tables at the
end of the book, there are 109 pages so that
even the busiest physician or surgeon should
have the time to read it. The articles are
intended for experts, but are so well written
they will be comprehensible to the beginner.
Specific details of material and methods are
included. The thickness of tumour that can be
treated by this method is necessarily limited,
but the range of interest by site includes lung,
bladder, brain, prostate and skin. Different
ways in which lasers can be used are described
including frontal illumination, light diffusion
media and embedding of the fiberoptic tip.
Potential complications and precautions are
dealt with in some detail.
I would recommend the book to all oncolo
gists whether surgical, medical, radiation, or
diagnostic. It will also be of interest to determatologists and ophthalmologists. One of the
strongest impressions the book creates is that
this is a field of potential research. For those
already expert in this field, there is the attrac
tion of material from China, not generally
available.
D av id F. R id e o u t , m b , f r c p c , fr cr
Chief, Department of Diagnostic Radiology,
Ontario Cancer Institute,
Toronto, Ont.
M4X 1K9
MANAGEMENT OF SPINAL DEFORMI
TIES. Orthopaedics 2. Edited by Robert A.
Dickson and David S. Bradford. 331 pp.
Illust. Butterworth & Co. (Publishers)
L td ., B oston , 1984. $39.95. ISBN
0-407-92347-X.

In recent years the treatment of spinal defor
mities has undergone major advances. Surgi
cal breakthroughs such as segmental spinal
instrumentation and Zielke anterior instrumen
tation, coupled with modern techniques in
bracing and electrical stimulation have enabled
continued on page 459

VOLUME 29, NO. 6, NOVEMBER 1986 / THE CANADIAN JOURNAL OF SURGERY

P.

Gregory H ayes ,

md ;

O ri

D.

Rotstein ,

md , frcsc

Gastrointestinal Phytobezoars:
Presentation and Management
A chart review fro m 1 9 7 5 to 1 9 8 5 at
the T oro n to W estern H o spital id entified
16 patients (9 w om en and 7 m en,
betw een the ages o f 3 9 and 8 3 years)
w ith gastro in te stin a l p h ytob e zo a rs. Nine
had previously undergone v a g o to m y and
drainage procedures. There w e re tw o
d is tin c t clinical groups, d e p en d e n t on the
location o f the bezoar: nine p a tie n ts w ith
isolated gastric bezoars presented w ith
chronic burning ep ig astric pain and
nausea and v o m itin g in a d d itio n to
anorexia and w e ig h t loss. Six o f seven
patients w ith sm all-bow el bezoars had
acute sm all-bow el o b stru ctio n ,
m anifested by cram py a b dom inal pain,
vom itin g and o b stip a tio n . In th e seventh
patien t th e bezoar w as fo u n d incidentally
in an e ffe re n t loop during endoscopy.
G astric bezoars w ere all diagnosed by
endoscopy; patien ts w ith sm all-bow el
bezoars had x-ray film s c o m p a tib le w ith
sm all-bow el o b stru ctio n . The o b stru ctin g
sm all-bow el bezoars w e re fo u n d a t m id
ileum and proxim al je ju nu m . Five patients
u n d erw e n t proxim al e n te ro to m y w ith
bezoar rem oval; in one th e bezoar was
milked distally in to the cecum . One
patien t also had m ultip le n o n o b stru ctin g
sm all-bow el bezoars rem oved th ro u g h
the single e n tero to m y and a n o th e r had a
separate g a stro to m y fo r rem oval o f a
g astric bezoar. The p o stop e ra tive
courses w ere unco m p lica te d e x c e p t for
w ound in fe c tio n in one p a tie n t. None of
the patients w ith an isolated g a stric
bezoar required surgery. T hree patients
w ere successfully treated w ith ga stric
lavage and th e others w ith clear flu id
diet.
Line etude des dossiers com piles de
1 9 7 5 a 1 9 8 5 au T oro n to W e ste rn Hospi-
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ta l a perm is d 'id e n tifie r 16 patients (9
fem m es et 7 hom m es ages de 3 9 a 8 3
ans) porteurs de phytobezoards g a stro inte stin a u x. N euf avaient prealablem ent
subi des operations de va gotom ie e t de
drainage. Selon la localisation des
bezoards on a id e n tifie d e u x groupes cliniques d istin cts: n e u f p a tien ts avec des
bezoards gastriques isoles, qui o n t et6
vus s o u ffra n t de brulure epigastrique

o f hair), phytobezoars (made up o f fruit
and vegetable fibres) and trichophytobezoars (a mixture o f the tw o).
Although rarely found in humans,
phytobezoars can occur in the stomach or
small intestine. W e carried out a 10-year
retrospective review o f the clinical presen
tation and management o f phytobezoars
in these two separate locations.

chronique, de nausees et de vom issem ent, accom pagnes d'an o re xie et de
perte de poids; six des se p t patients p o r
teurs de bezoards dans I'in te stin grele
avaient une o b stru ctio n aigue du p e tit
in te stin qui s 'e s t m a n ife sts par des cram pes abdom inales, des vom issem ents e t
une co n stipa tio n opiniatre. Chez le septiem e patien t le bezoard a ete d e co uve rt
dans une anse e ffe re n te a I'occasion
d 'u n e endoscopie. Les bezoards g a s tri
ques o n t tous ete diagnostiques a
I'endoscopie; les p a tien ts porteurs de
beozards de I'in te s tin grele o n t presente
des radiographies co m p a tib le s avec une
o b stru ctio n de I'in te s tin grele. Les
bezoards o b stru a n t I'in te s tin grele o n t
£te d ecouverts au niveau de I'ileon
m oyen et du je junum proxim al. Cinq
p a tien ts o n t subi une entero to m ie pour
enlever le bezoard; dans un cas, le
bezoard a ete pousse dans le caecum.
Chez un patien t plusieurs bezoards situ e s
dans I'in te stin grele mais qu i ne causaient pas d 'o b s tru c tio n o n t ete enleves
a trave rs une e n tero to m ie unique; chez
un autre, on a procede a une gastrotom ie separee pour I'e n le ve m e n t d 'un
bezoard gastrique. A I'e xce p tio n d 'u n
p a tie n t qui a s o u ffe rt d 'u n e in fe ctio n de
plaie, 1'evolution p o stop e ra toire des
p a tien ts a ete sans h istoire. Aucun des
p a tien ts qui avaient un bezoard gastrique
isol6 n 'a necessity de chirurgie. Trois
p a tien ts o n t et6 tra ite s avec succes par
lavage gastrique, e t les a utres par une
diete hydrique.

Methods

The term bezoar is derived from the Per
sian word “ padzahr” meaning “ to expel
poison” .1’2 In ancient times, bezoars
from goats and antelopes were ground up
and ingested as remedies for disease and
antidotes to poison. Bezoars may be one
o f three types: trichobezoars (composed

The charts o f patients admitted to the
Toronto Western Hospital between 1975
and 1985 with phytobezoars o f the gas
trointestinal tract were reviewed. The
diagnosis was confirm ed either by
endoscopy or at laparotom y in 16
patients.
The review sought inform ation about
the location o f the phytobezoars,
predisposing factors, presenting symp
toms, endoscopic findings and the
method and results o f therapy.
Findings

Nine patients had bezoars confined to
the stomach and seven had small-bowel
bezoars. One patient had concomitant
small-bowel and gastric bezoars. There
were nine women and seven men who
ranged in age from 39 to 83 years (mean
61.7 years).
Predisposing factors were identified in
all patients (Table I). The presence o f den
tures and previous va gotom y with
drainage procedures were the most com
mon findings. Eight patients had both
causative factors. The average time from
vagotomy and drainage to the develop
ment o f symptomatic phytobezoars was
7.5 years (range from 6 months to 14
years). Three patients, with no related
surgical or medical condition, had evi
dence o f gastric stasis on barium contrast
x-ray films or nuclear gastric-emptying
scans.
Presenting symptoms varied with the
anatomic location o f the bezoar (Table
II). Nine (56% ) patients had isolated gas
tric phytobezoars and complained o f
long-term intermittent epigastric pain.
Small-bowel phytobezoars were found in
seven (44% ) patients, six o f whom had
symptoms o f acute small-bowel obstruc-
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tion. In the seventh patient, whose
symptoms mimicked those of a patient
with a gastric phytobezoar, the smallbowel bezoar was found incidentally in
an efferent loop of a Billroth II gas
trojejunostomy during endoscopy.
All gastric bezoars were diagnosed at
endoscopy. Associated findings included
gastritis (two patients), stomal ulcer (one)
and gastric carcinoma (one). Obstructing
small-bowel bezoars were diagnosed at
laparotomy.
The gastric phytobezoars were all
treated conservatively. Three patients
underwent saline lavage during or after
gastroscopy and five patients were given
a clear fluid diet. All were free of bezoars
within 7 days, as noted by repeat
endoscopy or upper gastrointestinal
series, and obtained relief of their symp
toms. One patient with unresectable gas
tric carcinoma received no treatment. Five
patients were subsequently placed on
long-term metoclopramide therapy.
Patients with obstructing small-bowel
phytobezoars (mid-ileum in four, prox
im al jeju n u m in tw o) underw ent
laparotomy. In five, the bezoar was
removed through a transverse enterotomy
proximal to the site of obstruction, while
in one patient it was milked distally into
the cecum. One patient, in addition to the
obstructing bezoar, had multiple smallbowel bezoars, which were removed
through the same enterotomy. Another
required a separate gastrotomy for the
concomitant removal of a gastric bezoar.
There was a single postoperative wound
infection but no deaths. The patient with
an efferent-loop small-bowel bezoar was
treated successfully with a clear fluid diet.
Discussion
Phytobezoars have known predispos
Table 1-Factors Predisposing to
Bezoar Formation
Factor
Dentures
Vagotomy with drainage
Idiopathic gastric stasis
H2 blocker therapy
Type 1 diabetes mellitus
Carcinoma of the stomach

Symptom
Pain
Nausea/vomiting
Anorexia
Weight loss
Obstipation
Early satiety
Duration of symptoms

4 20

No. (%)
13(81)
9(56]
3(19)
2(12)
1 (6)
1 (6)

ing factors. A key element in the develop
ment of nonpersimmon phytobezoars is
gastric stasis,3’4 whether induced by gas
tric surgery, related to an underlying med
ical condition or idiopathic in nature.5
Brady4 noted delayed gastric emptying in
8 of 12 patients with phytobezoars. Con
tributing factors in the postgastrectomy
setting include reduced acid-pepsin secre
tion, chronic gastritis leading to increased
secretion of mucus and loss of pyloric
function permitting large boluses to enter
the intestine. A history of gastric surgery
was present in 56% of our patients, and
the average time from surgery to bezoar
formation was 7.5 years, an interval simi
lar to that reported by others.6 Medical
conditions producing gastric stasis include
insulin-dependent diabetes mellitus, as
noted in one patient, and hypothy
roidism.5 Idiopathic gastric stasis, con
firmed radiologically or by nuclear scan
ning was identified in three patients.
Other associated factors have been
noted. Edentulous patients may be at risk
due to inadequate mastication resulting
in large boluses of food entering the
stomach.5 Also reported7 is an associa
tion between H2 blocker therapy in the
elderly and phytobezoar formation,
presumably related to lowered gastric
secretion and reduced gastric emptying.
Both our patients receiving H2 blocker
therapy were over 80 years old, with no
history of gastric surgery. Finally, intake
of cellulose-rich fibrous fruits, frequently
oranges, may contribute to phytobezoar
formation in patients who have under
gone gastric surgery.s’8'9 No specific
dietary factors or persimmon bezoars
were noted in our patients; they appear
to have a different pathogenesis. Persim
mons contain shiboul, a tannin that poly
merizes in the presence of hydrochloric
acid and produces a sticky mass.5*6 Per
simmon bezoars may form regardless of
whether a patient has undergone gastric
surgery.
Chronic burning epigastric pain,
associated with nausea, vomiting and
weight loss constituted the major symp
toms in patients with gastric bezoars.
Diagnosis is made by endoscopy or upper
gastrointestinal series, although it may be
suspected by the appearance of a grossly
distended stomach with particulate mat

Table II—Presenting Symptoms
Gastric bezoar
(n - 9)
8
(epigastric, burning)
7
3
2
2
chronic
(months)

Small-bowel bezoar
In - 7)
6
(central, crampy)
6
1
-

4
1
acute
(hours)

ter on abdominal supine x-ray film.10
The treatment of choice for gastric
phytobezoars is nonoperative, consisting
of gastric lavage or clear fluid diet. Pro
teolytic enzymes alone or combined with
endoscopic removal have been used suc
cessfully to dissolve the bezoar.5’8’11 The
dissolution should be gradual, since intes
tinal obstruction may occur after frag
mentation and migration of the gastric
bezo ar.12 U lceration, perforation,
obstruction or gastritis can result from
prolonged enzymatic or mechanical treat
m ent.8 Rarely, gastrotom y may be
required.
DeBakey and Ochsner2 reported that
small-bowel obstruction was the most
common com plication o f bezoars.
Phytobezoars presenting as acute intesti
nal obstruction require operative manage
ment. In the absence of large-bowel stric
tures, attempts should be made to milk
the bezoar distally into the cecum. If this
fails, proximal enterotomy is required;
other small-bowel bezoars should be
removed through the same enterotomy.
DeBakey and Ochsner2 also recom
mended that the stomach should be pal
pated at surgery and if a gastric bezoar
is present (as in one of our patients), it
should be removed through a gastrotomy.
Since phytobezoars may recur in up to 33%
of patients,4,11 those with gastric stasis
should be advised that raw fruits or
stringy vegetables must be chewed
thoroughly and eaten slowly. Drugs to
stimulate gastric motility, such as
metoclopramide, can be added in an
effort to reduce the possibility of recur
rence.3’13
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Long-Term Results of Hyperselective Vagotomy
for Duodenal Ulcer
Although considered by many as the
operation of choice in the treatment of
duodenal ulcer, hyperselective vagotomy
without drainage is not unanimously
accepted because little is known about
its long-term efficiency in preventing
ulcer recurrence.
The long-term results of 20 3 patients
with duodenal ulcer, treated by hyper
selective vagotomy between 1974 and
1983 at the Hopital Laval, are reported.
Patients were followed at yearly intervals
and questionnaires were used to deter
mine whatever benefits they perceived.
The procedure was found to be a safe
one with an uncomplicated postoperative
course. The overall recurrence rate was
12% over a mean follow-up of 64
months. Recurrences may occur 5 or
more years after surgery. The operative
technique is important in preventing
recurrence. Dissection of the last 6 cm
of esophagus lowered the recurrence
rate at 5 years from 21% to 9% .
Only four patients required reoperation.
The majority of recurrences consisted of
a single episode, the ulcer being easily
controlled by short-course medical treat
ment. The authors found that 94% of
patients were satisfied with the results
of the operation.
Alors que la vagotomie hyperselective
sans drainage est consideree par plusieurs comme I'opdration de choix dans
le traitement de I'ulcere duodenal, son
acceptation ne sera pas unanime aussi
longtemps que les resultats a plus long
terme ne seront pas mieux connus.
Le present rapport comporte les resul
tats a long terme de 203 patients qui
ont subi une vagotomie hyperselective
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pour ulcdre duodenal entre 1974 et
1983. Ces patients ont ete suivis annuellement et des questionnaires ont ete
employes pour mesurer le degre de satis
faction des patients.
La vagotomie hyperselective est une
procedure sure avec evolution postoperatoire simple. Le taux de recidive est de
12% pour un suivi moyen de 64 mois.
Les recidives peuvent survenir plus tard
que 5 ans post-chirurgie. La technique
de I'operation est importante pour preve
n t la recidive. Une meilleure dissection
de la partie inferieure de I'oesophage a
fait chuter le taux de recidive a 5 ans de
21% a 9% .
L'etude fait aussi ressortir revolution
benigne des recidives. Seulement quatre
patients ont du etre reoperes. La majorite
des recidives a consists en un seul epi
sode d'ulcere facilement controlable par
un bref traitement medical. L'evaluation
du degre de satisfaction des patients
montre que pres de 94% d'entre eux
sont satisfaits des resultats de I’operation.

Hyperselective vagotomy without
drainage is considered in many centres to
be the operation of choice for duodenal
ulcer. Its acceptance, however, is not
unanimous because the long-term effica
cy with respect to ulcer recurrence is not
yet well documented.
Thus, many surgeons still do conven
tional procedures despite increased oper
ative morbidity and more long-term
problems relating to disturbed gastric
physiology.
This paper reflects our experience over
the past 10 years with hyperselective
vagotomy without drainage as the surgi
cal treatment for complicated or uncom
plicated duodenal ulcer. Operative mor
bidity and recurrence rates during
long-term follow-up are emphasized.
Patients and Method

Between 1974 and 1983, 203 patients
(161 men, 42 women) underwent hyper
selective vagotomy as treatment for duo
denal ulcer. Ages ranged from 22 to 83
years (mean 54 years).

Indications for surgery — ulcers resis
tant to medical treatment (145) and ulcers
with complication (58) — were identical
throughout the period. In the former
group, the period between diagnosis of
the ulcer and surgical treatment averaged
11.4 years. Among the whole group,
81 (40%) patients received medical treat
ment for more than 6 months before sur
gery and 87 (43%) needed at least one
period of hospitalization for their ulcer
disease. In the latter group, surgery was
indicated because of hemorrhage (36),
pyloric stenosis (14) and ulcer perforation
( 8).

With all elective cases, the preoperative
studies included a gastric secretion test.
(Basal acid output represents the sum of
four 15-minute samples obtained before
pentagastrin was given and maximal acid
output represents the sum of the four
15-minute acid output determinations
after injection).
The original surgical technique, as
described by Johnston and Wilkinson1
and Goligher2 was used until 1977. Then
special attention was paid to dissecting the
last 6 to 7 cm of the esophagus. Others3
had demonstrated that this improved the
results.
In 50 (25%) patients concomitant
procedures were added to the vagotomy
(cholecystectomy in 25, hiatal hernia
repair in 20, gastrostomy in 8 and closure
of perforated ulcer in 8).
Follow-up
All 203 patients were followed-up
annually as out-patients and were
required to complete a questionnaire spe
cifically designed to determine the
benefits of the operation, as perceived by
that patient. We classified patients as
being totally satisfied, moderately satis
fied or disappointed by the operation. We
also inquired about recurrence of sym
ptoms or the need for medication. If a
patient had gastrointestinal complaints,
the barium-swallow x-ray film or
endoscopy was repeated.
The rate of ulcer recurrence was calcu
lated from actuarial recurrence curves.
Because of changes in technique we com-
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pared the results for patients who had sur
gery before 1977 with the group who had
surgery after that year. The probability
of recurrence for each group was calcu
lated and compared according to the onetailed z value (p < 0.05) on a survival
curve.4 Calculations were done using the
time of symptom recurrence.
Findings

There were no operative deaths. The
overall complication rate was 3% —
esophageal fistula, gastrointestinal
hemorrhage, evisceration and pulmonary
embolus in one patient each and pulmo
nary infections in two. There were four
wound infections.
Among 153 patients who had hyperselective vagotomy only, 72 (47%) left the
hospital 4 days after operation and 125
(82%) were home by postoperative day
5. The average time between surgery and
discharge was 5.5 days.
Twelve patients died of unrelated
causes during the follow-up period. Of
the 98% answering the questionnaire,
80% were totally satisfied with the result
while 14% were moderately satisfied and
6% were disappointed. At the time of the
last follow-up (excluding those who died
[12] and those who had to be reoperated
on [4]), 161 (88%) patients had either no
gastrointestinal symptoms or minimal
complaints that did not require medical
attention. A further 16 (9%) had to take
antacids or cimetidine for ulcer symptoms
and 6 (3%) were under medical treatment
for recurrence at the time they completed
the questionnaire.
Recurrence
Twenty-four (12%) patients had
documented recurrence of their ulcer dis
ease during an average follow-up of 64
months. The interval between operation
and recurrence varied from 3 to 79
months (mean 38.2 months).
In 13 of the 24 the recurrence consisted
of a single episode that was successfully
treated medically; in 7 medical treatment
was required intermittently over the years
and in 4 a second operation was neces
sary. All second operations were per
formed within 2 years of the original
operation.
Three of the four patients had an
antrectomy and one a pyloroplasty. No
patient needed reoperation during the last
7 years of follow-up. For 16 patients the
recurrent ulcer was in the duodenum. Five
patients had recurrent gastric ulcer and
three a pyloric ulcer. There was no
increased incidence of recurrence in
patients who had pyloric or prepyloric
ulcers (3 of 33) or in patients with pyloric
obstruction (1 of 14).
A comparison was made of the recur
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rence rate in the 65 patients who under
went operation before 1977 (original
operation) and the 138 patients treated
after 1977 (longer esophageal dissection).
The probability of recurrence in each
group is shown in Fig. 1. The refinement
in technique resulted in a marked
improvement in the recurrence rate at 5
years. The probability of recurrence at 5
years for those operated on before 1977
was 21% compared with 9.3% for those
treated after 1977.
Analysis of gastric secretions done
preoperatively in 154 patients failed to
show any significant difference between
the number who eventually had recurrent
ulcer and those who did not. This is in
accordance with our previous report.5 In
19 patients who had recurrent ulcer, the
average base acidity was 7.2 mmol/L
(ranging from 0.1 to 16.6 mmol/L) and
28.2 mmol/L (ranging from 6 to 54
mmol/L) for maximum acidity. Of the
132 patients in this group who did not
have recurrent ulcer, the mean base acidity
was 5.2 m m ol/L (ranging from 0.1 to 37
mmol/L) and the mean maximum acidity
was 24.8 m m ol/L (ranging from 1.5 to
70 mmol/L).
Discussion

The operation of hyperselective vagot
omy is generally effective for short-term
control of duodenal ulcer, but more long
term evaluation is required. In that
respect, it parallels previous experience
with gastroenterostomy, which was
thought to be an adequate procedure, but
for which a high recurrence rate was
found on long-term studies. In our opin
ion the long-term results for hyperselec
tive vagotomy are quite different.
In evaluating the results of surgical
treatment of duodenal ulcer, it is impor
tant to remember that the disease is
benign and that, for most patients, med
ical treatment is satisfactory. Therefore
any kind of surgical approach must not
create more problems for the patient than
the disease itself. Surgery should be safe,

#N = *
N =«

give excellent control of the disease and
have minimal effects on the gastrointes
tinal physiology.
This study shows that hyperselective
vagotomy is a safe procedure associated
with an uncomplicated postoperative
course. Most patients have returned home
5 days after operation and operative
morbidity is comparable to or even lower
than that for most other surgical proce
dures for duodenal ulcer.
The overall recurrence rate of 12% is
comparable to recent results.6-14 The
data also suggest that recurrences may
occur 5 or more years after surgery so that
a long follow-up is necessary to obtain
meaningful results. The technique of
hyperselective vagotomy appears to be
important in the incidence of recurrence.
Dissection of the last 6 cm of the esopha
gus has lowered the recurrence rate at 5
years from 21% to 9.3%, and this is simi
lar to the experience of others.2,3,9-11 The
rate does not seem to be influenced by the
anatomy of the ulcer or by the presence
or absence of pyloric obstruction at the
time of surgery.
The favourable presentation of recur
rences after hyperselective vagotomy is
well known8 and is emphasized in this
series. Only 18% (4 of 24) of patients who
had a recurrence needed reoperation;
50% had only one episode that was eas
ily controlled by a short course of medi
cal therapy. These numbers differ some
what from reported studies6,15 in which
reoperation varied from 50% to 80% of
all recurrences. There is no explanation
for this apparent discrepancy.
Secondary effects of the procedure on
the gastrointestinal tract are uncommon.
We tried to evaluate these side effects by
having the patients complete a question
naire so that unsolicited answers could be
obtained. The results showed that 94%
of patients were totally or moderately
satisfied by the operation. Dumping syn
drome, diarrhea or food intolerance were
infrequent, an important consideration
when compared with other procedures for
duodenal ulcer.
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FIG. 1—Duodenal ulcer recurrence rate after hyperselective vagotomy for patients oper
ated on before (circles) and after (squares) 1977. * = number of patients available at end of
each period.
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Conclusions

This procedure has minimal operative
morbidity and the postoperative course is
usually uncomplicated. Most patients are
satisfied with the result of their operation,
and have a feeling of well-being; gastroin
testinal side effects are infrequent.
The rate of recurrence is low and in most
cases can be treated effectively by medi
cal therapy. The operative technique is
important in that it should include dissec
tion of the last 6 cm of the esophagus.
It is important to evaluate the overall
improvement of the patient as well as the
rate of recurrence of ulcer disease when
assessing the results o f surgery. Hyperselective vagotomy provides improvement
in gastrointestinal symptoms and an
acceptable rate o f ulcer recurrence.
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S E S A P V Question
33.
Which o f the following signifies the poorest prognosis for patients
with pyogenic abscess of the liver?
(A)

Anaerobic bacteria in the abscess

(B)

Loculations within the abscess cavity

(C)

Advanced age o f the patient

(D)

Jaundice

(E)

Multiple abscesses

For the critique of Item 33 see page 428.
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Predicting Septic Related Mortality
of the Individual Surgical Patient
Based on Admission Host-Defence Measurements
In ord e r to assign a num erical p ro b a b ility
o f s e p tic related death fo r a given
p a tie n t, th e fo llo w in g data w ere recorded
fo r 4 6 1 pa tie nts on adm ission to the
Royal V ic to ria H ospital in M o n tre a l fo r
m ajor surgical tre a tm e n t: age; delayedty p e h y p e rs e n s itiv ity (DTH) skin -te st
score; to ta l serum protein level; serum
a lbum in level; circu la tin g hem oglobin
level; n e u tro p h il adherence; p o lym o r
p h o nu cle a r chem otaxis; and sex. Logistic
regression w a s used to generate a
p re d ic tiv e e q uation o f the fo rm :
P j death | = 1 - { 1 + e x p [1 .3 4 3 - 1 .3 7 2
(album in) - 0 .1 7 3 In (DTH score) +
0 .0 2 6 (a g e ) - 0 .5 2 2 (s e x )]} - 1
(w h e re P is the p ro b a b ility o f death and
exp is th e exp o ne n tia l fu n ctio n ) th a t
co u ld be used to calculate th e actual
p ro b a b ility o f se p tic related death fo r an
in d iv id u a l p a tie nt. The p re d ictive
a ccu ra cy o f th is equation w a s te ste d on
a separate, pro sp e ctive ly co lle cte d data
base o f 6 2 5 surgical patients. There was
an e xce lle n t f it o f th e m odel. There w ere
6 8 se p tic related deaths w h e re 6 7 .2
w e re predicted. It is n o w possible to cal
cu la te precisely th e p ro b a b ility o f a sep
tic related death o f a given surgical
p a tie n t upon adm ission to the hospital.
T his should prove useful in clinical
d ecision-m aking.
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Dans le b u t d'assign e r une probability
num erique de deces par sepsie, les donnees qui s u iv e n t o n t ete enregistrees pour
461 paients lors de leur adm ission a
I'H o p ita l Royal V icto ria de M ontreal pour
une in te rve n tio n chirurgicale majeure:
age; score cutane d 'hyp e rse n sibilite
retarde (DTH); taux serique de proteines
to ta le s; ta u x serique d 'album ine; taux
d 'h e m o g lo b in e circu la nte ; adherence des
polynucleaires neutrophiles; chim iotaxie
des polym orphonucleaires; e t sexe. Une
analyse de regression logistique a ete utilisee pour generer une equation previsionnelle a ya n t la fo rm e suivante
P | deces | = 1 - {1 + exp [1 .3 4 3 1 .3 7 2 (album ine) - 0 .1 7 3 In (score DTH)
+ 0 .0 2 6 (age) - 0 .5 2 2 (sexe )]}-1
(ou p est la p ro b a b ility de dyces et exp est
la fo n c tio n exponentielle). Cette equation
p o u rra it e tre utilisee pour calculer la pro
b a b ility de dyces par in fe ctio n d ’ un
p a tie nt donne. L e x a c titu d e previsionnelle
de cette e q uation a ete m ise a I'epreuve
sur une serie independante de donnees
ceuillies de facon pro sp e ctive chez 6 2 5
pa tie nts de chirurgie. Le m odele mathem atique a o ffe rt une exceliente correla
tio n . On a enregistre 6 8 dyces par in fe c
tio n alors q u 'o n en avait prevu 6 7 .2 . II
est m ainte n a n t possible de calculer de
facon precise la p ro b a b ility de deces par
in fe ctio n d 'u n pa tie nt lors de son adm is
sion a I'h o p ita l. Ceci d e vra it fa cilite r les
prises de decision clinique.

There are three determinants of infection:
environment, such as an intact skin or
bowel mucosa; bacteria; and host-defence
mechanisms. The environment must be
disturbed during a surgical procedure.
Surgical attitudes and techniques, such as
operating with minimal tissue damage,
have reduced the risk of this determinant.
Bacteria can be minimized with adequate
skin disinfection, bowel preparation and

preoperative administration of antibi
otics. What remains is to understand and
improve host-defence mechanisms. A
means of globally assessing host-defence
was introduced 10 years ago by MacLean
and associates.1 They used the delayedtype hypersensitivity (DTH) skin-test
response to recall antigens2 as a predic
tor o f clinical outcome in surgical
patients. Anergic patients (those with no
response to any antigen) had higher rates
o f sepsis and death compared with reac
tive patients. This work has been con
firmed by others,3-10 although there are
some contrary views.11
The difficulty in accepting these find
ings and, more important, their use in
clinical practice, suffers from the inabil
ity to apply them to the individual patient.
For example, if one is presented with 100
anergic patients on admission to the
hospital, one can deduce, based on previ
ous findings in 2202 patients,12 that 33
o f them will die of septic related compli
cations during their hospital stay.
However, one cannot point out which
particular patient will die. What a surgeon
needs is a means o f assigning a probabil
ity o f a septic related death to an
individual patient on whose condition he
must make a clinical decision. By having
this information, he can then take
appropriate measures to minimize the
risk.
The purpose of this study was twofold:
(a) to develop a predictive model that
could assign a probability of septic related
death to an individual surgical patient on
admission to hospital, using those meas
ures of host defence that have been shown
previously to affect clinical outcome; (b)
to test the validity o f the predictive model
on a separate, prospectively collected,
surgical patient population.
The outcome of most importance fol
lowing hospitalization is death, which was
chosen as the dependent variable in this
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analysis, since it is irreversible and must
be prevented. Previous data have
associated septic and nonseptic related
complications with depressed host
resistance. Such outcomes can be equivo
cal. Major septic episodes such as bactere
mias can be missed unless frequent, rou
tine, blood cultures are performed in all
patients. Intra-abdominal abscesses,
although suspected, cannot always be
proven. Death cannot be missed and can
only occur once. With this outcome we
could derive a prognostic equation that
would satisfy all statistical assumptions
and predict a clinically useful and une
quivocal event.

* >

r*

Patients and Methods
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To achieve the purpose of the study,
that is, to develop a predictive equation
in a large number of surgical patients that
can be applied to all major surgical
admissions, a heterogeneous group of
patients was purposely studied. In the
first part of the study, we evaluated 499
patients who were admitted to the wards
and the surgical intensive care unit of the
Royal Victoria Hospital over 1.5 years.
The study was approved by the hospital
ethics review board concerning human
experimentation. All patients were
assessed within 24 hours of admission.
This included patients admitted for major
surgery (not such procedures as
cholecystectomy and herniorrhaphy) and
those who sustained traumatic injuries.
Some patients were operated upon at
other hospitals and were transferred to
the Royal Victoria Hospital for tertiary
care because of severe complications. A
history and physical examination was
done on all patients upon admission to
the study, taking care to note the presence
of sepsis.

>

Host-Defence Measurements

V

Skin tests were performed with five
recall antigens1 using the upper arm or
volar surface of the forearm. No skin test
ing or blood investigations were carried
out in the first 24 hours after surgery, in
order to avoid the effect of anesthetic
agents on these measurements. The anti
gens used were Candida (candidin 1:100
dilution), mumps skin-test antigen
(undiluted), purified protein derivative (5
TU), trichophytin and streptokinasestreptodornase (Varidase, 100 units/ml)
and were injected intradermally in a
volume of 0.1 ml. A saline control was
also used. The two greatest diameters of
the resulting induration at 24 or 48 hours
were measured, summed and divided by
two, and the resulting mean sum for each
antigen was noted. The erythema sur

4
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rounding the induration was ignored. The
final results were recorded as a delayedtype hypersensitivity (DTH) score,
defined as the sum of the average
diameters of each individual antigen
response, minus the saline control, as
measured above. Serum albumin (g/L)
and total protein (g/L) levels were meas
ured by serum electrophoresis. The cir
culating hemoglobin level (g/L) was
measured in the laboratory. Whole blood
neutrophil adherence to nylon wool was
measured by a m odification of
McGregor’s technique.13 The adherence
results were expressed as a percentage of
total leukocytes that adhered to the nylonwool column. Polymorphonuclear neu
trophil (PMN) chemotaxis was measured
by a modification of Boyden’s tech
nique.14 The PMN chemotactic migra
tion to an attractant (casein or 10%
zymosan-activated serum) was expressed
as the distance of cell migration in
microns.
Data Collection
All patients had the following data
recorded: demographic information
including sex, age, diagnosis, medical his
tory, previous related surgery, the timing
of surgical interventions, the organ oper
ated upon, and whether the operation was
a clean, clean-contaminated, contami
nated or dirty one. Also recorded was the
presence or subsequent development of
major sepsis and the final outcome and
cause of death if this occurred.
Definitions
Major sepsis was defined as a positive
blood culture, an abscess identified at sur
gery or autopsy or confirmed by per
cutaneous aspiration using computerized
tomography or ultrasonic guidance, or a
proven ascending cholangitis. Based on
the autopsy report, or the death certifi
cate if no autopsy was done, deaths were
defined as septic if sepsis was the stated
cause of death, septic related, if sepsis
contributed to but was not the stated
cause of death, or nonseptic if major sep
sis as defined above did not occur during
hospitalization.
Variables and Statistical Analysis
The variables determined to be signifi
cantly different between survivors and
nonsurvivors in univariate analysis from
a previous study12 are: age (years), DTH
skin-test score (mm), total serum protein
level (g/L), serum albumin level (g/L),
circulating hemoglobin level (g/L), neu
trophil adherence (%), PMN chemotaxis
(mm) and patient sex. Furthermore, the
DTH skin-test score was related in an
exponential manner to septic related mor

tality. Thus, the natural logarithm of the
DTH skin-test score was used in the
modelling equation, along with the other
seven variables. Stepwise, forward, logis
tic regressions, were fitted to obtain esti
mates of the risk of septic related death,
corrected for multiple factors that con
tributed to its development. The logistic
function takes the following form:15
P | outcome = death | = 1 — {1 + exp
( - b o -b ,x , - ... —bkxk)}_ 1
where P is the probability of death, exp
is the exponential function (natural
logarithm), b0, b, ... bk are the coeffi
cients to be estimated and x1; x2 ... xk are
the independent variables.
Starting with the constant model (i.e.,
b0 as the only parameter), a variable was
entered into the equation only if its addi
tion increased the likelihood of the model
with a significant p value (p < 0.05) using
two-tailed tests of significance. This anal
ysis was carried out with the statistical
software from the Statistical Analysis Sys
tem (SAS) version 82.4 at the McGill
University computing centre in close con
sultation with the Department of
Epidemiology and Health.
Once the predictive equation was
obtained, the fit was assessed on a
separate, prospectively collected data base
of 625 patients. The probability of septic
related death for each patient was calcu
lated, using the logistic regression equa
tion, by entering the host-defence varia
bles measured on admission. The patients
were then grouped into deciles of risk,
based on these probabilities. The
observed septic related deaths within each
decile were then compared to the expected
cases, the latter being determined by sum
ming the individual probabilities of each
patient within the decile.
Results

Of the 499 patients assessed in the first
part of the study, 95 died; 38 of the deaths
could not clearly be defined as septic or
septic related. These 38 patients were thus
excluded from the analysis, leaving 461
patients. The admitting diagnosis of these
patients is shown in Table I. A wide spec
trum of surgical diseases is represented,
including both acute and elective admis
sions. Over 80% of the patients under
went a major surgical procedure. The
variables entered into the logistic regres
sion analysis and some additional patient
characteristics are shown in Table II. Of
the 57 deaths, 35 were classified as clearly
due to sepsis and 22 as septic related. This
classification was based on autopsy find
ings in 81% of the deaths.
The final multiple logistic regression
model is shown in Table III. The varia-
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bles of serum albumin, DTH score and
age, in that order, contributed signifi
cantly to the model. Sex (p = 0.1085) was
retained in the model because of a previ
ous clinical observation that women had
a lower mortality overall than men fol
lowing serious surgical illness.16 The neu
trophil adherence and PMN chemotaxis,
although they were significantly related
to septic m ortality when analysed
individually, did not contribute to the
prediction of septic related mortality in
this multivariate analysis. This is not an
uncommon finding. Strong predictor
variables often replace weaker ones in
such analysis. The total protein levels also
did not contribute, as they were highly
correlated with the serum albumin value.
Their contribution to mortality lost sig
nificance when the albumin was ac
counted for. Similarly, the hemoglobin
level did not contribute significantly to the
predictability of the model.
Using the coefficients shown in Table
III, we could calculate the probability of

septic related death of a particular surgi
cal patient admitted to hospital from the
following equation:
P jdeath | = 1 - {1 + exp[1.343 - 1.372
(albumin) — 0.173 In (DTH score) +
0.026(age) - 0.522(sex)]}“ >
substituting for sex, the value of 1 for
men and 2 for women. Figure 1 shows a
plot of the calculated probabilities of sep
tic related death for the 461 patients used
to generate this equation with 95% con
fidence limits for each probability. The
model has reasonably narrow 95% con
fidence intervals especially at low proba
bilities of death. In other words, one can
be more certain of a favourable outcome
based on this model as compared with an
adverse outcome. Using this equation,
and substituting values for each variable
progressing from best to worst measure
ments, the mortality probability curve has
the shape shown in Fig. 2. If three of the
variables are kept constant and the fourth

is varied from the best to the worst, then
the contribution of the individual varia
ble to the overall probability of death can
be determined (Figs. 3, 4 and 5).
Such an equation for predicting the
actual probability of death of an
individual patient, needs validation using
a group of patients that is different from
the one used to generate the model. The
second part of this study involved the col
lection of such a data base of 625 surgi
cal patients. Their admission diagnoses
are shown in Table IV and additional data
profile in Table V. The only notable
difference from the previous 461 patients
is a lower number of severe trauma cases
in this group. The rates of surgery, type
of surgery (clean-contaminated, contami
nated or dirty) and the degree of surgery
were not significantly different.
The values for each patient’s age,
serum albumin, logarithm (DTH score)
and sex, all collected on admission, were
entered in the predictive equation and a
probability of death was calculated for
04)
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FIG. 1—Probabilities of septic related death
for 461 patients used to generate logistic regres
sion model. Upper and lower 95% confidence
intervals of each probability value are also
shown.
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FIG. 3—Contribution of serum albumin
level alone to overall probability of septic
related death in this model; DTH score, age
and sex are kept constant at their mean values
and serum albumin is varied as in Fig. 2.
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FIG. 2—Shape of probability curve of sep
tic related mortality when all predictive hostdefence measurements are varied from best to
worst values. Serum albumin level is varied
from highest measured value of 48 g/L to
lowest measured value of 14 g/L. Similarly,
delayed-type hypersentivity (DTH) skin-test
score is varied from 86 to 0 mm. Age is varied
from 16 to 90 years. Sex is kept constant at 1.5.

FIG. 4—Contribution of DTH score alone
to overall probability of septic related death
in this model; serum albumin, age and sex are
kept constant at their mean values and DTH
score is varied as in Fig. 2.
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serum albumin, DTH score and sex are kept
constant at their mean and age is varied as in
Fig. 2.
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each patient. The lowest probability was
0 and the highest was 0.77. The expected
deaths were then calculated within each
probability decile as already described.
For example, in the probability decile 0
to 0.1, there were 384 patients. The sum
of the individual probabilities of death
was 17.2 — the expected number of
deaths within this decile. The observed
number of deaths in this decile was 17,
indicating a good fit of the model. Figure
6 shows the observed and expected sep
tic related deaths for all deciles. There is
an excellent fit of the model in this large
separate set of surgical patients. The
model predicted a total of 67.2 septic
related deaths, and 72 deaths were
observed. This discrepancy, which was
not statistically different, was due to four
patients who died from hemorrhagic
shock secondary to bleeding from
esophageal varices, a condition that this
model was not expected to predict.
Discussion
Previous studies have clearly demon
strated the strong association between
abnormal host defence, as indicated by
a decreased delayed hypersensitivity skintest response, and septic related
death.3-10 This was true in all surgical
patients stratified by the first skin-test
response upon entry to the study, in the
subgroups of strictly elective patients
preoperatively or in those admitted to the
intensive care u n it.12 Johnson and
colleagues3 found a sepsis rate of 8%
and a mortality of 2% in reactive patients,
Table IV-Admitting Diagnosis for the
625 Patients Used to Test the Validity
of the Predictive Equation
No.
Diagnosis
10
Trauma
Cancer
10
Esophagus
29
Stomach
16
Pancreas
116
Colorectum
Other
36
54
Inflammatory bowel disease
62
Gastrointestinal bleeding
Pancreaticobiliary tract disease
60
82
Intra-abdominal sepsis
150
Miscellaneous

Table V—Additional Variables and
Characteristics of the 625 Patients Used
to Test the Validity of the Predictive Equation
Variable
Value (± SD)
60.2 ± 16.0
Age, yr
DTH score, mm
23.1 ± 20.1
Serum albumin, g/L
3.36 ± 0.65
Sex
Men
310
Women
315
Deaths
72

compared with 30% and 16% respectively
in anergic patien ts.7 The study of
G riffith and Ross17 o f 50 patients
preoperatively who then underwent colon
surgery, found a sepsis rate of 9% in reac
tive patients, compared with 28% in aner
gic patients. Associations between DTH
and sepsis were found by Mullen and
associates,6 Morath and associates,7
Harvey’s group,8 Casey and colleagues,9
Tasseau and colleagues5 and Kienlen and
colleagues.10
All these studies evaluated one risk fac
tor (i.e., abnormal host defence as indi
cated by failed DTH responses). Con
founding variables such as age and sex,
were not adjusted for. Also, the DTH
response was analysed as an ordered vari
able (i.e., reactive, relatively anergic or
anergic). The approach presented here not
only accounts for the confounding vari
ables of age and sex, but also expresses
the DTH response on a numerical discrete
scale of measurement. This allows for a
high degree of quantification o f this
response, compared with the previous
ordered approach.
The serum albumin level is the stron
gest of the predicting variables, with a
contribution to the overall correlation
coefficient of the model of r = 0.262. It
is tempting to hypothesize that this is due
to the effects of chronic malnutrition on
these patients. This is not readily accept
able for several reasons. First, the data
are collected on admission and include
acutely traumatized patients, who were
well nourished at the time. Second, when
a strictly elective, preoperative patient
subgroup is analysed, the serum albumin
level does not contribute significantly to
their outcome, even though some of these
patients have clinical “ chronic malnutri
tion” (unpublished data). Third, in the
face of acute sepsis or trauma, the
immediate reduction of the serum albu
min level may not indicate malnutrition.
The inability to correct the serum albu
min levels to normal, despite adequate
parenteral nutrition, a common finding,
indicates that liver function is abnormal.
Recent evidence suggests that, in acute
stress, there exists a condition of protein

mobilization and proteolysis, part of it
mediated by the interleukins, especially
interleukin-1, released by m acro 
phages.18 Patients with traum a or sepsis
have high levels of “ proteolysis-inducingfactor” activity which is thought to
be a stable circulating product of
interleukin-1. The ability to generate this
activity and achieve hepatic synthesis of
protein is essential to survival.19 This
defect may be compounded by the acute,
short-term denutrition that most of these
patients undergo, until the decision is
made to support them with parenteral
nutrition or until they resume oral feed
ing. It is more than likely that the low
serum albumin levels indicate such an
altered state in these patients. The defects
in host defence, as indicated by the low
DTH scores, and the “ acute stress” situ
ation reduce the ability of the host to
combat major life-threatening sepsis.
The DTH response is the next strongest
predictor variable contributing an r value
of 0.114 to the overall correlation coeffi
cient of the model. The DTH skin-test
score measured in these patients indicates
a transient, acquired, immunodeficiency
consisting of failure(s) of the immune sys
tem at various levels. Such failure(s) could
involve specific cell-mediated immune
function or nonspecific inflammation, or
both. This leads to decreased mobiliza
tion of sufficient phagocytes to an area
of bacterial invasion. The decisive period
for establishment or eradication of an
infection is the first 2 hours after bacterial
invasion.20 The weakened inflammatory
response mounted by these patients facili
tates the establishment of the initial
infection. The infection, which is itself
immunosuppressive, creates a vicious cir
cle. If the invaders break through these
“ first-line” defences, then a local infec
tion is established usually in the form of
an abscess. This abscess must be con
tained, otherwise the infection can
become invasive by local extension or sep
ticemia. At this level of infection control
other failures of host resistance, indicated
by suppressed DTH response, could
include depressed antibody synthesis,21
decreased complement levels and abnor-

FIG. 6—Observed deaths and predicted sep
tic related deaths in 625 patients used to test
predictive model. Discrepancy at 0.2 and 0.4
deciles, although not statistically different, is
due to four deaths from hemorrhagic shock,
which model was not designed to predict.

FIG. 7—Effect of developing major sepsis
following hospitalization on probability of sep
tic related death. Two curves show death prob
abilities when sepsis does (upper curve) or does
not (lower curve) occur, in relation to chang
ing remaining variables from best to worst
values.
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mal function of the reticuloendothelial
system.
The above hypothesis can be supported
by deriving a logistic model, where the
development of sepsis after admission is
entered into the model as an independent
variable, in addition to the variables
measured on admission. This analysis is
shown in Fig. 7. A patient with “ worse”
host-defence values who subsequently
suffers major sepsis has an increase in the
probability of septic related death from
0.35 to 0.9 or 0.55 points, compared with
the patient who never has life-threatening
sepsis in whom the septic related mortal
ity remains at 0.35.
The ability to calculate precisely the
risk of septic related death may be used
clinically in choosing the most appropri
ate treatment for a surgical patient. For
example, an 82-year-old man with a car
cinoma o f the esophagogastric junction,
a DTH score of 0 mm and an albumin
level of 20 g/L, has a probability of death
of 0.6 if he were to undergo palliative
resection. With such a high measurable
risk, one may consider radiotherapy
rather than surgical resection with the
possibility of a leak. If an anastomotic
leak occurred, his probability of death
would increase to more than 0.9. He
would not handle this septic challenge
well and would die. On the other hand,
if his DTH score were 34 mm and his
albumin level 34 g/L the probability of
death would be less than 0.1 (not con
sidering further septic complications). In
this situation the development of a leak
would only increase the probability of

death to 0.18 and he would handle this
septic challenge quite well. Another
approach, though not clearly proven,
might be an attempt to correct the abnor
malities preoperatively with a 2-week
course of nutrition.
Similar decisions can be reached using
evaluations based on clinical assessment.
The DTH score can be available within
24 hours of admission and this can now
be done in the surgeon’s office, before
admission, at reasonable cost.22 Meas
urement of the serum albumin level is part
of any preoperative assessment. With a
hand-held calculator the probability of
septic related death of any surgical patient
can be determined by using the logistic
equation presented here. This ability to
determine precisely the septic related risk
of a surgical patient, allows for proper
clinical decision-making and identifies a
group of patients who should be studied
in the future with the view of correcting
these abnormalities and improving their
clinical outcome.
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SESAP V Critique
IT E M 33

Multiple abscesses of the liver more commonly result in mortality than single abscess because of the difficulty of
achieving adequate drainage. Multiple abscesses frequently are the result of hematogeneous spread or severe biliary tract
disease. Although single abscesses may contain loculations, they can easily be broken up surgically to achieve good drainage.
Anaerobic organisms, although more resistant to antibiotic treatment, are more commonly found in single abscesses, which
can be easily drained. Although more abscesses are found in the elderly because of their increased incidence of biliary
tract disease, neoplasia, and other diseases decreasing their resistance to infection, they do not have a worse prognosis
when age alone is the variable.
~E
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1986 ROUSSEL' LECTURE
Introduction
The Southern Ontario Surgical Society
was founded in 1974 after a “ Day in Sur
gery” for general surgeons held at
McMaster University Medical Centre in
Hamilton. Dr. J.E. Mullens was proba
bly the major moving force in the initia
tion of the society, whose prime objec
tive is to promote professional, clinical
and social activities of general surgeons
in southern Ontario. It was agreed that
the society would pursue these objectives
by providing a forum for the discussion
of clinical and professional problems
related to the day-to-day practice of
general surgeons, fostering education in

the field of general surgery for its mem
bers and acting as a professional resource
body for the surgeons of the area.
Roussel Canada Inc. undertook to
sponsor a visiting professor for the
region, and in 1980, the first Roussel lec
ture was given by Dr. Malcolm Veidenheimer. Roussel Canada sponsors the
visiting professor for 3 days — 2 days are
spent in the region with the local hospi
tal staff surgeons and interested health
professionals, the third day is the
Southern Ontario Surgical Society annual
clinical meeting. The keynote address at
that meeting is the Roussel lecture deli
vered by the visiting professor. The Cana
dian Journal o f Surgery has agreed to

J ack P ickleman ,

publish the manuscript of this lecture if
it is acceptable for publication.
This concept of a community visiting
professor fulfils the important aspects of
the objectives of the Southern Ontario
Surgical Society and the society is grate
ful to the Roussel Canada Inc. for its con
tinued involvement and sponsorship.
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Controversies in Biliary Tract Surgery

There are many controversies regarding
the surgical management of calculous
gallbladder disease. Newer data in the
surgical literature and competing medical
treatments compound this confusion. In
this guest lecture the author reviews cur
rent data and provides an update in
seven controversial areas: the timing of
operation in acute cholecystitis, the
management of the diabetic patient with
gallstones, the treatment of the patient
with asymptomatic gallstones, the medi
cal treatment of gallstones, the use and
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abuse of operative cholangiography, the
management of the patient with gall
stone pancreatitis and management of
the patient with acalculous
cholecystopathy.
II existe plusieurs controverses concernant le traitement chirurgical des calculs
biliaires. Les donnees les plus recentes
apparues dans la presse chirurgicale et
dans les articles portant sur les traitements medicaux concurrents, n’ont servi
qu'a aggraver la confusion qui entoure le
sujet. L'orateur invite passe en revue les
donnees actuelles et propose une mise h
jour de sept sujets controverses: le choix
du moment d'operer dans les cas de
cholecystite aigue, le traitement du
patient diabetique souffrant de calculs
biliaires, le traitement du patient porteur
de calculs asymptomatiques, le traite
ment medical des calculs biliaires.
I'emploi et I'abus de la cholangiographie
operatoire, le traitement du patient souf
frant de pancreatite calculeuse et le trai
tement du patient atteint de cholecystopathie acalculeuse.

Operations on the biliary tract are com
monly performed in a variety of hospital
settings, outcomes are excellent, and there
is thus a certain complacency regard
ing the ease o f management of calculous
gallbladder disease. This obscures the
reality that morbidity and mortality after
biliary tract surgery are substantial in cer
tain circumstances and that a number of
competing treatments are being advo
cated. Because of this, the modern-day
biliary tract surgeon must be conversant
with and utilize the most up-to-date data
and management techniques if he is to
render state-of-the-art care to his patients.
In this lecture I will review and update
several controversial areas in biliary tract
surgery in an attempt to form a consensus
for the ’90s in each area. The topics
include the timing of operation in acute
cholecystitis, the treatment of acute
cholecystitis in the diabetic patient, the
treatment of the patient with asympto
matic gallstones, the current status of the
medical treatment of gallstones, the use
and abuse of operative cholangiography,
the treatment of gallstone pancreatitis and
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the treatment of the patient with acalculous cholecystopathy.
Timing of Operation
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this will be the recollection of an occa
sional patient who underwent elective
cholecystectomy, only to sustain various
For years, it has been accepted that complications, a bile-duct injury or death.
morbidity is increased after cholecystec And lastly, the physician will remember
tomy for acute cholecystitis in the diabetic at least a few patients whose dyspepsia
patient. Not only is this view common persisted or worsened postoperatively.
sense, but it was supported by several Additional ammunition to justify a course
large studies.9-11 Because of this
of inaction is provided by the periodic
increased risk and the perception that dia reports16 of an increased rate of colonic
betic patients who undergo even elective carcinoma after cholecystectomy.
cholecystectomy for cholelithiasis are at
The surgeon in turn could look at pub
increased risk, various medical authori lished statistics showing extremely low
ties still advocate cholecystectomy in dia mortality after elective cholecystectomy,
betic patients with asymptomatic gall an increasing number of older patients
stones while at the same time not with common-bile-duct stones complicat
recommending cholecystectomy for ing their cholelithiasis, increased death
asymptomatic nondiabetic patients.12 rate after cholecystectomy in the elderly
These recommendations are made regard and a litany of disasters centring around
less of whether the diabetes is controlled patients known to have stones who
by insulin, drugs or diet alone.
presented with acute cholecystitis, ascend
Recently, however, several studies have ing cholangitis, gallstone pancreatitis,
demonstrated no increase in complica gallstone ileus or even gallbladder car
tions or mortality in diabetic patients who cinoma.
underwent cholecystectomy for either
Several studies17-20 have indicated that
acute or chronic cholecystitis, with the if patients with asymptomatic stones are
consequent recommendation that diabetic followed up for long periods, approxi
patients with gallstones be treated no mately 30% to 50% will experience
differently from their nondiabetic coun symptoms, and that in perhaps one-third,
terparts.8-13-14 This has been supported in these are severe, usually consisting of
at least one prominent gastroenterology acute cholecystitis, common-bile-duct
text.15
stones or gallstone pancreatitis. In each
In our own series8 of 19 diabetic and of these series, patients over 60 years of
101 nondiabetic patients with acute age were at greater risk with death rates
cholecystitis, similar major complication of 7% to 15%.
rates of 5.3% and 6.9% respectively were
Recently, a number of articles have
noted, even though the diabetic group been published strongly recommending
was on average 11 years older than the that “ the silent gallstone” be allowed to
nondiabetic group (66 versus 55 years). requiescat in pace, indicating that perhaps
The only two deaths in this group of 120 only 20% to 30% of patients with stones
patients were in the nondiabetic group.8 ever experience symptoms. What has been
Thus, there appear to be no valid reasons overlooked is that most of these studies
to regard diabetic and nondiabetic are by one group of investigators who
patients w ith gallstones or acute looked mainly at small numbers of white
cholecystitis differently, and that the deci professional men.21-24 Whether their con
sion to operate should be made indepen clusion supporting a nonoperative stance
dently of the factor of diabetes.
in all patients with asymptomatic stones
is valid should await larger, moreThe Patient With
representative studies.
Asymptomatic Gallstones
What, then, should we recommend to
patients with asymptomatic stones? Cur
Of all the disputes in the adversarial rent death rates for patients younger than
relationship between physicians and sur 60 years who undergo elective chole
geons, few generate as much heat (and as cystectomy are 0% to 0.2% ,2-8-25 so it
little light) as the management of the seems reasonable to recommend opera
patient with asymptomatic gallstones. On tion to any such person who is in good
the one hand, the physician will recall that health and has a 10 to 15-year life expec
up to 20% of people in the United States tancy. Awaiting the onset of symptoms
harbour asymptomatic stones at autopsy, would not be supported by data from our
and that most stones produce symptoms institution, which showed that in 77% (92
before causing complications. Added to of 120) of our patients with acute

CO

It is surprising th a t although
cholecystectomy is the most common
abdominal operation performed by
general surgeons, there is still debate
about the optimal time to treat the patient
with acute cholecystitis. This is mainly
because of old data, indicating that
patient mortality following emergency
cholecystectomy for acute cholecystitis is
greater than that of elective cholecystec
tom y.1-2 At the outset, it should be
understood that acute cholecystitis refers
to patients who present with acute right
upper quadrant pain, tenderness, local
peritoneal signs, fever and leukocytosis,
not those merely presenting with biliary
colic.
This belief ignores several factors, not
the least of which is the unpredictability
of response to antibiotic therapy alone.
Patients over 60 years old and those with
diabetes mellitus will often fail to
improve, and therefore medical treatment
should consist of only nasogastric suc
tion, volume resuscitation and antibiotics
followed by urgent cholecystectomy.1-3'5
Overall, at least 25% of patients with
acute cholecystitis will fail to improve and
run a significant risk of gallbladder gan
grene and perforation. Even younger,
nondiabetic patients m ay become
progressively more septic on medical
treatment, making a trial of medical ther
apy unwise in nearly all. Most patients
who do recover from acute cholecystitis
with medical therapy alone will require
cholecystectomy subsequently for persis
tent or recurrent symptoms, so medical
treatment does not avoid the operation,
but merely postpones it. Sometimes acute
cholecystitis will recur during this wait
ing period or, when the operation is
finally carried out, there will still be evi
dence of acute cholecystitis, making the
operation technically no easier than it
would have been initially.6-7 Lastly, the
patient who fails to improve with medi
cal management who is then urgently
operated upon has been said to have a
substantially greater chance of death and
serious complications,7 although recent
data from our hospital indicate that even
in those patients whose operation was
delayed for up to 6 days, morbidity was
not increased, although, of course, the
total duration of hospitalization was
lengthened.8 This study disclosed no sig
nificant differences in mortality among
389 patients operated upon for either
acute or chronic cholecystitis (Table I),
further underscoring the changes in out
come brought about by modern anes
thetic techniques, improved perioperative
monitoring and intensive care, and the
judicious use of antibiotics.8

Acute Cholecystitis in the
Diabetic Patient

1 (1 .4 % ) | n - 69)
1 (1 .6 % ) I n - 6 2 )
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cholecystitis, this was the first evidence
of their disease.8 Also, early operation
will decrease the number of operations on
elderly patients and those requiring
common-bile-duct exploration, with its
increased morbidity, and will surely
diminish the number of patients with gall
bladder carcinoma, a condition that is
rarely curable and is associated with gall
stones 70% to 90% of the time.26-28
Medical Treatment of Gallstones

In years past, physicians and surgeons
agreed that the treatment of calculous dis
ease of the biliary tract was the responsi
bility of the surgeon alone, and the death
rates following the surgical treatment of
gallstones became low to the point of
inconsequence in many large series. Now
a determined group of interventional phy
sicians and radiologists have promised
still lower morbidity, equal success and,
of course, lower costs. With a variety of
drugs, instillations, manipulations and
percutaneous excursions ever deeper into
the biliary tree, a wide variety of
“ options” is being presented to the pub
lic and to practising physicians who have
not had the opportunity to evaluate crit
ically the conflicting sets of data. Predic
tably, the gallbladder has rebelled against
many of these planned (and sometimes
unplanned) forays into its domain, and
a collection of side effects, complications
and misadventures has accumulated anec
dotally which has conveniently been
ignored or excused by the dubious expec
tation that “ new is better” .
Currently, the most popular alternative
to cholecystectomy for patients with
stones is the administration of chenodeoxycholic acid which decreases the
hepatic synthesis and secretion of
cholesterol, thereby desaturating the bile.
Numerous studies of the efficacy and
safety of this drug have been carried out,
including the National Cooperative Gall
stone Study.29 In this study after 2 years,
complete dissolution of stones was noted
in only 13% of participants, while 41%
achieved p a rtia l d isso lu tio n . For
chenodeoxycholic acid to be effective, a
patient must have a functioning gallblad
der and radiolucent stones. This
elim inates approxim ately 15% of
patients. If only 13% of patients obtain
complete dissolution then only 11% of
the total number may benefit assuming
that the 41% of patients with smaller
stones represent a failure of the treat
ment. Furthermore, the drug must be
continued indefinitely as there is a high
risk of stone recurrence after the drug is
withdrawn. If one considers the diarrhea
that occurs in some patients, the 3% rate
of serious liver toxicity and the approxi
mate 10% increase in serum level of lowdensity-lipoprotein cholesterol, it is clear

that chenodeoxycholic acid is no
panacea.29' 31
Because of these considerations, a bet
ter dissolving agent is being sought. Cur
rently, ursodeoxycholic acid is being
investigated, with preliminary reports of
equal effectiveness (or ineffectiveness) but
decreased side effects.32 Ursodeoxycholic
acid is not currently approved for use in
the US.
Recently, a highly innovative method
of stone dissolution has been attempted
at the Mayo Clinic. This involves per
cutaneous transhepatic puncture of the
gallbladder with subsequent instillation of
methyl tert-butyl ether; cholesterol gall
stone may be dissolved within hours;33
so far, approximately 25 patients have
been safely treated, but obviously it is
premature to speculate on the usefulness
of this therapy (Thistle JL: Personal com
munication, 1986). Lastly, encouraged by
the urologists’ success with extracorporeal
shock-wave lithotripsy in fragmenting
renal calculi, some investigators are using
the technique for gallstone fragmentation
with modest success. But because of the
expense of the machine, the need for
general anesthesia and the problem of
stone fragments being flushed into the
common duct, it is unlikely that this mode
of treatment will ever be popular.34
All the above treatments must be com
pared with the standard treatment — elec
tive cholecystectomy — which, for
patients under 50 years of age, carries a
death rate of approximately 0.05% to
0.1%.2,3,8,25 It is a dubious proposition at
best, that current nonsurgical alternatives
will succeed in lowering the overall death
rate over the lifetime of the patient, when
stone recurrences, need for multiple treat
ment sessions and the complications of
treatment and subsequent stone disease
are taken into consideration.
Use and Abuse of
Operative Cholangiography

Many surgeons believe that operative
cholangiography is an integral part of
cholecystectomy. Numerous early papers
attest to its safety and advantages, which
include a decrease in the number of
unnecessary common-bile-duct explora
tions in patients with clinical or labora
tory indications for duct exploration and
the detection of unsuspected commonbile-duct stones.35-38 Another argument
has recently been put forth to support
routine cholangiography, namely a
medicolegal one in which it may be con
sidered deviant surgical practice not to
perform cholangiography.
The recent surgical literature argues for
a different stance. In patients with no
clinical or laboratory indications of
common-bile-duct stones, unsuspected
stones are actually present in less than

1%.39-41 Moreover, it is clear that many
common-bile-duct stones either remain
silent or pass spontaneously. With the
advent of endoscopic sphincterotomy, a
missed common-bile-duct stone is no
longer the problem it once was.
Added to these arguments must be the
disadvantages of operative cholangiogra
phy: increased operating and anesthesia
time (up to 30 minutes in some series),42
increased surgical and anesthesia fees,
charges for radiologic studies, increased
operating-room supplies, false-positive xray films leading to unnecessary commonbile-duct exploration and technical
problems at the time of cholangiography
that lead to duct injury or the need for
placement of a T-tube.43
Taking all these issues into considera
tion, I would favour the implementation
of nonroutine operative cholangiography
in patients who undergo cholecystectomy,
a position supported by surgeons.39-45 I
favour operative cholangiography if there
is a history of pancreatitis or jaundice, a
substantial elevation in any of the liver
function test values, operative findings of
an enlarged common bile duct (greater
than 1 cm), an enlarged cystic duct or pal
pable common-bile-duct stones. In these
circumstances use of operative cholan
giography should prove cost-effective and
should minimize the number of over
looked common-bile-duct stones.

Treatment of Gallstone Pancreatitis

There are perhaps only two areas of
universal agreement regarding patients
with gallstone pancreatitis. First, the con
dition is caused by passage of gallstones
into the common bile duct resulting in
temporary obstruction of the pancreatic
duct. This has been proven by the recov
ery of stones in the stools of such patients
in contrast to the absence of stones in the
stools of patients with other forms of
pancreatitis.46,47 Second, that after an
attack of pancreatitis in a patient with
gallstones, cholecystectomy must be per
formed to prevent future attacks, which
will occur in up to 60% of patients within
6 months.48,49
There are two schools of thought
regarding the management of patients
presenting with gallstone pancreatitis:
those favouring operation within 24 hours
of an attack and those favouring initial
treatment with fluids and nasogastric suc
tion, then cholecystectomy as soon as
symptoms subside and the serum amylase
level returns to normal. Those who
favour operation within 24 hours claim
an improved outcome, the finding of
common-bile-duct stones in up to 75% of
patients,50,51 the elimination of impacted
common-bile-duct stones and continuing
severe pancreatitis, and concomitant
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acute cholecystitis in 14% to 31% of
patients.49,51
The latter group, however, is in the
majority. It has been repeatedly noted
that 85% to 95% of patients with gall
stone pancreatitis will recover after
nasogastric suction and fluid replacement
so elective cholecystectomy can be under
taken.48,49,52 If such a protocol is fol
lowed, less than 15% of patients will be
found to harbour common-bile-duct
stones at operation, compared with the
65% to 75% noted when earlier opera
tion is undertaken; therefore fewer
patients will require common-bile-duct
exploration and possible manipulation
and instrumentation of the sphincter of
Oddi. Lastly, operation within 48 hours
of the onset of symptoms has been
associated with death rates ranging from
12% to 31% in three published
series.48,52,53
In summary, the weight of opinion
favours cholecystectomy and operative
cholangiography in all patients with gall
stone pancreatitis after symptoms have
subsided and before hospital discharge.
For patients exhibiting persistent or wor
sening symptoms, endoscopic papil
lotomy may be performed.54 If symp
toms worsen or if papillotomy cannot be
performed, cholecystectomy should be
undertaken immediately.
Acalculous Cholecystopathy
Despite considerable evidence to the
contrary, many surgeons are sceptical of
the existence of such an entity as acal
culous cholecystopathy.55'57 Yet all
experienced clinicians have seen patients
with biliary colic and normal findings on
conventional radiologic studies of the
gallbladder who were cured by chole
cystectomy. Although one of the major
problems regarding this condition is the
lack of a specific diagnostic test, other
problems such as tissue-committee con
siderations, difficulties of informed con
sent, the frequently normal histologic
findings and the surgeon’s natural reluc
tance to remove a “ normal” organ all
complicate the clinical situation. The
results of cholecystectomy for vague
upper abdominal pains or dyspepsia are
predictable in that the symptoms may
often persist postoperatively. But if only
patients with classic recurrent biliary colic
disease are considered, and if other gas
trointestinal disease has been ruled out,
over 90% of patients will be completely
relieved of their symptoms. Often, these
patients will have seen many physicians,
including psychiatrists, and will repeat
edly have had normal findings on oral
cholecystography and ultrasonography.
Biliary colic is often present for years
before cholecystectomy is recommended.
In the search for a useful diagnostic
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test, endoscopic retrograde cholangiopan
creatography, duodenal drainage and
cholecystokinin-stimulated oral chole
cystography have all been used with varied
success.56,58,59 Recently, we have begun
using sincalide cholescintigraphy, stand
ard radioisotope biliary excretion scan
ning coupled with sincalide (cholesystokinin) administration to stimulate gallblad
der emptying.55 The percentage of iso
tope cleared from the gallbladder can then
be expressed as the gallbladder “ ejection
fraction” , and less than 50% emptying
is considered abnormal. Although this
test will not be abnormal in all patients
with this syndrome, it can provide the
doctor and the patient with added reas
surance that biliary tract disease may be
present. Figures 1 and 2 show, respec
tively, a normal and abnormal response
to sincalide administration in two patients
with acalculous cholecystopathy.
Until a definitive test is available, the
history of classic recurrent biliary colic in
a patient with normal results from con
ventional biliary tract studies and an
upper gastrointestinal series is sufficient
to recommend cholecystectomy. If facil
ities are available, Sincalide cholescintig
raphy can be carried out if the patient
wishes additional reassurance. The histo
logic findings of the resected gallbladder
will often be normal,55,56 but nearly all
patients will be relieved of their symp
toms. Over the past 13 years, I have
studied over 100 such patients; 65 have
no4
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FIG. 1—Sincalide cholescintigraphy. Nor
mal gallbladder response with 88% ejection
fraction (EF).

FIG. 2—Sincalide cholescintigraphy. Abnor
mal gallbladder response with 19% ejection
fraction (EF).

undergone cholecystectomy and all but 2
were relieved of their pain. Other series
in the literature have noted comparable
success, and so whatever name one wishes
to attach to this entity, there is no longer
any reason to doubt its existence.57,60'62
Conclusions
Although the seven topics I have
covered are by no means the only areas
of controversy in biliary tract surgery, I
hope this review has proven useful in
attempting to resolve some of the conflict
ing data in the medical and surgical liter
ature, particularly with regard to compet
ing therapies. Before these are accepted
as the standard of care, we must insist on
the same careful studies and critical evalu
ation of results that surgeons have con
tributed to the literature over the past 50
years. Although some of the current alter
natives may ultimately prove to have
merit, most will likely go the way of other
highly acclaimed medical memorabilia
such as the iron lung, gastric freezing and
bloodletting.
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Hepatic Resection for Metastatic Disease
Hepatic resection fo r m e ta sta tic disease
is review ed in 3 0 pa tie nts (mean age
5 8 .9 years). The p rim ary site w a s the
colorectum in 2 5 ; the o ther prim a ry
tu m o u rs w ere leiom yosarcom a, plas
m acytom a, and adenocarcinom a (all of
gastric origin), ocular m elanom a and an
u n kn ow n prim ary. O perative procedures
included 7 wedge resections, 5 segmentecto m ie s and 21 lobectom ies (11 right,
4 extended rig h t and 6 le ft). M ajor co m 
plications in seven pa tie nts included
in traoperative hem orrhage in th re e , tw o
o f w hom died, bile -du ct in ju ry in tw o ,
sm all-bow el in fa rctio n in one and
cerebrovascular a ccid e n t in one. Opera
tiv e death rate w as 6 .7 % (2 o f 30 ).
Thirteen patients w e re alive and free
o f disease a mean o f 2 4 m on th s after
hepatic resection w h ile 5 m ore w ere
alive w ith disease a t a mean o f 3 6 .9
m onths. Life-table analysis pro je cte d a
5-year survival o f 5 0 .3 % fo r th o se w ith
colorectal prim aries, w ith no apparent
d ifference in survival b etw een patients
w ith single (5 5 .0 % ) and m ultiple
(5 4 .0 % ) m etastases. Im proved survival
w as projected fo r p a tie nts w ith
m etachronous (6 6 .6 % ) versus s y n 
chronous (4 5 .0 % ) tu m o u rs, prim ary
D ukes' class A or B (6 6 .1 % ) versus
D ukes' class C (4 6 .0 % ) tu m o u rs and
those having w edge resection or segm entectom y (6 6 .6 % ) versus lo b e ctom y
or extended lo b e ctom y (4 8 .0 % ).
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H epatic resection fo r m e ta sta tic d is
ease can be done w ith acceptable m o r
b id ity and m o rta lity and th e e xp e cta tio n
o f su b sta n tia lly prolonged su rvival p a rtic 
ularly in p a tie nts w ith m eta ch ro no u s
lesions or D ukes' A or B co lo re cta l
prim ary lesions.
On a etudie les resu lta ts de la rese ctio n
de m etastases hepatiques pratiquee chez
3 0 pa tie nts (age m oyen de 5 8 .9 ans).
Dans 2 5 cas, le fo ye r tu m o ra l p rim itif
e ta it localise au colon ou au re ctu m ; les
autres tu m e u rs p rim itive s etaient un
leiom yosarcom e, un p la sm a cyto m e et un
adenocarcinom e (tous d 'o rig in e g a strique), un m elanom e oculaire et une d 'o r i
gine inconnue. Les operations pratiquees
co m p re n n en t 7 resections cu neiform es,
5 segm e n te cto m ie s et 21 lobectom ies
(11 d roites, 4 d ro ite s etendues e t 6 gauches). Des co m p lica tio n s m ajeures o n t
ete enregistrees chez se p t patients:
hem orragie operatoire dans trois cas,
d o n t deux deces, lesion du choledoque
dans deux cas, in fa rctu s de I'in te s tin
grele dans un cas et un accident cerebrovasculaire. La m o rta lite operatoire a ete
de 6 .7 % (2 cas sur 30 ).
Treize pa tie nts v ive n t to u jo urs sans
maladie apparente, 2 4 m ois en m oyenne
apres resection hepatique; 5 autres sont
viva n ts m ais malades apres 3 6 .9 m ois
en m oyenne. Une analyse actuarielle a
projete une survie a 5 ans de 5 0 .3 %
pour ceux qui o n t des tum eurs co lo re cta les p rim itive s, sans d iffe re n ce apparente
entre les p a tie nts p o rte u rs de m etastases
uniques (5 5 .0 % ) ou m ultiples (5 4 .0 % ).
Une am elioration de la survie a e te projetee pour les pa tie nts s o u ffra n t de
tum eurs m etachrones (6 6 .6 % ) par rap
p o rt aux tu m e u rs synchrones (4 5 .0 % ),
pour les tu m e u rs p rim itive s de classe A
ou B dans la cla ssifica tio n de Dukes
(6 6 .1 % ) par rap p o rt aux tum eurs de
classe C (4 6 .0 % ) et pour les p a tie n ts qui
o n t subi une resection cu n e iform e ou
une sem e n te cto m ie (6 6 .6 % ) par ra p p o rt

a une lo b e ctom ie ou une lo b e cto m ie
etendue (4 8 .0 % ).
La resection des m eta sta se s h e p a ti
ques peut etre e ffe c tu e e avec une m o rb i
d ity et une m o rta lite a cce p ta b le s, e t avec
I'esperance d 'u n e su rvie n e tte m e n t prolongee, p a rticu lie re m e n t chez les p a tie n ts
s o u ffra n t de tu m e u rs m e ta ch ro n e s ou de
lesions co lo re cta le s p rim itiv e s de classe
A ou B dans la cla s s ific a tio n de Dukes.

An aggressive approach to resection of
solitary and multiple unilobar liver
metastases from primary colorectal
adenocarcinoma has been advocated
recently by numerous authors.18 This
recommendation has been based upon
data that suggest improved length and
quality of survival for patients who had
resection compared with those in whom
the natural history of metastatic liver dis
ease was studied,9,10 and those who were
treated without resection.11,12 Although
less than 15% of patients with colorectal
cancer and liver metastases will be can
didates for resection, 5-year survival in
the range of 20% to 25% has been
reported.8,10,12,13
This report summarizes the McGill
University experience with hepatic resec
tion for metastatic disease over the last
10 years; 80% (24 of 30) of the resections
were carried out after 1980.
Patients and Methods

The charts of patients who underwent
hepatic resection for metastatic disease at
four McGill University teaching hospitals
between 1974 and 1985 were reviewed.
Although we believe that all major
hepatic resections are included, an
unknown number of wedge resections
may have escaped review because of
incomplete coding of the medical record
for secondary surgical procedures. Most
resections (85%) were done in two hospi
tals by three of the coauthors (M.W.,
J.R., A.P.M.).
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In addition to general demographic
information, data included the grade,
stage and site of primary tumour, the size,
number and interval to diagnosis of liver
metastasis, and the relevant laboratory
and diagnostic tests performed preoperatively. The extent of surgery, morbidity,
mortality, adjuvant therapy and survival
status of each patient were also recorded.
Life-table analysis was used to express
survival.
Findings
Thirty patients, 15 men (mean age 60
years) and 15 women (mean age 56.7
years), underwent hepatic resection for
metastatic disease. The site, stage and
grade of the primary tumour is outlined
in Table I. The site of primary tumour
was predominantly the colorectum (25
patients). The liver metastases were syn
chronous in 17 patients and meta
chronous in 13. Metachronous disease
was diagnosed within 2 years of the
primary tumour resection in two patients
and a mean of 40 months after resection
in the other 11.
Among the 25 patients with primary
colorectal cancer, 14 had liver metastasis
synchronous with their primary tumour
and 11 had metachronous disease that
was diagnosed a mean of 34 months after
resection o f the primary tumour in 9 and
within 2 years in 2. Fifteen patients had
solitary metastases, 10 had multiple

lesions. In eight patients, the multiple
metastases were confined to one lobe; the
other two had lesions in both lobes,
requiring a right lobectomy and a left
wedge resection in one and bilateral segmentectomies in the other. Relevant
demographic data and tumour charac
teristics for all patients with colorectal
cancer are presented in Table II.
The alkaline phosphatase level was
elevated in 10 (35.7%) of 28 patients in
whom it was measured while the serum
aspartate aminotransferase (SGOT) level
was elevated in 4 (14.3%) of 28. The carcinoembryonic antigen (CEA) value was
elevated in 20 of 24 patients who had
primary colorectal tumours. All four
patients with a normal CEA value had
synchronous metastases.

Ultrasonography of the liver revealed
metastases in 23 of 24 patients, and liver
and spleen scanning also demonstrated
malignant lesions in 19 of the 20 patients
in whom it was performed. Computerized
axial tomography indicated malignant
disease in 12 of 14, as did angiography
in 18 of 19 patients. No patient had more
than one false-negative test result
although the number and size of
metastases were occasionally underesti
mated. With the exception of one false
negative liver and spleen scan that missed
a lesion 9 cm in size, all missed lesions
were smaller than 4.5 cm in their greatest
diameter.
Selected operative data are detailed in
Table III. Operating time, estimated
blood loss and the 24 hour perioperative

Table 1-Characteristics of Primary Tumour
Site
Colorectum

Gastric
Leiomyosarcoma
Adenocarcinoma
Plasmacytoma
Melanoma (ocular!
Unknown primary

Total no.
patients

Dukes'
stage

No.
patients

Broder's
grade*

25

A
B
C
Unknown

3
7
14
1

1
2
3
4
Unknown

1
1
1
1
1

-

-

-

—

-

-

-

-

-

No.
patients
5
6
5
1
8
-

—

'Grade 1 to grade 4, well differentiated to poorly differentiated.

Table II—Selected Demographic Data and Tumour Characteristics in 25 Patients With Colorectal Cancer
Age,
yr

Sex

Tumour
site

54
40
27
43
75
46

F
F
F
F
M
F

Colon
Colon
Colon
Rectum
Colon
Colon

61
51
61
69
59
65
48
64
45
62
68
78
47
54
59
75
46
62
66

M
F
F
M
F
F
M
M
F
M
M
F
M
M
M
F
M
F
F

Rectum
Rectum
Rectum
Colon
Colon
Colon
Colon
Rectum
Colon
Colon
Colon
Colon
Colon
Colon
Colon
Rectum
Colon
Colon
Colon

Stage'
C
C

c
c
c
c

Gradet
—
-

s
s
s

2
1
2

s
s
s
s
s
s
s
s

-

3
3
-

2
1
3
2
1
2
1
3
2

—

B
A
B
B
B
A
C
B
C

S
S
S

1
4
3

c
c
B
C
C
C
C
B
A

Synchronous
or
metachronous

—
—
-

M
M
M
M
M
M
M
M
M
M
M

Size,
cm

Solitary
or
multiple

10
2
24
8
6
5

M
S
S
M
M
M

9
5
12
3
2
5
10
6
7
2
17
15
6
3
6
3
8
5
10

S
M
M
M
S
S

s
M
M
S

s
s
M
S
S
S

s
s
s

Operation
L
R
R
R
R
R

segmentectomy
wedge resection
lobectomy
lobectomy
lobectomy
lobectomy +
L wedge resection
R segmentectomy
R lobectomy
R + L segmentectomy
R wedge resection
L wedge resection
R wedge resection
ER lobectomy
ER lobectomy
ER lobectomy
L lobectomy
L lobectomy
R lobectomy
R lobectomy
R wedge resection
L lobectomy
R lobectomy
R lobectomy
ER lobectomy
R lobectomy

Survival,
mo

Current
status

—

11

—

33
9
82
16

DWD
AFD
DWD
AFD
DWD

Major
morbidity

-

HEM
-

-

CHD
-

—
-

11
1
4
3
36
45
29
13

—

1

SBI

53
20
11
30
55
61
10
20

-

CVA
CHD
—
—

HEM
—

HEM

-

36
-

AFD
AFD
AFD
AFD
DWD
AWD
AFD
DWD
AFD
AFD
DWD
DWD
AFD
AFD
AWD
AFD
AWD
ORD
DWD
ORD

'Dukes' stage.
tBroder's grade.
R = right, L * left, ER - extended right, HEM = hemorrhage, CHD - transection of common hepatic duct, SBI - small-bowel infarction, CVA - cerebrovascular
accident, AFD - alive free of disease, AWD - alive with disease, DWD = dead with disease, ORD - operative death.
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FIG. 1—Projected 5-year survival after
hepatic resection (life-table analysis) for all
patients (black circles) and survivors of oper
ation who had primary colorectal tumour
(white circles).

FIG. 3—Projected 5-year survival (life-table
analysis) for patients with synchronous (white
circles) and metachronous (black circles)
metastases.

otherapy, 3 a combination of the two, 1
had immunotherapy and 1 immuno- and
c n c iu u iiie ra p y . A lt oi tne adjuvant
chemotherapy was given to patients with
synchronous disease, to control the
primary tumour, except in two instances.
The radiotherapy was directed at the
pelvis in patients with Dukes’ C rectal
cancer and synchronous liver metastases.
Immunotherapy in the form o f bacille
Calmette Guerin scarification was origi
nally administered in a 47-year-old man
who had a metachronous liver metasta
sis 3.5 years after resection of a Dukes’
B rectosigmoid tumour. Immunotherapy
was also received by the patient with
primary ocular melanoma that first
metastasized to the liver 7 years after
enuculeation of the primary tumour.
Table IV sets forth survival data for all
patients and those with primary colorec
tal carcinoma. Thirteen patients were
alive and free of disease an average o f 24
months after liver resection. Of patients
with recurrent disease, nine lived an aver
age of 30.8 months, and those still living
have survived a mean of 36 months.
Life-table analysis projected a 5-year
survival of 56.0% for all patients and
50.3% for the 23 operative survivors with
primary colorectal tumours (Fig. 1). For
patients with colorectal primaries, lifetable analysis projected a 5-year survival
of 55% for those with a single metastasis
and 48% for those with multiple m eta
stases (Fig. 2); 45.0% for patients with
synchronous and 66.6% for patients with
metachronous tumour (Fig. 3); 65.6% for
patients with primary Dukes’ A or B com
pared with 43.5% for patients with
Dukes’ C tumours (Fig. 4); and 66.1% for
patients who underwent wedge resection
or segmentectomy compared with 48.0%
for those who underwent lobectomy or
extended lobectomy (Fig. 5).
Five of six patients with metastases
smaller than 4 cm in diameter were alive
at a mean of 36 months (median 33
months) postoperatively, the sixth patient
died 36 months after operation. If the two
operative deaths are excluded, 11 of 17
patients with metastases larger than 4 cm

FIG. 2—Projected 5-year survival (life-table
analysis) for patients with colorectal primary
who had single hepatic metastasis (white cir
cles) and multiple metastases (black circles).

FIG. 4— Projected 5-year survival (life-table
analysis) for patients with Dukes’ class A or
B (black circles) and Dukes’ C (white circles)
primary disease.

FIG. 5—Projected 5-year survival (life-table
analysis) for patients who underwent wedge
resection or segmentectomy (black circles) and
lobectomy or extended lobectomy (white
circles).

(one patient each). The hospital stay aver
aged 15 days postoperatively; 20 days for

transfusion requirements correlated well
with the extent of hepatic resection.
\y T c» ir» r

---------------- ^ • “
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iu i
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postoperative complications.
Two deaths accounted for the 30-day
operative death rate of 6.7%. Both
resulted from intraoperative exsanguination in patients with primary colorectal
cancer, when technical difficulties were
encountered in attempting right hepatic
lobectomy for solitary metastases larger
than 8 cm in diameter.
Fourteen patients received no adjuvant
therapy — 7 had chemotherapy, 2 radi

patients. T hree had hem orrhage
intraoperatively and it proved fatal in
two. In two patients transection of the
common hepatic duct was satisfactorily
repaired over stents at the time of occur
rence. There was one case of small-bowel
infarction and one cerebrovascular acci
dent. Nine patients suffered minor com
plications; atelectasis (four), phlebitis
(two), lymph leak, bile leak, urinary tract
infection and subphrenic fluid collection

T a b le I I I - - O p e r a t iv e D a t a
E x te n t o f

No of

O p e r a t in g

re s e c tio n

p ro c e d u re s *

t im e , m in

U n it s
EBL, m lt

tra n s fu s e d *

W edge

7

221

900

1

Segm ent

4

213

950

1 .5
5 .7

6

290

2840

11

315

2962

7

4

421

2875

6 .3

L e f t lo b e
R ig h t lo b e
E x te n d e d rig h t lo b e
*1

p a t ie n t h a d b ila te r a l s e g m e n t e c t o m ie s , 1 h a d a w e d g e r e s e c t io n a n d r ig h t lo b e c t o m y .

t E s t im a t e d b lo o d lo s s .
t N o . o f u n its o f p a c k e d re d b lo o d c e lls t r a n s f u s e d in 1 s t 2 4 h.

T a b le I V - - O b s e r v e d S u r v iv a l (in M o n t h s ) *
A ll p a t ie n t s (N
No.

=

C o lo r e c t a l g ro u p (n =

30)
M e d ia n

M ean

25)
M e d ia n

S ta tu s

No.

M ean
2 6 .0

2 0 .0

13

2 4 .2

11

AFD

12

5

3 6 .9

39

AW D

4

3 6 .4

3 2 .5

10

3 0 .8

16

DW D

7

2 0 .5

1 2 .5

’ E x c lu d in g 2 p a t ie n t s w h o d ie d w it h in 3 0 d o f o p e r a t io n .

MONTHS
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in diameter were alive a mean of 25.4
months (median 11 months) after opera
tion, and 6 died of the disease at a mean
of 16 months (median 12 months) (Table
V).
The tumour grade was recorded in 17
patients. Four of five patients with a
grade 1 tumour were alive and disease free
at a mean of 42.5 months. The fifth
patient, with tumour recurrence, was alive
at 61 months. Four of six patients with
grade 2 tumours were alive and free of
disease at a mean of 15 months postoperatively. One was alive, with tumour recur
rence at 20 months and the other died 11
months after operation. Three of five
patients with grade 3 tumours were alive
and free of disease at a mean of 16.3
months. One was alive with recurrence at
45 months and the other died of the dis
ease at 20 months. The only patient with
a grade 4 tumour died 16 months after
operation (Table VI). Women did not
appear to do any better than men in this
series (Table VI).
Discussion
Of the patients presenting with primary
colorectal cancer, 15% to 25% will have
synchronous liver metastases.8'9'n ’12'14’15
Approximately 20% of these will be
amenable to hepatic resection.10'15-17
Foster and Berman2 estimated that resec
table liver metastases will develop
metachronously in an additional 5% to
8% with previous resection of a colorec
tal cancer. Thus, approximately 10% to
15% of patients with colorectal cancer
metastases may be candidates for hepa
tic resection of metastatic tumour.
Fifty percent of patients with primary
colorectal carcinoma die with or of liver
metastases,15 and there has been no
improvement in patient survival over the
last 30 years.14 While trials of intra
arterial chemotherapeutic agents have
demonstrated response rates as high as
80%, none have resulted in improved sur

vival.15-19 Likewise, systemic chemother
apy, hepatic artery ligation and
immunotherapy trials have not demon
strated improved patient survival when
compared with the natural history of
untreated m etastases,17'20-22 and no
patient has been cured using these treat
ment modalities.
Early studies that examined the natural
history of untreated liver metastases
reported mean survival rates of 6 to 9
months.9'1‘'15'23'24 These rates represented
the life expectancy of a heterogeneous
group of patients, many of whom would
never have qualified for hepatic resection.
More recently, Wanebo and colleagues13
demonstrated an average survival of 19
months in 18 patients with an untreated
solitary liver metastasis and 9.4 months
in 149 patients with multiple metastases.
Adson and colleagues10 reviewed the
natural history of a potentially resectable
liver metastasis, proven by biopsy, from
a colorectal primary tumour and found
the median 3-year survival to be 20%
am ong 24 patients with solitary
metastases. Survival data for patients
with multiple but potentially resectable
(unilobar) metastases are not available.
Recently an aggressive surgical
approach to the treatment of hepatic
metastases from primary colorectal
cancer has been adopted at McGill
University teaching hospitals, 80% of
resections having been performed since
1980. The major morbidity in this series
of 23.3% compares favourably with that
reported by Bengmark and associates,1
and Taylor’s group.8 Likewise, the oper
ative death rate of 6.7% is comparable
to those of other reported series that
range from 1.7% to n % . s'10'12'13'25 Our
life-table analysis projected an overall
5-year survival in patients with colorec
tal primary tumours of 50.3%, compara
ble to a 42.2% survival at 42 months
projected by Taylor and colleagues,8
given the small number of patients who
have actually reached this stage. It sup

Table V—Survival Related to Diameter of Largest Metastasis
Durarion of survival, mo
metastasis, cm
< 4 In = 6)
> 4 (n - 17)

Status
AFD
AWD
DWD
AFD
DWD

No. (%)
1 (16.7)
4 (66.6)
1 (16.7)
11 (64.7)
6 (35.3)

Mean
33
42
36
25.4
16

Median
45
11
12

Table VI—Survival (in Months) Related to Tumour Grade and Sex
Broder's grade (n = 17)__________
Sex (n - 23)
1
2
3
4
Status
Male
Female
—
42.5 (4)
15 (4)
16.3 (3)
AFD
30 (4)
24 (8)
—
61 (1)
20 (1)
45 (1)
AWD
32.5 (2)
61 (1)
20 (1)
11 (1)
16 (1)
DWD
16.5 (4)
18.6 (4)
( ) - no. of patients.
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ports the contention of numerous inves
tigators that survival can be notably
prolonged in some patients. Indeed, all
of our survival curves levelled off at the
24 to 30-month interval. This supports the
view of Adson and colleagues10 that 2
years is a reasonable interval in which to
examine and predict survival benefit from
hepatic resection for metastatic disease.
In our series, the presence of multiple
metastatic lesions appeared to have no
detrimental influence on survival as long
as the lesions were confined to one hepatic
lobe. This observation is corroborated in
reports by Foster and Berman2 and Mor
row and colleagues.26 Patients with syn
chronous disease appeared to do less well
than those with metachronous disease in
our series, and in those of Wilson and
A dson,25 F o ste r,12 Bengmark and
colleagues1 and Wanebo and associ
ates.13 Patients with Dukes’ class A or B
primary tumours have a longer projected
survival than those with Dukes’ C
primaries. Although this observation is
supported by Adson and colleagues,10
neither F o ster12 nor Logan and
colleagues5 demonstrated such a benefit.
Meticulous patient selection for major
resection of hepatic metastases cannot be
overemphasized. The operation can be
done with acceptable morbidity and mor
tality in properly screened patients, but
should be performed by surgeons with an
interest and training in hepatic surgery.
Both operative deaths in this series
occurred in patients with extremely large
lesions of dubious resectability. Major
resection should be reserved for patients
whose primary tumour is under control,
who manifest no evidence of extrahepatic
spread and those whose tumours are con
fined to one hepatic lobe, especially a soli
tary metastasis (synchronous or meta
chronous). Our data also suggest that the
simple wedging out of small metastatic
deposits is of potential benefit, perhaps
equivalent to major resection, and should
be considered by all surgeons when
appropriate. There is some debate regard
ing patients with multiple metastatic
deposits, especially in view of the recent
finding by Adson and associates10 that
patients with multiple, small, syn
chronous metastases were not definitely
helped by resection but that those with
large metachronous metastases were
helped. Although our data showed no sig
nificant difference in survival between
patients with single or multiple metastases
there was a difference between syn
chronous and metachronous lesions.
Numbers were too small to permit scien
tific analysis of patients with multiple,
small, synchronous lesions. Of eight
patients in this category, three died with
disease while five were alive and disease
free at the time of writing, but in only one
was the follow-up longer than 1 year
(Table II).
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Hepatic resection for metastatic lesions
other than from a colorectal primary has
been disappointing, although some suc
cess has been reported with gastric
leiomyosarcoma, Wilms’ tumour and
ocular melanoma. Our small experience
corroborates these findings.
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Iatrogenic Duodenocolic Fistula
Benign duodenocolic fistula is a rare, sur
gically curable, but potentially lethal
entity. Etiology, symptomatology, diag
nosis and management are discussed.
The authors describe the fifth reported
case of an iatrogenic cause and review
the literature on benign duodenocolic
fistula. Early diagnosis and aggressive
nutritional and surgical management are
necessary to avoid serious morbidity and
malnutrition leading eventually to death.
La fistule duodeno-colique benigne est
une entity rare, guerissable par chirurgie,
mais qui peut neanmoins etre mortelle.
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Son etiologie, sa symptomatologie et son
diagnostic sont commentes. Les auteurs
font la description du cinquieme cas
latrogene signale et font la revue des
publications sur la fistule duodenocolique benigne. Son diagnostic precoce
et un traitement alimentaire et chirurgical
agressif sont necessaires si I'on veut eviter la serieuse morbidity et la malnutri
tion qui en decoulent et qui peuvent con
duce a la mort.

colic fistula can result in considerable
morbidity, progressive undernutrition
and death.5 Am ong 62 cases o f benign
nonbiliary etiology we identified only
four instances in which gastrointestinal
surgery resulted in iatrogenic duodeno
colic fistula. We present an additional
case to illustrate the importance o f early
diagnosis with aggressive nutritional and
surgical management of this rare, but
curable, condition.
Case Report

Direct communication between two
abdominal viscera is an uncommon com
plication of gastrointestinal surgery com
pared with external gastrointestinal
fistulas that usually occur as a result of
surgical complications.1'4 Communica
tion between the duodenum and colon is
most commonly the result o f cancer at the
hepatic flexure o f the colon and is often
amenable only to palliation. On the other
hand, when the fistula is from a benign
cause, management is usually successful.
If untreated, however, a benign duodeno

A 59-year-old white woman was referred to
the surgical service o f the Montreal General
Hospital with fever, prostration and bile
drainage from an abdominal incision in the
right upper quadrant. She had undergone a
cholecystectomy for cholelithiasis, performed
elsewhere 5 years earlier, but otherwise there
was nothing of note in her medical history.
She had been well until 3 months before her
referral, when pancreatitis and jaundice had
developed secondary to choledocholithiasis.
Common-bile-duct exploration at the time rev
ealed a single stone, but a T-tube cholangiogram obtained 2 weeks later revealed two addi-
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tional stones, one at the lower end of the
common bile duct. At a second laparo tc..,,,
a duodenotomy and sphincteroplasty were per
formed and the two remaining stones removed.
During the procedure, the hepatic flexure of
the colon was entered inadvertently and the
resulting laceration closed in two layers. Her
postoperative course was complicated by
prolonged fever and ileus requiring a gas
trostomy for continuous gastric drainage. One
month after the second abdominal exploration,
bilious drainage from the drain site in the right
upper quadrant appeared spontaneously.
Upon admission to the Montreal General
Hospital, the patient was gravely ill with a
blood pressure of 90/50 mm Hg, a pulse rate
of 110 beats/min, body temperature of 40°C
and respiration rate of 25/min. The abdomen
was tender in the right upper quadrant.
Peristaltic bowel sounds were absent and bile
drainage was evident from the previous drain
site. The patient had been started on
intravenous nutrition through a line placed in
the right femoral vein.
The femoral line was removed and cultured.
Blood cultures revealed Staphylococcus albus.
After we had restored the fluid and electrolyte
balance, given general supportive care and
antibiotic therapy and had controlled the sep
sis, we inserted a subclavian line to provide
total parenteral nutrition. A sinogram obtained
through the drainage site in the right upper
quadrant revealed communication between the
second portion of the duodenum and the
hepatic flexure of the colon. The radiologic
findings after barium enema identified the
anatomy more clearly (Fig. 1). During the
preoperative phase of intravenous nutrition, no
change in bile output or size of fistula was
noted; however, the nutritional measures were
maintained and the nitrogen balance was
positive.
Two weeks after admission, the patient’s
abdomen was re-explored. Dense adhesions
were found throughout the right upper quad
rant making identification of anatomical struc
tures difficult. The entire right colon was fore
shortened and the cecum was adherent to the
duodenum. Retroperitoneal exposure o f the
inferior vena cava and second portion of the
duodenum, with identification of the right ure
ter, permitted access to the fistula between the
duodenum and colon. A right colectomy was
performed and an end-to-end ileotransverse
colonic anastomosis used in reconstruction.
The duodenotomy was closed in two layers.
Vagotomy and gastroenterostomy were per
formed in an attempt to enhance healing of the
difficult duodenal closure. A Stamm gas
trostomy was fashioned and the right paraduo
denal region drained with suction catheters
(Fig. 2). Her recovery was uncomplicated and
2 weeks after surgery she was eating a normal
diet and was ready for discharge. She remains
asymptomatic.

continued to appear in the literature until
1959 when Starzl and colleagues9 made
an important contribution to the
knowledge o f the etiology, pathogenesis,
clinical features and treatment of this con
dition. Their report contained 19 cases
o f communication, from nonbiliary
causes.8-20 Since then, 27 well-docu
mented reports containing 43 additional
cases have appeared in the English liter
ature.21-47
The etiology o f this condition is largely
related to benign processes originating in
the duodenum or colon with very few
cases having their origin outside both
organs (Table I). Duodenal ulcer is by far
the most common etiologic factor, being
implicated in 14 o f the 62 cases reported.
Although ulcerative colitis was reported
in three instances prior to 1951, Crohn’s
disease was probably responsible for the
condition more often than realized, as evi
denced by seven additional cases in the
last three decades reported to have
occurred secondary to regional ileitis.
Spontaneous duodenocolic fistula occur-

ring as a result o f benign biliary tract
disease has been excluded from the
discussion because it invariably causes the
formation of a triple fistula (cholecystoduodenocolic). Duodenal diverticulum
has been implicated in nine instances, and
other embryologic anomalies account for
four additional cases.
Since neonatal duodenocolic fistula has
never been demonstrated, some5 have
questioned embryologic anomalies as an
etiologic factor. It is noteworthy that
infectious processes such as tuberculosis,
typhoid fever, amebiasis and appendici
tis have played a role in the development
of duodenocolic fistulas. Although exter
nal injuries have never been implicated,
at least one report suggests that a foreign
body may have caused the fistula. Several
authors were unable to find a plausible
cause for nine reported cases.
Iatrogenic d u o d en o co lic fistula
accounts for a minority o f reported cases.
We could find only four authentic reports
from the Western literature,10,21-23 but it
is probable that an operative injury to one
or both organs resulting in fistula forma
tion occurs more frequently. In the cases
reported by Clayton and Thornton,11
Marinaccio and associates,13 Rife18 and
Masters,47 patients had previous abdomi
nal surgery, but the fistulas were related
more clearly to underlying disease.

T a b le 1 - C a u s e s o f B e n ig n D u o d e n o c o lic F is tu la
Cause
D u o d e n a l u lc e r

F1G. 1—Barium enema obtained preoperatively. Arrows show fistulous communication
between right colon and third portion of
duodenum.

N o . o f cases
14

D u o d e n a l d iv e r t ic u lu m

9

T u b e rc u lo s is

8

R e g io n a l ile itis

7

Id io p a t h y

6

E m b ry o lo g ic a n o m a lie s

4

ia t r o g e n ic

4

A p p e n d ic itis

3

U lc e r a t iv e c o litis

3

T ra u m a

2

T y p h o id

1

A m e b ia s is

1

T o ta l

62

Discussion
Although identified by Haldane6 in a
case o f cancer o f the cecum in 1862, the
first report o f a benign duodenocolic
fistula is credited to Sanderson7 who, in
1863, reported on a case produced by a
duodenal ulcer. The first successful
preoperative diagnosis o f the condition is
attributed to McPeak.8 Sporadic reports
440
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Gastric or duodenal ulcer disease
precipitated the course of events that led
to iatrogenic fistula formation in three of
the reported cases. Fistula formation
between the duodenum and colon
occurred 3 years after gastric resection in
the case reported by Michell,21 represent
ing a rare long-term complication of sur
gery for peptic ulcer disease. It is
noteworthy that no disease was found to
explain the fistula formation. Internal
fistula following gastric resection is most
commonly related to recurrent anasto
motic ulceration or recurrence of a malig
nant lesion after gastric or colonic sur
gery. Hardy48 reported 10 instances of
internal fistula following gastric surgery
for benign disease, representing less than
1.7% of the postoperative complications
in 604 cases; none of the fistulas occurred
between the duodenum and colon. Duo
denal stump leak was clearly the
precipitating factor in two of these iatro
genic cases, one occurring 3 years after
the duodenal blow-out and the second 16
days after gastric resection during the
same hospitalization. It is evident that a
chronic or an acute inflammatory process
may produce a simultaneous erosion into
the duodenum and colon. Duodenocolic
fistula as a result of a duodenal stump
blow-out was not reported to have
occurred according to two large series that
recorded a 3.3% incidence of stump
leakage.48,49
Our case report has certain similarities
to that of Bucaille10 in which operations
upon the biliary tract resulted in recog
nizable injury to the duodenum and
colon. Fistula formation between two
penetrated visci is not uncommon, par
ticularly when the contaminated large
bowel is entered. Diverting colostomy
may have prevented this complication if
gross contamination actually occurred,
although this is speculative.
The symptoms of benign duodenocolic
fistula are characteristic of an initial
process in the right upper quadrant of the
abdomen that may elicit fever, pain and
crampy abdominal pain. Symptoms com
mon to virtually every reported case
include diarrhea that may be bloody, fecal
vomiting or foul-smelling eructations and
passage of undigested food per rectum.
Weight loss, often resulting in severe mal
nutrition, invariably occurs. This virtual
bypass of the entire small intestine is not
compatible with life.
Duodenocolic fistula is curable. With
the availability of modern parenteral
nutrition, it no longer represents an
urgent surgical problem, particularly
when sepsis is not present. Severe proteincalorie undernutrition is not only prevent
able but is also reversible, thus decreas
ing the risks of postoperative complica
tions.
Barium enema exam ination will

demonstrate the fistula in the majority of
cases. Since most benign duodenocolic
fistulas are secondary to peptic ulcer dis
ease and biliary lithiasis, upper gastroin
testinal contrast studies may demonstrate
air or contrast material in the biliary tree,
when the fistula is secondary to lithiasis,
or a normal colonic mucosal outline,
when it is due to peptic ulcer disease. The
anatomy of the upper gastrointestinal
tract should be defined before surgery.
As Starzl and associates9 have sug
gested, corrective surgery is performed
either for direct closure of the fistula or
to enhance spontaneous closure.
Although authors have used direct closure
with total success, prevention of a lateral
duodenal fistula can be achieved by duo
denal diverticulization, as originally
reported by Berne and colleagues50 in
discussions of severe duodenal trauma. A
variety of other procedures may be
employed if primary duodenal closure is
difficult; they include serosal patching,
Roux-en-Y duodenojejunostomy or par
tial duodenal exclusion with vagotomy
and gastrojejunostomy, as in our case,
although the last technique lacks suppor
tive data and is not routinely recom
mended.
The literature reviewed contains only
two deaths among 61 reported cases. The
natural tendency to report successful out
comes may give a false impression and,
indeed, this operation is a formidable one
for the inexperienced surgeon. When the
abdomen is entered, the right upper quad
rant may best be exposed by a retro
peritoneal approach with identification of
the right renal vessels, inferior vena cava,
right ureter and lower common bile duct,
reflecting the right colon medially and
gaining access to the retroperitoneal por
tion of the duodenum. At this point, the
fistula can be divided, avoiding sacrifice
of excessive duodenal wall, to permit
primary closure. A partial colectomy can
then be performed, if needed. Since spon
taneous closure of a benign duodenocolic
fistula has been reported in only one
instance,9 this condition remains a surgi
cal entity.
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Campylobacter pyloridis Is Associated
With Acid-Peptic Disease in Toronto
Campylobacter pyloridis has been
associated with acid-peptic disease in
centres outside Canada. The authors
conducted a pilot study to see if this
association existed in Toronto. Patients
in whom esophagogastroscopy was indi
cated on clinical grounds were arbitrarily
selected for determination of the
presence of C. pyloridis. Included in the
study were 100 patients who underwent
105 endoscopies. In 75 patients (80
endoscopies) there was some form of
acid-peptic disease (inflammation or
ulceration of stomach or duodenum). Of
those with acid-peptic disease, 34% had
C. pyloridis compared with 4% among
patients without acid-peptic disease (p
< 0.0 1 ). Men with acid-peptic disease
were more likely to harbour C. pyloridis
than women (48% versus 16%, p <
0.0 1 ). The organisms were curved gram
negative rods that appeared as small
colonies after 4 days of incubation under
microaerobic conditions. They were
strongly urease positive.
There was considerable heterogeneity
of endoscopic diagnoses. Future clinical
studies of C. pyloridis need careful
endoscopic and histologic classification.
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Campylobacter pyloridis a ete, dans des
centres situes hors du Canada, relie a la
maladie ulcereuse de I'estomac. Les
auteurs ont mene une etude pilote pour
verifier Texistence d'une pareille associa
tion a Toronto. Des patients dont le
tableau clinique commandait une oesophagastroscopie ont ete choisis de facon
arbitraire pour rechercher chez-eux la
presence de C. pyloridis. On compte
dans I'etude 100 patients qui ont subi
105 endoscopies. II existait chez 75
patients (80 endoscopies) une forme ou
I'autre de la maladie ulcereuse (inflamma
tion ou ulceration de I'estomac ou du
duodenum). Parmi ceux qui souffrait de
maladie ulcereuse, 34% etaient porteurs
de C. pyloridis comparativement a 4%
chez les patients sans maladie ulcereuse
(p < 0.01). Les hommes souffrant de
maladie ulcereuse etaient plus susceptibles que les femmes d'avoir du C. pylori
dis (48% contre 16%, p < 0.01). Les
microorganismes sont des batonnets
gram negatifs qui apparaissent sous la
forme de petites colonies apres 4 jours
d'incubation sous conditions microaerobiques. Ms sont fortement urease positifs.
On a constate une heterogeneite consi
derable de diagnostics endoscopiques.
Les prochaines etudes de C. pyloridis
devraient porter une attention particuliere
a la classification endoscopique et histologique.

Campylobacter sp. are a known cause of
gastroenteritis. Recently Warren1 and
Marshall2 found a new species, now clas
sified as Campylobacter pyloridis,3 in
the stomachs and duodenums of patients
with acid-peptic disease. These findings
prompted worldwide interest as the cause
of acid-peptic disease is unknown.
Although several other centres have
reported a similar association,4-7 it has
not been investigated in Canada. Since
there are geographic variations in the
natural history of acid-peptic diseases8
we conducted a pilot study to determine
if there is an association between these
conditions and C. pyloridis in Toronto,
Ont.

Methods
Patients
All patients who underwent upper gas
trointestinal endoscopy performed by one
of two gastroenterologists (J.A. and J.K.)
between March 1984 and May 1985 at St.
Joseph’s Health Centre were potential
candidates for study. Endoscopy was
indicated on clinical grounds. Patients
were selected for investigation of C.
pyloridis on the basis of convenience
rather than by formal randomization.
Most were included because of endoscopically visible disease, but enough patients
with no endoscopic evidence of disease or
with evidence of conditions other than
acid-peptic disease were included to allow
comparisons. For each patient we
recorded the age, sex and endoscopy
number of that day (e.g., second, third,
and so on). Biopsies were not examined
histologically.
The endoscopic diagnosis was
recorded. When gastric disease was seen,
a tissue biopsy of the abnormal region
was sent for culture of C. pyloridis. When
duodenal disease was found, brushings
were taken from the area for culture.
Similarly, when an esophageal lesion was
found, brushings were taken for culture.
W hen no disease was visible on
endoscopy, brushings were taken from
the duodenum and gastric antrum. All
specimens were transported in 10 ml of
normal saline and plated within 1 hour
of arrival in the microbiology laboratory.
Microbiology
Specimens were plated on chocolate
agar and 5% sheep’s blood agar at 37°C
under microaerobic conditions (5% oxy
gen, 10% carbon dioxide, 85% nitro
gen).5 Campylobacter pyloridis was iden
tified using tests for susceptibility to
nalidixic acid and cephalothin, oxidase,
catalase, nitrate reduction, hippurate
hydrolysis, growth at 37°C but not 43°C
and urease production in Christensen’s
medium.5,9
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Data Analysis
For the sake of this study we defined
acid-peptic disease as the presence of ulcer
or gross inflammation in the stomach or
duodenum but not esophagus. If a patient
underwent gastroscopy twice and C.
pyloridis was found only once, the results
from both gastroscopies were still counted
to avoid bias in favour of a connection
between acid-peptic disease and C.
pyloridis. However, in the analysis of fre
quency of C. pyloridis by sex, each
patient was counted only once. For com
parisons of proportions, Fisher’s exact
test and the x2 test with Yates’ correction
were used, depending on sample size. For
comparisons of mean ages, the two-tailed
/-test was used.
Findings

We studied 100 patients; 5 were sub
jected to gastroscopy twice. Their ages
ranged from 15 to 88 years (mean 57
years). There were 12 patients in whom
the endoscopic findings were normal.
They ranged in age from 15 to 68 years
(mean 46 years). The other 88 patients (93
endoscopies) in whom some type of dis
ease was evident on endoscopy ranged in
age from 20 to 88 years (mean 58 years).
Seventy-five patients (80 endoscopies) had
acid-peptic disease. Their mean age was
59 years. Patients were arbitrarily divided
into three groups: duodenal, gastric or
other. Fifteen patients with gastritis, gas
tric erosion and gastric atrophy were

found in both the duodenal and gastric
groups.
The organism s identified as C.
pyloridis were curved gram-negative rods
that grew on chocolate agar at 37°C but
not at 43°C. They appeared as 0.5 mm
to 1 mm diameter transparent colonies
after 4 days of incubation. They gave a
rapid (less than 2 minutes), strongly posi
tive urease reaction, were catalase and
oxidase positive and gave a negative result
for nitrate reduction and hippurate
hydrolysis. The isolates were resistant to
nalidixic acid (30 pg disc) and sensitive to
cephalothin (30 pg disc).
A great heterogeneity of endoscopic
diagnoses was encountered (Table I).
Campylobacter pyloridis was found in
27 (34%) of 80 endoscopies that revealed
acid-peptic disease compared with 1 (4%)
of 25 endoscopies that showed no abnor
mality or revealed disease other than acidpeptic (p < 0.01). Of the five patients
who underwent two endoscopies, the
specimens in one grew C. pyloridis on
both occasions and another was negative
for the organism at each endoscopy.
Three patients had a specimen that was
positive for C. pyloridis at one endoscopy
and negative at the other.
Of the 75 patients with acid-peptic dis
ease, 21 (48%) of 44 men harboured the
organism, compared with 5 (16%) of 31
women (p < 0.01). This sex difference
was most striking in the gastric ulcer
group in which 9 of 12 men versus 2 of
12 women had specimens positive for C.
pyloridis (p < 0.025). This trend was

Table 1—Endoscopic Diagnosis and Incidence of Campylobacter pyloridis
No. with
Total no. of
C. pyloridis (%)
patients
Diagnosis
27 (34)
80
Acid-peptic disease
5 (25)
20
Duodenal ulcer
5 (38)
13
Prepyloric ulcer
4
2
Duodenal ulcer + gastric erosion
0
1
Duodenal ulcer + gastritis
1
0
Prepyloric ulcer + esophageal ulcer
1
3
Duodenitis
0
1
Duodenitis, gastritis, esophagitis
1
0
Duodenitis + gastritis
2
1
Duodenitis + gastric ulcer
1
0
Duodenal ulcer + gastric ulcer
47
14 (30)
Total
11 (46)
24
Gastric ulcer
2
0
Gastritis
1
1
Gastroesophageal ulcer
1
3
Gastric ulcer + gastric erosion
1
0
Gastric erosion
0
1
Gastric atrophy
0
1
Gastritis + esophageal stricture
13
(39)
33
Total
25
1
(4)
No acid-peptic disease
0
6
Esophagitis
3
0
Carcinoma of the stomach
1
0
Esophageal stricture
1
0
Esophageal ulcer
1
0
Duodenal polyp
1
0
Gastric polyp
1
12
Normal

present, but not statistically significant,
in the duodenal ulcer and prepyloric ulcer
groups; combining these two groups, 9
(39%) of 23 men had C. pyloridis com
pared with 1 (10%) of 10 women (p =
0 . 1) .

In patients with acid-peptic disease
there was no correlation between age and
the finding of C. pyloridis, but in the duo
denal ulcer group it was more common
in younger patients. In duodenal ulcer
patients the mean age of those with the
organism was 42 years compared with 59
years in patients who did not have the
organism (p = 0.046). A similar trend in
those with gastric ulcer was not statisti
cally significant: those with a specimen
positive for the organism had a mean age
of 58 years and those without had a mean
age of 65 years (p = 0.2). No age corre
lation was found in patients with
prepyloric ulcer.
One patient with a gastric ulcer 14
months after a highly selective vagotomy
was found to have C. pyloridis in the
ulcer. Three patients, during short-term
follow-up for gastric ulcers, were found
to have C. pyloridis in biopsies of the
healing ulcers. We did not find that
patients who underwent gastroscopy later
on the day’s list were more likely to have
C. pyloridis.
Discussion

The cause of acid-peptic diseases is elu
sive and probably multifactorial.10 Previ
ous attempts to link ulcers with micro
organisms have shown only spurious con
nections.11-14 In 1983, W arren1 and
Marshall2 reported a strong association
between “ unidentified curved bacilli” and
histologically confirmed gastritis and
other types of acid-peptic disease. This
association has been confirmed by inves
tigators in other parts of the world.4-7
The organism has recently been classified
as C. pyloridis .3 We have now shown
that C. pyloridis is associated with acidpeptic disease in at least one city in
Canada.
Campylobacter pyloridis was not iso
lated from stomachs in the past because
it is a microaerophilic, slow-growing
organism and conditions for growing
such bacteria had not been used.
However, curved rods were found in
histologic sections of human gastric
mucosa as early as 1940, and more
recently by several investigators.5,15-17 In
our pilot study we did not use this impor
tant method of studying C. pyloridis.
Although there is clearly an association
between C. pyloridis and acid-peptic dis
ease, a cause-and-effect relationship has
not been proven; however, evidence is
beginning to accumulate. The presence of
C. pyloridis does give rise to a host
immune response.16,18 There is a correla
tion between the degree of histologic gas-
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tritis and number o f bacteria in the gas
tric m ucosa.5 In a remarkable sequence
of events, an epidemic of gastritis with
hypochlorhydria developed in a group of
healthy volunteers who underwent gastric
in tu b ation s.19 A fter this event was
reported a retrospective examination of
the gastric biopsies revealed the presence
o f what appeared to be C. pyloridis.20
Lastly, studies have shown that patients
with duodenal ulcers are less likely to
suffer relapse when treated with bismuth
compounds, which kill C. pyloridis, than
when treated with antacids or histamine
blocking agents.21,22
Among patients with acid-peptic dis
ease we found correlations between the
presence o f C. pyloridis and both youn
ger age and the male gender. To our
knowledge, similar associations have not
been reported. The significance of these
findings is unclear; they may be coin
cidental. Our arbitrary method o f select
ing patients could have introduced
unknown biases. The great heterogeneity
o f clinical diagnoses in our study empha
sizes the need for histologic classification
and rigorous stratifications in future ther
apeutic trials.
Because Campylobacter- like organisms
have been found to adhere to gastroscopes,23 we investigated whether sam
ples from patients who underwent
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endoscopy later in the day were more
likely to contain C. pyloridis, but such
was not the case.
An etiologic role for C. pyloridis in
acid-peptic diseases would have tremen
dous clinical importance. By directing
medical therapy towards eradication of
the organism, it may be possible to reduce
the very high relapse rate associated with
current therapies.24 The remote possibil
ity o f carcinogenicity25 and the frequent
need for long-term therapy with histamine
blocking agents make other therapeutic
approaches worth consideration.
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Thymostimulin Prophylaxis of
Postoperative Infections in Anergic Patients
The rate of postoperative infections is
significantly increased in anergic
patients. The authors evaluated prospec
tively, in a controlled, randomized and
stratified study, the efficiency of
thymostimulin in reducing postoperative
infections in 42 such patients. Excluded
were those who were malnourished in
whom preoperative alimentation cor
rected the anergy. The incidence of
infections was significantly |p<0.05)
reduced in thymostimulin-treated patients
(4 .8 % versus 28.6%).
Le taux des infections postoperatoires
est grandement augmente chez les
patients anergiques. Les auteurs ont eva
lue prospectivement dans une etude controlee, randomisee avec groupes strati
fies, I'efficacite de la thymostimuline
comme moyen de r^duire des infections
postoperatoires chez 42 patients anergi
ques. Exclus de cette etude etaient ceux
qui souffraient de malnutrition et chez
qui une alimentation preoperatoire a permis de corriger I'anergie. La frequence
des infections a ete significativement
reduite (p < 0.05) chez les patients traites a la thymostimuline (4.8% contre
28.6%).

Excluding patients in intensive care units,
6% to 30% of the hospital population is
anergic1-3 as verified by the skin-test
response.4-6 In anergic surgical patients
morbidity and mortality are greatly
increased; postoperative infections have
reportedly risen from 7% to 46%,7 8%
to 50%3 and from 8% to 24%;6 death
from infection, according to these same
sources, rises from 2% to 31%, from 1%
to 28% and from 4% to 20%.
Malnutrition is responsible for about
one-third of immunoincompentence.8
Anergy is also caused by advanced
age,3'4 neoplasia,3’9'10 sepsis,4 drugs11 and
severe hepatic insufficiency.3
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Immunocompetence can be restored by
removing the cause of the anergy, while
antibiotics should be administered to
these patients only if required at the time
of surgery. Although preoperative nutri
tion programs may correct anergy due to
m alnutrition,12 it is not always possible
to eliminate etiologic factors. It seems
reasonable therefore to consider the use
of an immunomodulator.13
Several reports have described the use
of levamisole,7 bacterial derivatives2 and
dithiocarbamate;3 and other substances,
such as thiabendazole, muramyl dipeptide
and tuftsin, have been used in animal
experiments.
Thymostimulin is a thymic hormonal
complex that can revive and potentiate
host-defence mechanisms; its activity has
been demonstrated in vitro14 and under
diverse clinical conditions.15-18
We report the results of a trial of
thymostimulin prophylaxis designed to
reduce postoperative infections in aner
gic but not malnourished patients.
Patients and Methods
The study was prospective, controlled,
randomized and stratified. All patients
awaiting elective surgery in whom anergy
was identified by the Multitest C.M .I.
(Institut Merieux, Lyon, France), which
correlates well with the usual bacteria
employed in skin tests,3'5’19 were admit
ted to the study. An anergic patient was
defined as one with less than two positive
responses (diameter of induration equal
to or greater than 2 mm).3 Excluded
were patients less than 14 years old, those
with signs of malnutrition according to
the criteria of Mullen20 and patients who
were to undergo minor surgery. Informed
consent was obtained from all patients.
The trial was stratified into two levels
according to the type of surgery: (a) clean
and (b) clean-contaminated and contami
nated (in these patients short-term antibi
otic prophylaxis with mezlocillin was
used).
Patients were randomly assigned either
to the group receiving thymostimulin (1.5
mg/kg daily intramuscularly, as a single
dose, beginning 2 days before surgery and
continuing after until day 7) or to a con
trol group.
In all patients daily temperature records

were kept and blood chemistry studies
and urine cultures were done preoperatively and on day 7 postoperatively. In the
case of respiratory infection a chest film
was obtained, and for a wound infection
the pus was cultured. All patients were
observed until discharge and examined
again 1 month after surgery.
Statistical analysis was performed using
2 x 2 contingency tables with the Fisher’s
exact test, and probability a posteriori
was calculated according to Bayes’
theorem.
Findings
Forty-five anergic patients were admit
ted to the study between Jan. 1 and Aug.
31, 1985; 42 completed the study. Two
patients were excluded from the trial for
protocol deviations and one patient died
from causes unrelated to infection (two
belonged to the control group, one to the
treated group).
Of the 42 patients, 21 were assigned to
the control group and 21 received
thymostimulin. There were no significant
differences in patient characteristics
between these groups.
Twenty patients underwent clean sur
gery and 22 underwent clean-contamin
ated or contaminated surgery. The con
ditions found and the types of surgery are
reported in Tables I and II.
The infections discovered were: wound
infection (defined as discharge of puru
lent material), peritoneal cavity infection
(peritonitis or localized abscess not secon
dary to dehiscence of an anastomosis),
generalized sepsis, respiratory tract infec
tions, urinary tract infections (urine cul
ture with > 105 bacteria/m l, in the
absence of a positive preoperative cul
ture), hyperthermia (>38°C ) for at least
Table 1-Diseases and Operations in Patients
Who Had Clean Surgery
Disease/operation
Neoplasms
Spleen
Thyroid
Gastrointestinal tract
Other
Laparotomy
Thyroidectomy
Mastectomy
Other
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No. of patients
6
4
4
2
4
12
4
1
3
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2 days. There were seven infections — six
(28.6%) in the control group and one
(4.8%) in the thymostimulin-treated
group (Table III). Table IV indicates divi
sions among the two stratified groups and
lists the infections found.
The lower incidence of postoperative
infections in patients treated with
thymostimulin (4.8% versus 28.6%) is
significant (p = 0.046). We also exa
m ined the two stratified groups
separately; the percentage differences
(0% versus 20% for clean surgery and
9.1% versus 36.4% for cleancontaminated and contaminated surgery)
are not significant (p = 0.236 and 0.155
respectively).
Discussion
Clean-contaminated and contaminated
surgical procedures were grouped
together because in our department both
groups of patients received antibiotics
prophylactically; therefore, a more
homogeneous group than one formed by
clean and clean-contaminated surgery was
obtained.
The frequency of postoperative infec
Table 11-Diseases and Operations in Patients
Who Had Clean-Contaminated and
Contaminated Surgery
□isease/operation

No. of patients

Neoplasms
Colon/rectum
Gastric
Other
Biliary tract
Other

17

tions in the untreated group was 28.6%,
20% for clean procedures and 36.4% for
clean-contaminated and contaminated
operations; these values are similar to
those described by others for immunoincompetent patients. The number of infec
tions in the treated group is similar to that
for standard values reported for surgery
in general.21,22
Four of the seven infections recorded
involved the respiratory tract and three
the wound. The lack of urinary tract
infections, often the most common
type,23 could be due to the restrictions
we imposed and also because most of the
catheterized patients (20 of 24) received
antibiotics prophylactically.
Dehiscence of an anastomosis was not
considered an infective complication
because we believe that in almost all cases
it is due to problems of surgical tech
nique. In our series dehiscence did not
occur.
Statistical analysis indicates fewer
infections in those patients treated with
thymostimulin (p < 0.05). This is con
firmed by Bayes’ analysis which fur
nishes, for each probability a prjori, prob
ability a posteriori that is notably greater,
producing a curve with pronounced in
ferior concavity (Fig. 1). Also, separate
analysis of the two stratified groups (clean
surgery, p = 0.236 and clean-contami
nated and contaminated surgery, p =
0.155), gave curves with inferior but lessaccentuated concavities. Therefore, in

8
7
2
3
2
14

Resection
Large intestine
Gastric
Biliary tract
Laparotomy
Other

7
7
3
3
2

Table Ill-Infections, All Patients
Infection

Control

No
Yes

15
6

%

28.6

Treated
20
1

FIG. 1—Bayes’ analysis: probability a pri
ori (p.p.) and probability a posteriori (P.P.)
------------ = all patients;------------- ---- clean
surgery g r o u p ; ---------------- =
cleancontaminated and contaminated group.

4.8

p - 0.046.

Table IV—Infections in Two Stratified Groups
Clean*
Infection
No
Yes
%

Control

Treated

Control

Treated

8
2»
20

10
0

7
4 t*§ §

10
1§
9.1

*p - 0.236.
tp - 0.155.
IRespiratory tract infection.
§Wound infection.
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Clean-contaminated/contaminatedf

0

36.4

each of these two groups (especially the
latter) thymostimulin probably had a sub
stantial action that was masked by the
small numbers in these groups.
Conclusion
The results of this trial demonstrate the
efficiency of thymostimulin, administered
pre- and postoperatively, in reducing
postoperative infections in anergic
patients not suffering from malnutrition.
We thank Elizabeth M. Tully, MD, MS, for
her translation of this manuscript.
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Ligation of the External Carotid
and Anterior Ethmoidal Arteries for Severe or
Unusual Epistaxis Resulting From Facial Fractures
From July 1980 to December 1983, 16
patients with severe posterior epistaxis
were treated by arterial ligation. The
procedure was successful in all.
Two cases of life-threatening and
unusual epistaxis resulting from maxillary
fractures are presented in detail. The
authors conclude that ligation of the
external carotid and anterior ethmoidal
arteries is a speedy, safe and highly suc
cessful method of dealing with posterior
epistaxis.

in 16 patients with severe posterior
epistaxis — to make a plea for ligation
of the external carotid and anterior eth
moidal arteries as the procedure of choice
for this condition. We include two case
histories of young patients who required
ligation of the external carotid artery
secondary to complications of maxillary
fractures. We found this an efficient and
safe method of controlling severe or
unusual epistaxis.
Patients and Methods

De juillet 1980 a decembre 1983,
16 cas d'epistaxis posterieur grave ont
ete traites par ligature arterielle. Dans
tous les cas, I'intervention fut couronnee
de succes.
On decrit ici deux cas I'dpistaxis inhabituel ayant menace la vie des patients
et resultant de fractures du maxillaire.
Les auteurs concluent que la ligature de
la carotide externe et des art&res ethrnoidales anterieures est une methode
rapide, sOre et hautement efficace de
traiter Tepistaxis posterieur.

Our 16 patients (2 women, 14 men),
ranged in age from 17 to 86 years
(Fig. 1). In 12 patients the epistaxis was
spontaneous, in 4 young men it occurred
as a result of trauma.
Apart from the two cases presented in
detail all patients requiring the ligation of
external carotid and anterior ethmoidal
arteries had an anterior and posterior
packing or a nasostat inserted at least
twice.
Patients referred from other hospitals
with anterior and posterior packing or a
nasostat in place were first observed while
Severe epistaxis often requires close col associated medical problems were cor
laboration between the otolaryngologist rected. When bleeding persisted despite
and internist. We describe our experience packing, the latter was removed and the
bleeding site identified if possible. In the
majority of patients with posterior
epistaxis, the packing or nasostat was
replaced. The external carotid and
From the Department of Otolaryngology,
anterior ethmoidal arteries were ligated if
Dalhousie University, Halifax, NS
the bleeding persisted or recurred despite
adequate packing and medical
Presented at the annual meeting o f the
Canadian Otolaryngological Society, Hali
management.
fax, NS, June 7, 1984
Patients who presented with epistaxis
in our emergency department were
*Otolaryngologist, Youngstown, Ohio
assessed by our house-staff and the nose
tResident in otolaryngology, Dalhousie
packed, if necessary. Again, when
University, Halifax Infirmary, Halifax
epistaxis continued, despite adequate
sedation, bed rest and control of arterial
XAssociate professor, Department of
hypertension, the packing was changed or
Otolaryngology, Dalhousie University
the nasostat repositioned, and when
Accepted fo r publication Apr. 18, 1986
bleeding persisted while the second pack
ing
was in place, or several days after its
Reprint requests to: Dr. A.D. Hassard, Ste.
removal, then the arteries were ligated.
235, 1005 Belmont Ave., Youngstown, OH
44504, USA
A similar method of treatment was fol

lowed when the patient was admitted for
observation without initial packing.
The technique of arterial ligation has
been well described.1 We ligate the exter
nal carotid artery twice with 0 silk, above
the superior thyroid artery take-off. We
do not divide the artery. Following this,
one or two small Week clips (Division of
Squibb Canada, Inc., Weston, Ont.) are
applied to the anterior ethmoidal artery;
it is divided only when there is an ade
quate arterial cuff on each side.
Case Reports

Case 1
A 22-year-old man was admitted after a
motor vehicle accident. On admission he had
a Le Fort III fracture with an obvious
cerebrospinal fluid leak, a “ rocker” fracture
of his nasal bones and a fracture of the hard
palate. In addition, he had a pneumothorax
and a transverse fracture of the right femur.
After stabilization in the intensive care unit,
he underwent a tracheostomy, suspension of
the Le Fort III fracture and reduction of the
nasal fracture.
Five days later, while coughing he had a
small amount of bleeding through the
tracheostomy tube. That same day the
tracheostomy tube was changed, and immedi
ately he began to hemorrhage. Approximately
2000 ml of venous blood drained from the
tracheostomy tube, the mouth and nose.
Fortunately, the tracheostomy cuff was
inflated immediately, the intermaxillary sus
pension wires were cut and clots removed by
suction and manually. This episode occurred
with the patient in a supine position and on
continuous leg traction.
A Foley catheter was inserted through the
right nostril and inflated to stop what turned
out to be a massive venous hemorrhage aris
ing from the pterygoid plexus. At the same
time, the right external carotid and anterior
ethmoidal arteries were ligated and bron
choscopy was performed, with suctioning of
clots from the basal bronchi bilaterally.
Two days later, under local anesthesia, the
intermaxillary wiring was repositioned. The
patient suffered a pulmonary embolism and
required anticoagulation but there was no
recurrence of epistaxis. After 80 days in the
hospital he was discharged. On follow-up (Fig.
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2) he had a large perforation of the bony nasal
septum and right epiphora, successfully treated
later with dacryocystorhinostomy.

Comment
This case demonstrates an unusal com
plication of a Le Fort III fracture with a
profuse venous epistaxis and hemoptysis
originating from the pterygoid plexus.
Case 2
A 17-year-old man sustained a punch injury
to the right maxilla. Three months later max
illary sinusitis and right facial cellulitis deve
loped (Fig. 3). Sinus x-ray films revealed right
pansinusitis and an old fracture of the right
maxillary sinus. Swabs obtained from an inci
sion in the buccal fat pad and nasal pus rev
ealed the presence of Haemophilus influenzae.
The patient was given an adequate dosage of
intravenous cefazolin, then amoxicillin, and
discharged from hospital 5 days after admis
sion. Follow-up sinus x-ray films showed a
mucocyst nearly filling the right antrum. Later
he underwent a right Caldwell-Luc antrostomy
to remove the mucocyst. A longitudinal frac
ture was seen on the lateral wall of the maxil
lary sinus, close to its posterior wall. Upon
exploration of the fracture site, which commu
nicated with the infratemporal fossa, the inter
nal maxillary artery was torn. Bleeding was
partially controlled with packing and Week
clips, followed immediately by external carotid
artery ligation because of persistent bleeding.
There were no postoperative complications
and when he was last seen there was no recur
rence of sinusitis.

Results
All patients left the hospital in stable
condition and none required further
admission for epistaxis. One elderly man
needed ligation of the right external
carotid artery and anterior ethmoidal
artery and then 4 days later, because of
persistent bleeding, required ligation of
the left external carotid artery.
The mean number of units transfused
per patient was 5.25. None had an abnor

AGE

mal platelet count or prolonged proth
rombin time or partial thromboplastin
time.
Complications o f Treatment
o f Severe Epistaxis
The complications in this study resulted
from either packing alone or arterial liga
tion. Two patients suffered necrosis of the
inferior aspect of the nostril at the point
of maximum pressure from the metal
clamp holding the catheter under tension.
Regardless of anterior packing and gauze
padding between the clamp and nose, this
complication still occurred. After arterial
ligation, we released the metal clamp and
the necrotic area was covered with antibi
otic ointment for several days, then left
to dry and slough off on its own. The
remaining scar could be seen only with
difficulty.
One woman died of epistaxis. She was
over 70 years old and had had a
dacryocystorhinostomy done by an eye
surgeon. She died while under sedation,
with posterior and anterior packing in
place. She had a long history of conges
tive heart failure and required several
blood transfusions, but she was alert and
in stable condition when seen on morn
ing rounds 2 hours before she died. Per
mission for an autopsy was not granted.
The only complication of external carotid
artery ligation was weakness of the lower
lip in one patient, resulting from division
of a marginal branch of the facial nerve
through the upper neck crease incision.
The wound was re-explored and a divided
nerve branch identified. Continuity could
not be re-established because the distal
portion of the nerve could not be located.
At follow-up 6 months later the function
of the lower lip was completely restored.

FIG. 2—Case 1. Six months after accident.
Note hypertelorism and ocular slant that
followed Le Fort III fracture.

Discussion
The recent literature has placed empha
sis on internal maxillary artery ligation as

( years )

FIG. 1—Age range of 16 patients who underwent arterial ligations; youngest was 17 years
and oldest 86.
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the procedure of choice for severe, uncon
trollable posterior epistaxis.2'4 However,
because of restricted operating-room
time, the two senior authors prefer liga
tion of external carotid and anterior eth
moidal arteries which is a much quicker
procedure.
Ligation of the internal maxillary artery
only was done in one case, a 25-year-old
woman who had a punch injury to her
face as the result of an assault. She had
severe posterior epistaxis requiring three
posterior packings on two different
admissions. We elected to explore her
maxillary sinus for possible fracture and
then ligate the internal maxillary artery.
There was no fracture and the bleeding

FIG. 3—Case 2. During first hospital admis
sion; there is right facial cellulitis and maxil
lary sinusitis.
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did not recur after ligation. In terms o f
choice between packing and surgery, all
patients preferred the surgery.
Advantages o f external carotid artery
ligation are: expediency in an elderly
patient with multiple medical problems,
minimal morbidity because o f constant
anatomical landmarks, patient preference
and no recurrence o f epistaxis in our ser
ies. The procedure usually takes 1 hour
and can be done under general, local, or
neurolept anesthesia. Neurolept anesthe

sia was used in one elderly woman with
previous cervical spine fusion, in whom
endotracheal intubation was not possible.
The disadvantages are: an external
scar, the risk o f facial nerve damage and
o f interference with collateral cerebral cir
culation in a patient with cerebrovascu
lar insufficiency from atheroma o f the
internal carotid artery.
We thank Dr. Mohamed Nabile AbdelHamid from Thunder Bay, Ont. for drawing

up a questionnaire sent to patients on the treat
ment o f posterior epistaxis.
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Percutaneous Drainage of a
Tuberculous Liver Abscess
The authors describe the management
by percutaneous drainage of a rare soli
tary tuberculous liver abscess in a
37-year-old woman. Open surgical
drainage of such abscesses can be
avoided using percutaneous drainage
combined with transcatheter infusions of
antituberculous agents. For the safe and
successful use of this method three
criteria must be met: the abscess should
be unilocular, there must be a safe
access route and a previously sterile
compartment must not be contaminated.
In addition a small (22 or 23 gauge) nee
dle should be used for the initial
puncture.

ces antituberculeuses. Pour s'assurer de
Tinnocuite et du succes de cette
methode, trois criteres doivent etre ren
contres: I'abces doit etre uniloculaire, il
doit exister une voie d'acces sure, et il
faut eviter de contaminer un compartiment sterile auparavant. De plus, il y a
lieu d'utiliser une petite aiguille (de cali
bre 22 ou 23) pour la piqure initiate.

Tuberculous liver abscess is rare.
Although the liver is commonly involved
in pulmonary and extrapulmonary tuber
culosis in the form o f multiple granu
lomas, these are seldom important clini
cally and can readily be diagnosed by
percutaneous liver biopsy. We present a
case of extrapulmonary tuberculosis com
plicated by a tuberculous liver abscess.

Les auteurs decrivent le traitement par
drainage percutane d'un abces tuberculeux solitaire du foie, une affection
rare, chez une femme de 37 ans. Le drai
nage chirurgical ouvert de tels abces
peut etre evite en ayant recours a un
drainage percutane en association avec
des perfusions transcatheter de substan-
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FIG. 1—Computerized tomogram shows well-defined cavity (arrow) in right lobe of liver.
Lesion abuts abdominal wall and has enhancing rim.
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Case Report
A 37-year-old woman was admitted to The
Wellesley Hospital in February 1980 for inves
tigation of a 3-month history of hoarseness.
She had emigrated from the Phillipines and was
employed in Canada as a hospital laboratory
technician. Suspension microlaryngoscopy and
biopsy were carried out. The biopsy cultures
grew Myobacterium tuberculosis var. hominis
(sputum cultures were not done). Isoniazid 300
mg, ethambutol 600 mg and rifampin 400 mg
once a day were prescribed.
One m onth later she began to complain of
right upper quadrant abdominal pain, aggra
vated by deep breathing and coughing. This
was associated with intermittent fever. Physi
cal examination revealed mild to moderate
tenderness in the right upper quadrant on pal-

pation. Results of liver function studies,
aminotransferase and alkaline phosphatase
levels, were normal.
Oral cholecystography gave normal findings.
An isotope study of the liver and spleen demon
strated a vaguely defined defect in the liver.
Computerized tomography (Fig. 1) demon
strated a moderate-sized, ovoid, cystic lesion
in the right lobe of the liver. It did not have
the radiologic characteristics of a hydatid cyst,
and a complement fixation test for echinococ
cosis gave negative results. Amoebic serologic
tests likewise were negative. A chest film
appeared normal.
The patient was readmitted in September
1980 for celiac angiography. This excluded
hepatoma and adenoma as possible diagnoses.
The cystic lesion was again demonstrated.
Under computerized tomographic control, a
20-gauge needle was introduced into the cavity
and purulent material was aspirated, a sample
of which was cultured. No fungi or bacteria
were grown, but acid-fast bacilli were seen with
Ziehl-Neelsen-stained preparations. Cultures
did not reveal the presence of viable mycobac
teria. Contrast was injected to outline the cavity
and a no. 8.3 French pigtail catheter with mul
tiple side-holes was placed into the cavity under
fluoroscopic control (Fig. 2).1 The cavity was
flushed with isoniazid (1 g) and rifampin (1 g)
in 30 ml of normal saline. The abscess was
flushed four times a day for 6 days with this
solution. Following this, injection of contrast
material demonstrated a small irregular cavity
at the tip of the catheter, which was then
removed.
The patient’s symptoms resolved over several
weeks. A follow-up computerized tomogram
in January 1981 demonstrated resolution of the
cavity in the right hepatic lobe (Fig. 3). She
continued on isoniazid, ethambutol and rifam
pin therapy until May 1982. At a clinical
follow-up in January 1986 there were no signs
or symptoms of this abscess.

Discussion
FIG. 2— Sinogram through drainage
catheter shows size of cavity in liver.

The development o f symptoms due to

a tuberculous liver abscess after the insti
tution of treatment for tuberculosis, as in
our patient, has been reported.2 In that
case, the authors speculated that the
cicatrix that formed around the coalesc
ing tuberculoma prevented the antibiotics
from entering the abscess cavity. Resolu
tion of the abscess after the injection of
antituberculous agents into the abscess
cavity is in agreement with this hypothe
sis although, while we did identify
myocobacteria on direct smear, we were
unable to culture them. This suggested
that antituberculous agents had entered
the cavity and rendered the bacilli nonviable and that the abscess had formed
before therapy for the laryngeal tubercu
losis was begun. The late appearance of
symptoms after treatment o f the initial
lesion remains unexplained.
Previous reports o f tuberculous
abscesses o f the liver have emphasized the
importance o f open surgical drainage.2'3
The development o f reliable ultrasonog
raphy and, more recently, computerized
tomography, has allowed accurate locali
zation of intravisceral lesions preoperatively. This has permitted the radiologist
to plan a safe route for percutaneous aspi
ration of the intra-abdominal lesion.
The safety o f diagnostic and therapeu
tic needle aspiration has been greatly
improved by the use of small (22 or 23
gauge) needles for the initial puncture.
Percutaneous drainage o f an abscess is
usually curative when the following three
basic criteria can be met: the abscess is
unilocular; there is a safe access route, so
that the large drainage catheters do not
penetrate bowel or viscera other than the
organ containing the abscess; a previously
sterile compartment is not contami
nated.4 If these criteria cannot be met,
then open surgical drainage should be
considered.
Drainage o f amoebic and pyogenic
abscesses by the percutaneous route has
been described previously.5 Our case
demonstrates that this method is also
applicable to tuberculous liver abscesses,
so that when combined with transcatheter
infusions4'6 o f antituberculous drugs,
open surgical drainage can be avoided.
References
1.

van Sonnenberg E, F errucci JT j r , M ueller PR, et
al: Percutaneous drainage of abscesses and fluid col
lections: technique, results, and applications. Radiology
1982; 142: 1-10

2. GRACEY L: Tuberculosis abscess of the liver. Br J Surg
1965; 52: 442-443
3. S herlock S: Diseases o f the Liver and Biliary System,
7th ed, Blackwell Sci, Oxford, 1985
4. G attegno B, C roisier G, HUGU1ER M, et al: Abces
tuberculeux du foie. Arch Fr Mai A p p Dig 1973; 62:
241-244
5. SCHWARTZ S, Shires GT: Principles o f Surgery, 2 vols,
4th ed, McGraw, Toronto, 1983: 1264

FIG. 3—Follow-up scan shows resolution of cavity.
450

6. Martin EC, Karlson KB, Fankuchen E, et al: Per
cutaneous drainage in the management of hepatic
abscesses. Surg Clin North Am 1981; 61: 157-167

VOLUME 29, NO. 6, NOVEMBER 1986 / THE CANADIAN JOURNAL OF SURGERY

Steven Gallinger, md;* Steven M. Strasberg, md, frcsc;*
H erbert I. Marcus, ms, md;* J ames Brunton, md, FRCPct

Local Hepatic Tuberculosis,
the Cause of a Painful Hepatic Mass:
Case Report and Review of the Literature
Local hepatic tuberculosis is an unusual
form of extrapulmonary tuberculosis. The
authors describe the case of a 39-yearold woman with this disease who posed
diagnostic difficulties. She presented
with abdominal pain, minimal constitu
tional symptoms, hepatomegaly and radi
ologic findings of a focal hepatic lesion.
Laparotomy was required for diagnosis.
A literature review revealed that most
individuals with local hepatic tuberculosis
have fever, night sweats and weight
loss. Hepatomegaly is often the only
abnormal physical sign. Minimally
elevated serum bilirubin and alkaline
phosphatase levels are common.
Ultrasonography and computerized
tomography will demonstrate a lobulated, hypoechoic liver mass. Definitive
diagnosis requires demonstration of acidfast bacilli in biopsy material obtained by
percutaneous techniques or at
laparotomy. Cultures of the diseased
liver are usually negative. Antituber
culous drug therapy appears to be the
preferred method of treatment.
La tuberculose hepatique localisee est
une forme inhabituelle de tuberculose
extrapulmonaire. Les auteurs en decrivent un cas dont le diagnostic a pose
des difficultes. Le patient a ete recu presentant des douleurs abdominales, des
symptomes constitutionnels minimes,
une hepatomegalie et ses radiographies
montraient une lesion hepatique focale.
Une laparotomie diagnostique a ete
necessaire. Une revue de litterature
revele que la plupart des malades souffrant de tuberculose hepatique localisee
ont de la fievre, des sueurs nocturnes et
une perte de poids. L'hepatomegalie est
souvent le seul signe physique anormal.
Des augmentations discretes des taux de
bilirubine et de phosphatase alcaline sont
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frequentes. L'echographie et la tomographie par ordinateur demontrent la pre
sence d'une masse hepatique lobulee. Le
diagnostic ddfinitif exige la demonstra
tion de bacilles acido-resistants dans les
prelevements de biopsie obtenus par voie
percutanee ou a la laparotomie. Les cultu
res obtenues du foie malade sont habituellement negatives. Une antibiotherapie
antituberculeuse semble etre le mode de
traitement prdfere.

Hepatic tuberculosis is a common find
ing in patients with disseminated miliary
tuberculosis.1-3 Even in autopsies of
patients with nonmiliary pulmonary
tuberculosis, miliary hepatic tuberculosis
is found in 50% to 80% of cases.3
However, local hepatic tuberculosis is
rare and tuberculomas or tuberculous
pseudotumours of the liver, in the absence
of active extrahepatic tuberculosis, are
extremely uncommon.
We describe a patient who had local
hepatic tuberculosis without evidence of
active extrahepatic tuberculosis, and we
review the literature on this subject.
Case Report

A 39-year-old woman, native to the Phillipines, was referred for evaluation of abdomi
nal pain. Her symptoms had begun approxi
mately 3 months before admission, becoming
slightly more severe over the ensuing period.
The pain was steady, predominantly in the right
upper quadrant and epigastrium, and was
aggravated by lying on the right side. The only
other positive symptom was mild anorexia. She
denied any weight loss, fever, chills or night
sweats. The remainder of the medical history
and functional enquiry were negative.
On physical examination she was a thin
woman who appeared well and in no distress.
Her body temperature was 37.5°C, the pulse
rate 92 beats/min and the blood pressure
130/70 mm Hg. The head and neck were nor
mal on examination. There was slight dullness
to percussion over the lower left lung field with
good air entry bilaterally. The cardiovascular
system was normal. The liver edge was palpa
ble 8 cm below the right costal margin with a
firm , nontender edge. There was no
splenomegaly. Bowel sounds were present.
Mild tenderness to deep palpation was present
in the right upper quadrant. Rectal and pelvic

examinations gave normal results. Neurologic
examination was unremarkable.
Serum electrolyte, urea, creatinine, calcium,
magnesium and glucose levels were normal.
The hemoglobin value was 110 g/L and leu
kocyte count 7.6 x 109/L with a normal
differential. Findings on urinalysis were nor
mal. The total protein value was 83 g/L, albu
min 40 g/L and total bilirubin 8.0 /tmol/L. The
serum gamma glutamyl transferase level was
93 U/L (normal 5 to 30 U/L), alanine trans
aminase level 36 U/L (normal 5 to 20 U/L) and
lactate dehydrogenase level 62 U/L (normal 45
to 85 U/L). Prothrombin and partial throm
boplastin times were normal. Urine and spu
tum cultures were sterile. Serologic tests for
hydatid disease were negative. A Mantoux test
was positive using 1 TU.
A small left pleural effusion was seen on a
chest x-ray film. Tomograms of the left chest
showed a poorly defined nodular density 2 to
3 cm in dimension, anterior to the 8th thoracic
vertebral body (Fig. 1). Bronchoscopic find
ings were normal with negative bronchial wash
ings and brushings. A limited (4 cm) left thora
cotomy and pleuroscopy revealed pleural
thickening with biopsies of the pleura show
ing only dense fibrosis. On abdominal
ultrasonography, the kidneys, spleen, pancreas
and gallbladder appeared normal; however, a
4-cm mass was noted in the posterior segment
of the right hepatic lobe. The mass had the
characteristics of a cyst filled with debris or
necrotic tissue (i.e., echoes were reduced but

FIG. 1—Chest film shows nodular density
2 to 3 cm in diameter anterior to 8th thoracic
vertebra.
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not absent). Computerized tomography of the
liver showed that the mass was lobulated and
nonenhancing (Fig. 2). It seemed to be made
up of a cluster of spherical masses lying just
beside the inferior vena cava in its intrahepatic
portion. The tomographic density of the lesion
indicated that it was solid and the radiologic
interpretation was that of a tumour. Abdomi
nal angiography was normal except for a
hypovascular area in the posterior segment of
the right lobe of the liver. Barium radiologic
examinations of the upper and lower gastroin
testinal tract showed no abnormalities.
Intravenous pyelography revealed an irregular
extrarenal calcification near the lower pole of
the left kidney, but the right kidney appeared
normal. Attempts to biopsy the liver lesion
using percutaneous needle aspiration directed
by computerized tomography were unsuccess
ful on two occasions because of the superior
and posterior location of the lesion in the right
lobe.
At laparotomy, a lesion 4 cm in diameter was
found on the posterior surface of the right lobe
of the liver as well as a 0.5-cm lesion on the
inferior surface of the right lobe. Similar
lesions were present in the lateral segment of
the left lobe of the liver. A needle biopsy of
one o f the lesions revealed caseating
granulom atous inflam m ation. All other
abdominal organs were normal. Ziehl-Neelsen
stains of the liver biopsy showed acid-fast
bacilli. Culture of the liver biopsy tissue did
not grow tuberculous bacilli. The patient was
treated with isoniazid, rifampin and ethambutol. She did well except for a transient, drugrelated elevation in liver enzyme levels. Repeat
computerized tomography at 4 months’ follow
up revealed a rim of calcification surrounding
the hepatic lesion. The patient is free of ab
dominal pain and doing well at 1 'k years. The
liver is softer and considerably smaller.

Discussion
Since Bristowe’s4 original description
of 12 cases of local hepatic tuberculosis
in 1858, only a few more cases have been
reported. Hersch5 found fewer than 100
cases in a literature review up to 1964.
Involvement of the liver in patients with
tuberculosis is not uncommon, but the
majority of patients with hepatic tuber
culosis have the miliary type consisting of

FIG. 2—Computerized tomogram shows
lobulated nonenhancing mass in posterior seg
ment of right lobe of liver.
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widespread multiple granulomas 0.6 to 2
mm in diameter. Lesions larger than 2
mm are classified as local tuberculo
sis.2’5'6 These focal lesions present as
conglomerate tubercles, granulomas, biled uct tuberculosis or tuberculous
abscesses.5
The histologic findings in local hepatic
tuberculosis have been well described by
Korn and associates.1 Large granulomas
and conglomerate tubercles often have
central caseation with Langhans giant
cells. Occasionally, the caseous granula
tion tissue breaks down and may dis
charge into the bile ducts causing cholan
gitis.2 In miliary hepatic tuberculosis, the
granulomas appear concentrated near the
heptic veins, while in the local form, the
bacilli are usually found in the portal
regions.2,5 The tubercle bacillus probably
reaches the liver through the hepatic
artery in cases of miliary tuberculosis and
from the intestine, through the portal
vein, in local hepatic tuberculosis.2’45
The rarity of the local form of this dis
ease may be because the liver is resistant
to challenge with tubercle bacilli.7 This
may be due to the relatively low tissue
oxygen tension in the liver.5
Patients described in case reports of
local hepatic tuberculosis have presented
with fever, chills, night sweats and weight
loss,5’6,8 but they may, as in our case,
present without systemic manifesta
tions.5,9 In a review of 20 cases of local
hepatic tuberculosis, Hersch5 noted that
the average age at presentation was 44
years with 90% of the patients having
fever, 75% weight loss and 55% anorexia.
Physical findings are variable. Patients
may appear entirely well without the typi
cal cachexia characteristic of disseminated
miliary tuberculosis. Hepatomegaly is a
consistent finding in individual case
reports,6,9,10 and was described in 19 of
Hersch’s 20 patients.5 The enlarged liver
is often tender.5’10 Splenomegaly may
also be present.5 The remainder of the
physical exam ination is often un
remarkable.
The results of liver function tests are
occasionally normal,6’8 but serum liver
enzyme levels, most commonly alkaline
phosphatase, are usually minimally
elevated. Hyperbilirubinemia, if present,
is often m ild.1’5 With modern imaging
techniques such as ultrasonography and
computerized tomography, local hepatic
tuberculosis may become easier to diag
nose than in the past. In their manage
ment of a patient with a tuberculous pseu
dotumour of the liver, Forward and
colleagues10 used these two techniques to
demonstrate the hypoechoic, lobulated
mass, which was similar to the findings
in our patient. In our case ultrasonogra
phy suggested a cystic mass filled with
debris, but computerized tomography
suggested a tumour. The high-density
number of the caseous material was mis

leading in this case. Furthermore, lesions
in the left lateral lobe were not visible on
scanning or ultrasonography.
To diagnose local hepatic tuberculosis
definitively, involved liver tissue must be
obtained for histologic examination and
culture. Percutaneous liver biopsy, when
successful, is the least morbid approach
and may be an adequate method of
obtaining tissue; however, laparotomy
may be required when the lesions are inac
cessible as in our case. The presence of
acid-fast bacilli in the biopsy is diagnos
tic. Perhaps surprisingly, cultures of the
liver biopsy often do not grow tubercle
bacilli. In three o f four recent
reports,6'8-10 cultures of infected liver tis
sue were negative as in our case.
The differential diagnosis of local
hepatic tuberculosis includes benign
hepatic neoplasms, primary and secon
dary liver tumours and infective processes
that produce focal hepatic lesions.
Granulomatous diseases such as sarcoi
dosis may make the histologic diagnosis
difficult if acid-fast bacilli are not seen.11
Antituberculous drug therapy is usually
effective for localized hepatic tuberculo
sis,6’8,9 although hepatic resection has
been carried out successfully.9
Although our patient had minimal
symptoms, she did have laboratory and
radiologic findings consistent with local
hepatic tuberculosis. Laparotomy was
necessary for tissue diagnosis. The abnor
mal chest x-ray film and perirenal calcifi
cation suggest that she had tuberculosis
at extrahepatic sites, but the liver
appeared to be the only organ affected by
active tuberculosis.
In summary, although local hepatic
tuberculosis is rare, it should be consi
dered in any patient presenting with fever,
night sweats, weight loss, an enlarged
liver and focal hepatic lesions.
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Ileal Perforation Due to
Cytomegaloviral Enteritis
As the AIDS epidemic unfolds, many
newly described clinical syndromes
resulting from unusual manifestations of
opportunistic infections are being seen.
The authors report the clinical and patho
logical features of intestinal perforation
in an AIDS patient caused by extensive
small-bowel ulcerations due to
cytomegalovirus. The diagnosis was con
firmed by ultrastructural and immunohistochemical studies. It is suggested
that infection and destruction of the
muscularis propria by the virus contrib
utes to intestinal perforation.
Au fur et & mesure qu'apparait I'ampleur
de I'epidemie de SIDA, on observe plusieurs nouveaux syndromes cliniques
resultant de manifestations inhabituelles
d'infections opportunistes. Les auteurs
presentent les caractdristiques cliniques
et pathologiques d'une perforation de
I'intestin chez une victime du SIDA, per
foration provoqu6e par une ulceration
etendue du petit intestin due au cytome
galovirus. Le diagnostic fut confirme par
des etudes d'ultrastructures et des examens immunohistochimiques. II est pro
pose que I'infection, puis la destruction
de la muscularis propria par le virus a
contribue a la perforation intestinale.

In the im m unocom prom ised host,
cytomegalovirus (CMV) infection is a
major cause of morbidity and mortal
ity.1 Patients with the acquired immune
deficiency syndrome (AIDS) have a pro
found defect o f cell-mediated immunity
and are susceptible to infection by fungi,
viruses, protozoa and intracellular bac
teria.2 These infections occur with
devastating severity and in unusual loca-
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tions, resulting in a myriad o f hitherto
unencountered clinical syndromes. We
report a case in which ileal perforation
due to CMV enteritis occurred in a
homosexual man suffering from AIDS.

Case Report
A 22-year-old male homosexual was treated
intravenously with acyclovir for a perianal
ulceration due to herpes simplex virus that had
not healed over 3 months. Investigation rev
ealed cotton-wool exudates in the fundi, a leu
kocyte count of 2.7 x 109/L (0.42 lympho
cytes), anergy to seven out of eight skin-test
antigens and severely reduced in-vitro lympho
cyte response to phytohemagglutinin, concanavalin A and pokeweed mitogen. Antibod
ies to human T-lymphotropic virus type III
(HTLV-III*), determined at the Laboratory
Centre for Disease Control, Ottawa, were posi
tive by the Western blot technique.3 The
ulcers responded to acyclovir, and chronic
oroesophageal candidiasis was controlled with
orally administered ketoconazole (200 mg twice
daily). He continued to have low-grade, inter
mittent fever (body temperature 38° to
37.5°C), anorexia, weight loss and intermittent
diarrhea. Stools were consistently negative for
parasites. Six months later, the diarrhea
became more severe, requiring rehydration dur
ing a visit to Cuba. Periumbilical cramping
pain also became prominent. The weight loss
progressed after his return to Canada and he
was admitted to hospital for investigation. He
was severely cachectic and had a body temper
ature of 38°C. The pulse was 110 beats/m in,
blood pressure 100/60 mm Hg and respirations
20/min.
Oral candidiasis was noted. The abdominal
examination showed no organomegaly. There
were local areas of tenderness without rebound
or guarding. The bowel sounds were normal.
The hemoglobin was 89 g/L , the leukocyte
count 6.2 x 109/L and platelet count
347 x 109/L . T wo days after admission frank
signs of peritonitis developed and an abdomi
nal film showed a small amount of free air
under the right hemidiaphragm, with multiple
air-fluid levels.
At laparotomy diffuse peritonitis with fecal
contamination was found. Numerous ulcers
♦Recently the Human Retrovirus Subcom
mittee of the International Committee on the
Taxonomy of Viruses proposed the name
human immunodeficiency virus (HIV) for all
the closely related members of this group of
viruses (Science 1986; 232: 697).

were palpable along the antimesenteric border
of the small intestine, from the ligament of
Treitz to the ileocecal valve. Many ulcers were
deeply penetrating and in two locations had
perforated the serosal surface. A limited resec
tion of the portion of intestine with the perfo
rated ulcers was performed and intestinal
continuity re-established by an end-to-end
anastomosis.
He was started on cefazolin, metronidazole
and netilmycin. His postoperative course was
complicated by cardiac failure and hypoten
sion. In addition, pneumocystis pneumonia
was diagnosed by bronchoalveolar lavage and
treated with pentamidine isothionate. He refu
sed treatment with interferon and CMV hyper
immunoglobulin; 7 days after operation
refractory hypotension developed and he died.
Permission for autopsy was refused.

Pathological Findings
The 25-cm segment o f small bowel had
four ulcers on the mucosal surface (Fig.
1). The serosal surface was congested and
covered with a fibrinopurulent exudate.
The ulcers measured between 2 and 3 cm
in diameter. Their edges were irregular
but sharply delineated from the adjacent,
unaffected mucosa. The ulcers were deep
and excavated with beds composed o f
necrotic debris and friable tissue. The
serosal surface underlying the ulcers pro
truded as rounded sacculations (Fig. 2).
One o f the ulcers had perforated, while
the bases o f the others were greatly
attenuated. The intervening uninvolved
mucosa demonstrated some congestion
but otherwise appeared normal.
Microscopically, there was loss o f the
mucosa and underlying tissue in the areas

FIG. 1—Mucosal surface of ileum showing
multiple well-defined ulcers.

VOLUME 29, NO. 6, NOVEMBER 1986 / THE CANADIAN JOURNAL OF SURGERY

453

of ulceration. The ulcer bases consisted
of granulation tissue with intense acute
and chronic transmural inflammation
with some undermining of the mucosal
surface laterally (Fig. 3). This was
associated with destruction of the muscularis propria, resulting in thinning of
the ulcer bed. In the area of inflamma
tion there was a vasculitis involving arteri
oles and venules, but this was mild com
pared with the degree of inflammation.
The inflammatory infiltrate was com
posed predominantly of polymorphs and
macrophages with few lymphocytes.
Prominent intranuclear inclusions were
present in large numbers. These were
noted in tissue macrophages, vascular
endothelial and smooth-muscle cells
(Figs. 4 and 5). In some areas there was
inflammation and destruction of the muscularis propria without involvement of
the overlying mucosa. Stains for fungi,
acid-fast bacilli and protozoa failed to
reveal the presence of any organisms. The
mesenteric lymph nodes showed lym
phoid depletion, scattered macrophages
and endothelial cells containing large
intranuclear inclusions.
Ultrastructural examination demon
strated numerous viral capsids in the
nuclei of macrophages containing inclu
sions (Fig. 6). The capsids measured 100
nm in diameter and frequently contained
a concentric inner shell although some
had an electron-lucent centre or an
electron-dense core. Immunoperoxidase
staining revealed the presence of CMV
(early) antigen in the nuclei of scattered
macrophages (Fig. 7). Cytomegalovirus
was also cultured from the urine
postoperatively.

FIG. 3—Section of ulcer border showing transmural inflammation and destruction of muscularis propria (hematoxylin and eosin, initial magnification x 20).

Discussion
Infection by CMV is most often asymp
tomatic and diagnosed retrospectively by
serologic testing. However, in the
immunocompromised host, it is a fre
quent cause of symptomatic infections. In
patients with AIDS, infection of the gas
trointestinal tract by CMV is being recog
nized more often.4 7 The patient usually
presents with diarrhea or gastrointestinal

FIG. 4—High-power detail of inclusions in endothelial cells (short arrow) and macrophage
(long arrow) (hematoxylin and eosin, initial magnification x 750).

FIG. 2—Serosal surface of ileum showing
protruding ulcer base with central area of per
foration.

FIG. 5— High-power view of muscularis propria showing inflammatory cell infiltrate, des
truction of muscle and inclusion body in smooth-muscle cell (arrow) (hematoxylin and eosin,
initial magnification x 600).
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hem orrhage. In renal tran sp lan t
recipients, colonic bleeding from
cytomegaloviral ulceration of the cecum
is the commonest cause of massive gas
trointestinal hemorrhage.8 In patients
with AIDS, systemic infection with CMV
is being increasingly recognized and
believed to be a major cause of death.9
Our patient suffered from an acute
abdominal emergency condition due to
perforation of an ileal ulcer caused by
CMV infection. This unusual manifesta
tion adds a new dimension to the surgi
cal complications in patients with AIDS.
One previous case of ileal perforation due
to such infection has been reported.10 As
in our patient, the disease was fatal within
2 weeks of diagnosis. Perforation of the
colon has been reported more often10’11

and probably reflects the more frequent
occurrence of infection of the colon and
rectum .12' 15 However, it is now recog
nized that all parts of the gastrointesti
nal tract, including esophagus, stomach
and biliary tree can be infected by CMV
in patients with AIDS.4-7 Enteric infec
tions in AIDS can also be caused by Cryp
tosporidium, Isospora belli, Mycobac
terium avium-intracellulare, Salmonella
typhi, Shigella sp. and Entamoeba
histolytica.16 The last three could be the
cause of intestinal perforation through
ulceration.
The ulceration caused by CMV infec
tion is localized and associated with
intense transmural inflammation that at
times undermines the overlying mucosa.
It has been suggested that a vasculitis is

FIG. 6—Electron micrograph of viral capsids in nucleus of macrophage (initial magnifica
tion X 85 200).

the mechanism by which CMV induces
lesions in the gastrointestinal tra c t.13
Some vascular inflammation was noted
in the capillaries and venules of the ulcer
ated areas in our case and may have con
tributed to the superficial ulceration of
the mucosa. However, the extent o f the
inflammation with dissolution of the
muscularis could not be attributed to a
vasculitis alone. In addition, infection and
destruction of the muscularis propria was
observed without involvement o f the
overlying mucosa. Some w o rk ers,17
using in-situ hybridization, have dem on
strated widespread infection of epithelial
and mesenchymal cells by CMV. It has
been suggested that local inflammation
may occur in these infected areas. Our
observation of inclusion bodies in
smooth-muscle cells associated with
severe inflammation supports this notion.
It appears that destruction of the mus
cularis propria accounts in large part for
the perforation and the diverticular pro
trusions in the serosa.
Drugs that hold some promise for
effective treatment of cytomegaloviral
disease include 9(1,3-dihydroxy-2propoxymethyl) guanine (DHPG)18 and
trisodium phosphonoformate.19 Thus,
early diagnosis of intestinal disease due
to CMV is important. Upper and lower
intestinal disease could be diagnosed early
by endoscopy, although it must be
remembered that inclusion bodies may be
sparse. The use of ultrastructure and
immunoperoxidase stains can help in con
firming the diagnosis. Evidence of syste
mic disease in the form of CMV cultured
from the urine or detected by DNA hybri
dization, or a positive buffy-coat culture
must be sought if the condition is to be
diagnosed early enough to institute
treatment.
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Anteromedial Displacement of the Tibial Tubercle
for Patellofemoral Arthralgia
Anterior and medial repositioning of the
tibial tubercle (anteromedialization)
reduces patellofemoral pressure and cor
rects patellar malalignment. Over the last
6 years this simple procedure was car
ried out on 53 knees in patients who had
no athletic inclinations. The average age
was 40.4 years. Follow-up was at least
1 year.
A rating system was developed and
overall the results were 65.9% excellent,
15.9% good, 11.4% fair and 6.8%
poor. In the over-45 age group, the
results were 57.1% excellent, 28.6%
good, 14.3% fair and none poor. The
complication rate was relatively low
(18.7% ).
This procedure appears to be satisfac
tory for patellofemoral arthralgia when
malalignment is present, particularly in
the elderly.
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Le repositionnement median du tubercule
tibial reduit la pression patello-femorale
et corrige les defauts d'alignement rotulien. Au cours des 6 dernieres annees,
cette operation simple a ete pratiquee
sur 53 genoux chez des patients n'ayant
aucun penchant pour les sports. L'age
moyen etait de 40.4 ans. Des examens
de surveillance se sont poursuivis sur au
moins 1 an.
Un systeme devaluation a ete developpe qui a mis en evidence 65.9%
d'excellents, 15.9% de bons, 11.4% de
moyens et 6.8% de mauvais resultats.
Chez les plus de 45 ans, les resultats
ont ete excellents dans 57.1% des cas,
bons dans 28.6% et moyens dans
14.3%; il n'y a eu aucun mauvais resultat. Le taux de complication a ete relativement faible (18.7%).
Cette operation semble etre satisfaisante dans les cas d'arthralgie patellofemorale quand il y a defaut d'aligne
ment, et particulierement chez les
patients plus ages.

ment,3'4 tibial tuberosity anteriorization
(Maquet),5-6 to patellectomy.
Variable results have been reported
with all of these techniques. Overall,
patellectomy probably gives the best
results but, interestingly, after multiple
patellar procedures, it seldom provides
total relief of pain.7 The Maquet proce
dure also gives excellent results, but the
complication rate is high.7’8
For the last 6 years a simple technique
of medial repositioning of the tibial tuber
cle (anteromedialization) combined with
a lateral release has been used for patel
lofemoral arthralgia with reasonable
results, especially in the elderly.
Patients and Methods

Patients who had this procedure per
formed between 1979 and 1985 were exa
mined. In all, the follow-up was at least
1 year. The indications for surgery were
failure of conservative treatment, after
more than 6 months of therapy, and some
degree of patellar malalignment. The
diagnosis of malalignment was made clin
ically (i.e., a greater than normal Q
angle). Radiologic assessment was not
attempted because we found considera
ble difficulty in interpreting minor degrees
of malalignment. Palpable crepitus aris
ing from the patellofemoral joint was
present in all cases.

The genesis of patellofemoral pain is
obscure, and symptoms bear little relation
to pathological findings.1 The impor
tance of observable damage to the artic
ular cartilage is in doubt as are minor
degrees of malalignment of the patella.
Treatment of patellofemoral arthralgia
consists initially of exercises, mainly Surgical Procedure
quadriceps strengthening and stretching
and, if that fails, surgery. The surgery
The actual technique is a combination
ranges from patellar shaving and lateral of a Maquet56 and an Elmslie-Trillat
release,2 proximal or distal realign procedure.9 Under tourniquet control, a
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long midline skin incision is made from
the midpole of the patella to about 7 cm
below the tibial tuberosity. The prepatel
lar fascia is elevated and a wide lateral
retinacular release performed. The patella
is then palpated. In cases with severe
damage to the articular cartilage, the
patella is shaved. (This may not be neces
sary as the senior author [H.U.C.] has
refrained from doing so over the last 3
years, with no obvious change in results.)
The periosteum over the tibial tuber
cle is incised longitudinally, leaving a strip
as wide as the patellar tendon. Residual
medial and lateral periosteum in the area
is then elevated. A half-inch osteotome
is used to cut a rectangular strip of bone
as wide as the patellar tendon attachment,
7 cm long and about 1 cm thick. The strip
is left in place distally and cut proximally

just above the attachment of the patellar
tendon. The free proximal end is then
twisted up onto the medial cortex of the
tibia. While it is held in place by thumb
pressure, the knee is flexed to check that
the malalignment has been corrected and
the patella tracks smoothly. The block of
bone is anchored into place with two or
three counter sunk AO (Association for
Osteosynthesis) cancellous screws (Fig. 1).
The anterior and medial displacement
usually results in some degree of patellar
tendon laxity. A small amount of cancel
lous bone is removed from the original
donor site and placed under the medial
side of the graft at its new location and
the elevated medial periosteum is then
drawn over it. The tibialis anterior mus
cle is not sutured back to bone to avoid
the possibility of an anterior compart
ment syndrome. A Hemovac drain is left
in the donor site.
A compression bandage reinforced
with plaster is used for a day or so, then
replaced with a plastic back-splint for 6
weeks for walking. The patient can' be
fully weight bearing and may start knee
flexion the day after surgery. Straight leg
raising is avoided for 6 weeks, although
gentle isometric contractions of the quad
riceps are allowed. Most patients reach
75° of flexion within 5 days at which time
they are discharged.
Healing of the transposed bone is quite
rapid. Use of the splint is discontinued at
6 weeks and vigorous quadriceps exer
cises, both strengthening and stretching
are begun. The screws are usually
removed about 1 year after surgery (Fig.
2).

Rating System
We developed a rating system to assess
the results o f operation: excellent implied
no pain, full flexion and a return to
preoperative activity levels or better; good
in which there was mild pain (that did not
interfere with activity), full flexion and
a return to preoperative activity levels,
fair was associated with moderate pain
(occasioned by increased activity that in
termittently required analgesics), flexion
from 0° to 100° and a return to preoper
ative activity levels; poor implied a result
less than fair and not improved by
surgery.
Findings
There were 53 patients (33 women, 20
men), ranging in age from 19 to 71 years
(average 40.4 years). Twenty-two patients
were 45 years of age or older. The
primary disease in 45 was chondromala
cia or patellofemoral osteoarthritis; in the
other 8 it was recurrent patellar subluxa
tion with accompanying chondromalacia.
Nine patients were excluded from the
study — five had a high tibial osteotomy
at the time of the procedure, one a patel
lofemoral resurfacing and two had under
gone total knee replacement. One patient
was not available for review.
Of the 44 patients reviewed, 1 had a
previous patellectomy and 4 had under
gone Hauser procedures. Eight had recur
rent patellar subluxation as the primary
problem and six a history of direct trauma
to the anterior aspect of the patella fol
lowed by the development of retropatel
lar pain. Of the remaining 30 patients, in
whom there was no obvious cause of
patellofemoral chondromalacia, 15 were
obese.
Of the 44 patients reviewed the rating
was excellent in 65.9%, good in 15.9%,
fair in 11.4% and poor in 6.8%. In the
poor cases, two had a subsequent
patellectomy and one a patellofemoral
resurfacing.
Fourteen patients 45 years of age and
over who had a tibial tuberosity
anteromedialization only scored 57.1%
excellent, 28.6% good and 14.3% fair.
There were no poor results.
Complications

FIG. 1—View of knee 4 weeks after substan
tial anteromedialization for severe patellar
malalignment. Graft has not yet united.

FIG. 2—Just before removal of screws, graft
is solidly united. This patient required less than
I cm of anteriorization but considerable medialization.

Three of the 53 patients who underwent
anteromedialization had minor wound
infections that resolved with antibiotics
and 3 had wound infections that necessi
tated drainage and hardware removal.
Two patients had a neuroma from divi
sion of the infrapatellar branch of the
saphenous nerve. One patient fell, sus
taining a graft fracture with 1 cm of sepa
ration. He still has a 10° quadriceps lag
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18 months later and will probably require
further surgery. One had a stress fracture
of the tibia through the distal screw hole
after hardware removal. It healed
uneventfully with casting.
Discussion

Our technique is similar to that
described by Fulkerson10 and Miller and
LaRochelle.11 It is a simple procedure,
healing is rapid and immobilization
minimal. Advancement and medialization
of approximately 1 cm has usually been
employed, but greater advancement can
be achieved simply by using a thicker
graft.
The procedure is a combination of a
Hauser or Elmslie-Trillat and Maquet.
The Hauser tibial tubercle transfer,
because of the slope of the medial surface
of the tibia, often recesses the patellar ten-

FIG. 3—Congenital dislocation of patella
shows virtual absence of trochlear groove —
contraindication for anteriomedialization.

60

don attachment, thus tightening the patel
lar tendon — in effect a reverse Maquet,
conceivably increasing patellofemoral
pressures. This may well explain the com
plications of late patellofemoral osteoar
thritis described by Crosby and Insall.12
Similarly, the Elmslie-Trillat procedure,
because a thin slab of bone is used, may
result in increased patellofem oral
pressure.
In young people, chondromalacia is
frequently but not always associated with
abnormal patellar tracking or a large Q
angle. We have not seen patients with
severe patellofemoral chondromalacia
who had a negative Q angle, and medi
alization would clearly be contraindicated
in such cases.
In the elderly and in those with
advanced patellofemoral osteoarthritis,
lateral patellar subluxation is almost the
rule. Skyline x-ray films of advanced
patellofemoral osteoarthritis show wear
ing down of the lateral trochlear ridge and
grooving of the lateral facet. A straight
forward tibial tubercle anteriorization
cannot restore normal tracking and sub
stantial medialization is required. In our
opinion complete loss of the lateral troch
lear ridge is a contraindication to this
procedure as is congenital absence of the
ridge (Fig. 3). In these rare cases, patel
lofemoral resurfacing is preferred. Sub
stantial medialization is difficult with a
classic Maquet technique, and several
reports have shown a high complication
rate with graft breakage, displacement
and absorption, and skin sloughs.7’8
The incidence of wound problems
tends to increase with the degree of anteri
orization as the skin becomes stretched
(Fig. 4). The subcutaneous tissue in this
region is of poor quality, especially in
very obese patients, in whom the majority
of problems in this series occurred.
There is disagreement about the degree
of anteriorization required to reduce
patellofemoral pressure substantially.
Maquet6 calculated that 2 cm were neces
sary to reduce patellofemoral pressure by
50%. Ferguson13 and Ferguson and
colleagues14 reported that an elevation of
13 mm reduced stress by 83.5%.
Nakamura and associates15 suggested

90

FIG. 4—Well-healed knee after Maquet procedure in which anteriorization was of con
siderable magnitude. This degree of anteriorization is greater than that normally required to
relieve patellofemoral symptoms and can present difficulties in wound healing.
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that a 1-cm elevation was optimal and
that roughly was followed in this series.
Any degree of rotation on the x-ray film
appreciably alters measurements of
advancement. In a series of routine x-ray
films, therefore, measurements would be
very inexact.
The present procedure of tibial tuber
cle anteromedialization combined with a
lateral release is quick and simple.
Because no bone graft is harvested from
elsewhere there is no problem with pain
at the graft site or graft absorption. With
the exception of one case of fracture, sub
sequent tuberosity displacement has not
proved a problem because the bone is held
rigidly by the AO screws. Complications
have been relatively few and results
reasonably good. It should be emphasized
that none of our patients were athletes.
Of considerable interest are the excel
lent results achieved in the elderly with
frank patellofemoral osteoarthritis. While
this disease is common in the elderly, it
is not usually symptomatic. This tech
nique has worked suprisingly well and in
the senior author’s hands has completely
obviated the necessity for patellectomy in
this age group.
All the patients in this study had sub
stantial articular cartilage damage. No
distinction has been made between patel
lofemoral osteoarthritis and chon
dromalacia as it is impossible pathologi
cally to distinguish between the two
conditions.
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BOOKS REVIEW S
continued from page 418
the orthopedic surgeon to treat these deformi
ties predictably and with success. The Manage
ment o f Spina! Deformities concisely reviews
these and other topics with the help of an
impressive list of international contributors.
Timely chapters, using the most recent infor
mation on the pathogenesis and epidemiology
of idiopathic scoliosis, have been included with
an excellent chapter on the biomechanics of spi
nal deformities. Biomechanics is also threaded
through each chapter skilfully and presented
in a readable fashion.
Most of the contributors have addressed var
ious aspects of idiopathic scoliosis and there
is a thorough review of infantile scoliosis.
Adult scoliosis and Scheuermann’s kyphosis
are also briefly discussed.
Each author provides an extensive bibliog
raphy citing the most recent information in
most instances. However, whenever a field is
progressing rapidly, some issues may be left
out. The method of interpedicular fixation and
the important use of spinal cord monitoring
are not covered in this book. This oversight
does not detract from this readable and highly
informative book, but merely points out the
ever-changing nature of the field.
The book is a welcome addition to the liter
ature on spinal deformities and should be read
by the resident staff and the general orthopedic
surgeon who is interested in keeping abreast
of this complex field.

Gordon W.D. A rmstrong, m d , frcsc
Chief,
Division of Orthopedic Surgery,
Ottawa Civic Hospital,
Ottawa, Ont.
K1Y 4E9
SILVERGIRL'S SURGERY. BILIARY
TRACT. Edited by James O. Robinson.
233 pp. Illust. Silvcrgirl, Inc., Austin, Tex.,
1985. $55., clothbound; $19. (US), paperbound. ISBN 9-941432-14-9.

This is the second of a 13-volume series on sur
gery, medicine and pediatrics to be published
by Silvergirl, Inc. Each volume will address a
subspecialty by presenting papers, with
editorial comment, that were important in the
development of the respective fields, in this case
the development of surgery of the biliary tract.
It is an attractive concept, and at least one
good reason for pursuing the idea was stated
in 1903 by Mayo-Robson, one of the surgeons
featured in this history: “ It is sometimes use
ful in surgical as well as in other matters to
pause and look backward, if this be done with
a mind open to find fault with its own past
acts.”
The volume is divided into nine parts. In my
view, one should begin by reading part 9, an
erudite and charming musing on some histor
ical figures and events. This chapter, read as
a preface, will arouse one’s interest.
Part 1, written in 1863 by Thudicum, dis
cusses the historical features of biliary surgery.
Thudicum reminds us that gallstones have been
recognized since 1500 BC, the earliest known
occurrence being an Egyptian priestess whose
mummy has been dissected. Trallianus and
Avicenna make reference to gallstones, partic
ularly as a medicament. Modern biliary sur
gery began in 1667 when Von der Weil and

Thilesius completed the drainage o f an
empyema necessitatis of the gallbladder.
Part 2 presents the contributions of several
famous surgeons from Jean-Louis Petit (1743)
to Lawson Tait (1879). John Bobbs of Indi
ana did the first cholecystotomy for the
removal o f stones, and Blodgett (1877),
another American, performed the first planned
cholecystostomy. His patient died and so did
the patient on whom Marion Sims operated in
1878. Although this operation took place in
Paris, both patient and surgeon were Ameri
cans. The patient died of bleeding, probably
because of vitamin K deficiency, a feature of
obstructive jaundice that was not understood
until Dam and Schonheyder (1929) and Quick
(1935) elucidated vitamin K deficiency in the
jaundiced patient. The redoubtable Swiss sur
geon Theodor Kocher in 1878 was the first to
have a patient survive cholecystostomy. He per
formed the operation in two stages.
Efforts to establish a safe cholecystoenterostomy are addressed in part 3, notably by
Murphy with his “ button” . Part 4 deals with
the establishment of cholecystectomy as the
operation of choice. Langenbuch has priority
here. One can imagine being at this landmark
operation as one attending a “ wet clinic” when
Langenbuch’s memorialist states that he
“ ...was not an operator of great excellence, but
much more a careful, thoughtful individual
who operated with only strong indications, but
then was sure and courageous, undaunted by
hindrances and equal to all bad occasions” .
Parts 5 and 6 deal with the advance of sur
gery into the bile ducts and with reconstruc
tive surgery of the injured bile duct. Abbe of
New York (1889) did the first choledochostomy
for gallstones. William Mayo was the first to
describe repair of the injured duct. In 1916 he
stated, “ It is the general experience that inju
ries to the common and hepatic ducts are
usually the result of various operative acci
dents. In the large majority of cases the acci
dent is not discovered at the time of operation”
— and this remains true today.
In part 7, Kelly and Noble describe chronic
pancreatitis, but curiously make no mention
of alcoholism as a cause. Best and Hicken dis
cuss papillary stenosis under the term of biliary
dyssynergia.
Evarts Graham gives an interesting account
of the discovery of cholecystography (1924) in
part 8. It is another story of how excellent
preparation was consummated by good luck,
and how either alone would not have sufficed.
Mirizzi of Argentina (1937) introduced oper
ative cholangiography, and Bean and
Mahorner of New Orleans (1972) were the first
to remove stones from the common bile duct
by means of Dormia baskets introduced
through the T-tube tract, using a steerable
angiography catheter. Credit is given to Oti,
Takemoto and Nakayama (1970) for introduc
ing fiberduodenoscopy and retrograde cannulation of the papilla of Vater, but William
McCune of Washington (1968) and his col
leagues should actually be given this credit.
This book is a welcome addition to the liter
ature of surgery of the biliary tract and to the
history of surgery.

J.E. Mullens , md , frcsc
Assistant secretary-treasurer,
The Canadian Medical Protective Association,
PO Box 8225,
Ottawa, Ont.
K1G 3H7

Calgary District
Hospital Group

Trauma Surgeon —
Director of
Trauma Care
Rockyview General
Hospital
The Rockyview General
Hospital, a 450 bed active
treatment hospital serving
Calgary and Southern Alberta, is
seeking an individual to become
Director of our Level 2 Trauma
Unit. This hospital is a
progressive, ultramodern facility
which already participates in
existing air and ground
prehospital transport
Responsibilites to coordinate
clinical activites of our Trauma
Unit and assist in the
development of a regional trauma
system.
To organize and be responsible
for ongoing clinical teaching
programs in trauma and clinical
research. To play an active role
in the Department of Surgery and
head the Division of Truama
Surgery.

Requirements — Board certified
General or Thoracic Surgeon with
special expertise and training in
trauma surgery. Non-smokers
preferred.

Replies should be directed to:
The Director of Surgery,
c/o Rockyview General
Hospital, 7007 - 14th
Street S.W., Calgary,
Alberta T2V 1P9.

Calgary District Hospital Group owns
and operates Rockyview General
Hospital, Holy Cross Hospital, Colonel
Belcher Hospital and Peter Lougheed
General Hospital
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The deadline is 1 month before issue
date. Regular classified rates (for each insertion): $38.00 for the first 40 words or less, additional words 45C each (additional $15.00 for frame). Special Display
under 75 words, 2 X
A" X 2" $95.00. $5.00 charge (first insertion only) for CJS box numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
GENERAL SURGEON: ON — w ith training and ex
perience in fracture surgery. The opening is avail
able im m ediately w ith staff privileges at St.
M ary's General Hospital, a 184-bed active tre a t
m ent fa c ility . This is an excellent opportunity to
establish a practice in a district referral centre,
w ith private office space available in a dow ntow n
professional building. The call schedule is shared
in cooperation w ith three other certified general
surgeons. Canadian certification is required. For
further inform ation contact: Mrs. Irene Krys, Ex
ecutive Director, St. Mary's General Hospital, 41
Pine St. North, Timmins, ON P4N 6K7. Tel.: (705)
2 6 7 -2 1 3 1 , ext. 21 20 or Dr. Rob Williams,
Chief of Staff, St. Mary's General Hospital,
(705) 2 6 8 -1 4 4 7 (office).
-S 8 6 -2 8
CLINICAL BURN FELLOWSHIP: - Six m onths or
tw elve months, Regional Adult Burn Centre,
Wellesley Hospital beginning January 1, 1987.
New ten-bed ultra-modern burn centre, 100 burns
per year. Position totally funded. Clinical research.
For more inform ation please contact: Dr. Walter
Peters, Ste. 22 4, Turner Wing, Wellesley Hospi
tal. 160 Wellesley St. E., Toronto, ON M 4Y 1J3.
Tel.: (416) 92 6-77 90.
-S 8 6 -2 7

ADVERTISERS' INDEX
Canadian Association of
General Surgeons
433

CARDIOVASCULAR & THORACIC SURGEON: AB
— required for a salaried position for a thoracic and
vascular practice. The candidate should hold
FRCSC in cardiovascular and thoracic surgery or
equivalent. As this is a non-cardiac surgical prac
tice at present, the candidate should have at least
tw o years' experience in thoracic surgery and
demonstrable experience in full-tim e research.
Post-fellowship level is essential. The candidate
should be eligible for a specialist's licence in A l
berta. Please refer all correspondence to: Dr. S.S.
Nakai, 214 Academy Place, 11520-100 Ave., Ed
monton, AB T5K 0J7.
-S 8 6 -2 9
GENERAL SURGEON: ON — required to replace
a general surgeon in the com munity of Deep River
situated on the Ottawa River approximately 200
km from O ttaw a. Fully accredited 35-bed active
treatm ent hospital w ith one OR. Practice draws
from a com m unity population o f 5000 and a
catchm ent area of approximately 8000. Current
medical staff includes four general practitioners
and one general surgeon. Excellent recreational fa
cilities. Apply to: Ellen Sills, Chairman, Deep River
& District Hospital Board, Box 307, Deep River,
ON K0J 1P0.
—S 86-30

VASCULAR SURGEON: - The Division of Vascu
lar Surgery at the Wellesley Hospital has an open
ing for a third vascular surgeon. The appointment
w ill be full time, w ill carry a university rank, and
the successful applicant will be expected to car
ry out teaching and research in addition to clini
cal activities. The division is accredited by the
Royal College of Physicians and Surgeons of
Canada for post-graduate vascular training. The
Wellesley Hospital is a fully affiliated teaching
hospital of the University of Toronto w ith 565 ac
tive beds and a full range of medical and surgical
services. Applications should be sent imme
diately to: Dr. John Provan, Surgeon-in-Chief,
Chief, Division of Vascular Surgery, 160 Welles
ley St. East, Ste. 217, E.K. Jones Building, Toron
to, ON M4Y 1J3.
—S86-22
MICROSURGICAL COURSE: — The Department
of Surgery, McMaster University is now offering
one week, on-going courses in microsurgery, us
ing animal facilities and videotapes. These courses
are for anyone interested in small vessel anasto
mosis, nerve repairs, vas and fallopian tube recon
structions. The laboratory is organized to guide
you through the basic microsurgical techniques to
more advanced tasks w ith the help o f an assis
tan t on a one-to-one basis. Please call: Dr. A. Thoma at (416) 523-0019 for further information.
—S 86-23

POSITION AVAILABLE
THE HOSPITAL FOR SICK CHILDREN
TORONTO, CANADA

Davis & Geek
Outside Back Cover
Applications are invited for a position of staff neu
rosurgeon in the Division of Neurosurgery, The Hospi
tal for Sick Children.

Ethicon Ltd.
Inside Front Cover

The neurosurgical division at The Hospital for Sick
Children is an active tertiary care unit with 53 beds,
which carries out 1000 operative procedures per year.

Glaxo Laboratories
Zantax
396, 407
Hoffm ann-La Roche Limited
Bactrim
390, 444

The successful candidate will have an academic ap
pointment, commensurate with his/her qualifications
in the Department of Surgery, University of Toronto.

Lederle
Pipracil

In accordance with Canadian Immigration rules this
advertisement is directed at Canadian citizens and
residents.

392, 434, Inside Back Cover

Rhone-Poulenc Pharma Inc.
Stemetil
410
The Trauma Association
of Canada
423
Upjohn Company of Canada. The
Dalacin CL 399, 400. 401
460

’
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Applications with curriculum vitae and a list of three
referees should be forwarded to:
Dr. Harold J. Hoffman
Neurosurgeon-in-chief
The Hospital for Sick Children
555 University Avenue
Toronto, Canada
M5G 1X8
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(piperacillin sodium)

ANTIBIOTIC THERAPY FOR P.I.D.
PIPRACIL"... appears to be both
efficacious and (relatively) safe for the
treatment of polymicrobial infections
encountered in obstetrics and
gynecology."1 (Gilstrap)

PIPRACIL was found to be the
most active beta-lactam against

B. frag His1 (Tally)

PIPRACIL provides highly effec
tive broad spectrum activity
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SKIN STAPLER

Staples are now
immediately, automatically
and completely released
regardless of direction of
stapler movement.
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S HOT
you’re used to
without
the problems
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problems- So we took catgut and made it
• soft and supple
. easy to tie
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DEXON* PLUS
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